M (2010-2017)

STUDIES ON CONDITIONS and RELATED ARTICLES 2010-2017


+Studies in 2000-2009 List
*Studies in Pre-2000 List

MACROPHAGES + (Your Body’s ‘Clean-up Crew’ Cells)
MACULAR DEGENERATION +
MAD COW/CRUETZFELDT-JACOB DISEASE + (See Also PRIONS)
MAGNETIC STIMULATION
MALARIA
MALE SEXUAL FUNCTION*+
MARFAN SYNDROME
MASSAGE
MAST CELLS (Immune Cells Involved With Allergies, Wound Healing and Fighting Germs)
MEDICAL MARIJUANA-STUDIES*+
MEIGE’S SYNDROME (See Pre-2000 List)
MEMORY (See IQ/MEMORY/COGNITIVE EFFECTS)
MENIERES SYNDROME (See News Articles 2010-2017)
MENINGITIS*
MENOPAUSE/OVARIECTOMY*+ (See Also AGING, GYNECOLOGY)
MENTAL DISORDERS (See SCHIZOPHRENIA/MENTAL DISORDERS, DEPRESSION, PTSD)
METABOLIC SYNDROME
METHODS OF USE-CAPSULES*+
METHODS OF USE-‘DABS’/HASH OIL/CONCENTRATES
METHODS OF USE-DECARBOXYLATION + (Method to Increase Potency)
METHODS OF USE-E-CIGARETTES
METHODS OF USE-EDIBLES (GENERAL)*+
METHODS-EDIBLES*+ (BEVERAGES, CANNABIS TEA – See News Articles 2010-2017)
METHODS-EDIBLES (BEVERAGES, OTHER)*+
METHODS-EDIBLES (FOODS)*+
METHODS-EDIBLES (RAW UNHEATED CANNABIS JUICE) +
METHODS-EDIBLES (RECIPES) +
METHODS OF USE–HASHISH
METHODS OF USE-INHALERS +
METHODS OF USE-INJECTION* DO NOT TRY! (See Also Pre-2000 Studies)
METHODS OF USE-NANOPLATFORMS/NANOPARTICLES Etc
METHODS OF USE-NASAL SPRAYS +
METHODS OF USE-RSO/RICK SIMPSON’S OIL/HEMP OIL/PHOENIX OIL +
METHODS OF USE-SECOND-HAND SMOKE
METHODS OF USE-SMOKING + (See Also SMOKED CANNABIS AS MEDICINE)
METHODS OF USE-SUPPOSITORIES/RECTAL USE
METHODS OF USE-TINCTURES +
METHODS OF USE-TOPICAL OINTMENTS +
METHODS OF USE-TRANSDERMAL PATCH*+
METHODS OF USE-VAPORIZERS*+
METHODS OF USE-VARIOUS/OTHER*+
MIDLIFE ADULT USE (Ages 30-65 in Humans)
MIGRAINE/HEADACHE*+
MILITARY and CANNABINOIDS
MISCELLANEOUS STUFF-STUDIES + (Fun Section-No Date Restrictions)
MITOCHONDRIA +
MORNING SICKNESS (See Also NAUSEA) +
MORTALITY RATES/DEATH*+
MOTION SICKNESS +
MRSA/METHICILLIN-RESISTANT STAPHLOCOCCUS AUREUS*+
MULTIPLE SCLEROSIS/MS*+
MULTIPLE SYSTEM ATROPHY
MUSCLES/MUSCLE RELAXANT +
MUSCULAR DYSTROPHY/MD*+
MYOCLONUS DIAPHRAGMATIC FLUTTER (See News Articles 2010-2017)


MACROPHAGES
Cannabinoid inhibition of macrophage migration to the trans-activating (Tat) protein of HIV-1 is linked to the CB(2) cannabinoid receptor (full-2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2846023/?tool=pubmed
Cannabidiol attenuates delayed-type hypersensitivity reactions via suppressing T-cell and macrophage reactivity (full-2010) http://www.nature.com/aps/journal/v31/n12/full/aps2010155a.html
Cannabinoid type 2 receptor activation downregulates stroke-induced classic and alternative brain macrophage/microglial activation concomitant to neuroprotection (full–2012) http://stroke.ahajournals.org/content/43/1/211.long
DAGLβ inhibition perturbs a lipid network involved in macrophage inflammatory responses (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3513945/
N-arachidonoyl glycine induces macrophage apoptosis via GPR18 (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22266325
The cannabinoid TRPA1 agonist cannabichromene inhibits nitric oxide production in macrophages and ameliorates murine colitis (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3632250/
Implication of the anti-inflammatory bioactive lipid prostaglandin D2-glycerol ester in the control of macrophage activation and inflammation by ABHD6 (full–2013) http://www.pnas.org/content/110/43/17558.long
Attenuation of HIV-1 replication in macrophages by cannabinoid receptor 2 agonists (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3629438/
The cannabinoid TRPA1 agonist cannabichromene inhibits nitric oxide production in macrophages and ameliorates murine colitis (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3632250/
Palmitoylethanolamide stimulates phagocytosis of Escherichia coli K1 by macrophages and increases the resistance of mice against infections (full-2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4080545/
The in vitro GcMAF effects on endocannabinoid system transcriptionomics, receptor formation and cell activity of autism-derived macrophages (full-2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3996516/
Δ(9)-Tetrahydrocannabinol treatment during human monocyte differentiation reduces macrophage susceptibility to HIV-1 infection (full–2014) http://www.ncbi.nlm.nih.gov/pubmed/24562630
Detailed characterization of the endocannabinoid system in human macrophages and foam cells and anti-inflammatory role of type-2 cannabinoid receptor (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24529123
Protective Role of CB2 Receptor Activation in Galactosamine/LPS-induced Acute Liver Failure Through Regulation of Macrophage Polarization and miRNAs (full–2015) http://jpet.aspetjournals.org/content/early/2015/03/06/jpet.114.220368.long
top
Inhibition of COX-2-mediated eicosanoid production plays a major role in the anti-inflammatory effects of the endocannabinoid N-docosahexaenoylethanolamine (DHEA) in macrophages (full–2015)  http://onlinelibrary.wiley.com/doi/10.1111/bph.12747/full
Activation of GPR55 Receptors Exacerbates oxLDL-Induced Lipid Accumulation and Inflammatory Responses, while Reducing Cholesterol Efflux from Human Macrophages (full-2015) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0126839
Primary Macrophage Chemotaxis Induced by Cannabinoid Receptor 2 Agonists Occurs Independently of the CB2 Receptor (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4451551/
Activation of Cannabinoid Type Two Receptors (CB2) Diminish Inflammatory Responses in Macrophages and Brain Endothelium (full–2015) http://tinyurl.com/pv5snej
Cannabinoid receptor 1 but not 2 mediates macrophage phagocytosis by G(α)i / o / RhoA / ROCK signaling pathway (full–2015) http://www.ncbi.nlm.nih.gov/pubmed/25545473

Lipid signaling in adipose tissue: Connecting inflammation & metabolism (abst–2015) http://www.sciencedirect.com/science/article/pii/S1388198114002091
Editorial: Lung macrophages high on cannabinoids: jamming PAMs and taming TAMs? (full–2016) http://www.jleukbio.org/content/99/4/518.full Targeting Cannabinoid CB2 Receptors in the Central Nervous System. Medicinal Chemistry Approaches with Focus on Neurodegenerative Disorders (full–2016) http://journal.frontiersin.org/article/10.3389/fnins.2016.00406/full Cannabinoid 2 Receptor Agonist Improves Systemic Sensitivity to Insulin in High-Fat Diet / Streptozotocin-Induced Diabetic Mice (full–2016) https://www.karger.com/Article/FullText/453171
Activation of Cannabinoid Receptor 2 Ameliorates DSS-Induced Colitis through Inhibiting NLRP3 Inflammasome in Macrophages (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5017608/
Decreased in vivo availability of the cannabinoid type 2 receptor in Alzheimer’s disease (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27488857
Selective activation of CB2 receptor improves efferocytosis in cultured macrophages (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27474129
Docosahexaenoyl Serotonin, an endogenously formed n-3 fatty acid-serotonin conjugate has anti-inflammatory properties by attenuating IL-23–IL-17 signalling in macrophages (abst–2016) http://www.sciencedirect.com/science/article/pii/S1388198116302499
Oxyradical Stress Increases the Biosynthesis of 2-Arachidonoylglycerol: Involvement of NADPH Oxidase (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27784678
The combination of β-caryophyllene, baicalin and catechin synergistically suppresses the proliferation and promotes the death of RAW267.4 macrophages in vitro (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27840942
Developmental Role of Macrophage Cannabinoid-1 Receptor Signaling in Type-2 Diabetes (abst–2017) http://diabetes.diabetesjournals.org/content/early/2017/01/11/db16-1199.long N-acylethanolamine-hydrolyzing acid amidase and fatty acid amide hydrolase inhibition differentially affect N-acylethanolamine levels and macrophage activation (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28065729


MACULAR DEGENERATION
Association between a genetic variant of type-1 cannabinoid receptor and inflammatory neurodegeneration in multiple sclerosis (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3877004/
The role of Cannabinoid receptors on light-induced photoreceptor degeneration (abst–2013) http://iovs.arvojournals.org/article.aspx?articleid=2149928&resultClick=1
Protective role of the cannabinoid receptor system in A2E-mediated photo-toxicity to retinal pigment epithelium (RPE) cells in an in-vitro model of age-related macular degeneration (AMD) (abst–2014) http://iovs.arvojournals.org/article.aspx?articleid=2271845&resultClick=1


MAD COW/CRUETZFELDT-JACOB DISEASE
Alteration of the endocannabinoid system in mouse brain during prion disease (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21195746


MAGNETIC STIMULATION
Anti-depressive mechanism of repetitive transcranial magnetic stimulation in rat: The role of the endocannabinoid system (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24479995
top


MALARIA
Effect of anandamide in Plasmodium Berghei-infected mice (full–2010) http://www.karger.com/Article/Pdf/320559
Adult mortality and blood feeding behavioral effects of α-amyrin acetate, a novel bioactive compound on in vivo exposed females of Anopheles stephensi Liston (Diptera: Culicidae) (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22167372
Cannabidiol attenuates the long lasting cognitive deficits and anxiogenic-like behaviors promoted by murine cerebral malaria (abst–2013) http://www.fasebj.org/cgi/content/meeting_abstract/27/1_MeetingAbstracts/1097.9?sid=eea722c0-971c-4daa-8b8c-38c0c63c19ad
Selected terpenoids from medicinal plants modulate endoplasmic reticulum stress in metabolic disorders (full–2014) http://onlinelibrary.wiley.com/doi/10.1111/jphp.12267/full
Cannabidiol increases survival and promotes rescue of cognitive function in a murine model of Cerebral Malaria (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25595981
Cannabinoid receptor 2 modulates susceptibility to experimental cerebral malaria through a CCL17-dependent mechanism (full–2016) http://www.jbc.org/content/early/2016/07/29/jbc.M116.746594.long
A systematic review of the effect of cannabidiol on cognitive function: Relevance to schizophrenia (abst–2016) http://www.sciencedirect.com/science/article/pii/S0149763416304390


MALE SEXUAL FUNCTION
Energetic Metabolism and Human Sperm Motility: Impact of CB1 Receptor Activation (full–2010) http://endo.endojournals.org/content/151/12/5882.full
Characterization of the Endocannabinoid System in Human Spermatozoa and Involvement of Transient Receptor Potential Vanilloid 1 Receptor in Their Fertilizing Ability (full–2010) http://endo.endojournals.org/content/150/10/4692.full?sid=f5b14012-9fbe-4f10-890c-386313060cf8
Human sperm anatomy: ultrastructural localization of the cannabinoid1 receptor and a potential role of anandamide in sperm survival and acrosome reaction (full–2010) http://onlinelibrary.wiley.com/doi/10.1002/ar.21042/full
Endocannabinoids and Human Sperm Cells (link to PDF–2010) http://www.mdpi.com/1424-8247/3/10/3200
Localization and function of cannabinoid receptors in the corpus cavernosum: basis for modulation of nitric oxide synthase nerve activity (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/19147270
Anandamide capacitates bull spermatozoa through CB1 and TRPV1 activation (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3037938/?tool=pubmed
Treatment with tetrahydrocannabinol (THC) prevents infertility in male cystic fibrosis mice (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/22865360
Effect of capacitation on the endocannabinoid system of mouse sperm (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21723369
top
Anandamide Induces Sperm Release from Oviductal Epithelia through Nitric Oxide Pathway in Bovines (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3281848/?tool=pubmed
Differences in the endocannabinoid system of sperm from fertile and infertile men (full–2012) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0047704
Sex Hormones Levels as Influenced by Cannabis sativa in Rats and Men (full–2012) http://scialert.net/qredirect.php?doi=pjn.2012.419.422&linkid=pdf
Anandamide regulates the expression of GnRH1, GnRH2, and GnRH-Rs in frog testis (full–2012) http://ajpendo.physiology.org/content/303/4/E475.long
Minireview: Endocannabinoids and Gonadal Hormones: Bidirectional Interactions in Physiology and Behavior (full–2012) http://press.endocrine.org/doi/full/10.1210/en.2011-1643
The role of endocannabinoids in gonadal function and fertility along the evolutionary axis (full–2012) http://www.sciencedirect.com/science/article/pii/S0303720712000445
Impact of reference gene selection for type 2 cannabinoid receptor gene expression studies in human spermatozoa (abst–2012) http://onlinelibrary.wiley.com/doi/10.1111/and.12006/abstract
Long-term use of HU210 adversely affects spermatogenesis in rats by modulating the endocannabinoid system (abst–2012) http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2605.2012.01259.x/abstract
Honokiol attenuates torsion/detorsion-induced testicular injury in rat testis by way of suppressing endoplasmic reticulum stress-related apoptosis (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22285174
Treatment with CB 2 Agonist JWH-133 Reduces Histological Features Associated with Erectile Dysfunction in Hypercholesterolemic Mice (full–2013) http://www.hindawi.com/journals/cdi/2013/263846/
Estrogens and Spermiogenesis: New Insights from Type 1 Cannabinoid Receptor Knockout Mice (full–2013) http://www.hindawi.com/journals/ije/2013/501350/
Anandamide Levels Fluctuate in the Bovine Oviduct during the Oestrous Cycle (full–2013) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0072521
The Endocannabinoid System and Spermatogenesis (full–2013)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3864102/
Endocannabinoids as markers of sperm quality: hot spots (full–2013) http://www.frontiersin.org/Journal/10.3389/fendo.2013.00169/full
Brain Levels of Prostaglandins, Endocannabinoids, and Related Lipids Are Affected by Mating Strategies (full–2013) http://www.hindawi.com/journals/ije/2013/436252/
Low 17beta-Estradiol Levels in Cnr1 Knock-Out Mice Affect Spermatid Chromatin Remodeling by Interfering with Chromatin Reorganization (full–2013) http://www.biolreprod.org/content/88/6/152.long
top
Anandamide modulates human sperm motility: implications for men with asthenozoospermia and oligoasthenoteratozoospermia (full–2013) http://humrep.oxfordjournals.org/content/28/8/2058.long
Endocannabinoids are Involved in Male Vertebrate Reproduction: Regulatory Mechanisms at Central and Gonadal Level (full–2014) http://journal.frontiersin.org/Journal/10.3389/fendo.2014.00054/full
A role for endocannabinoids in acute stress-induced suppression of the hypothalamic pituitary-gonadal axis in male rats (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3913894/
Involvement of cannabinoid receptor-1 activation in mitochondrial depolarizing effect of lipopolysaccharide in human spermatozoa (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/24692267
Endocannabinoids as biomarkers of human reproduction (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24516083
The biological networks in studying cell signal transduction complexity: The examples of sperm capacitation and of endocannabinoid system (full–2014)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4212279/
Priapism in a patient with sickle cell trait using marijuana (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24798364
Low anandamide doses facilitate male rat sexual behaviour through the activation of CB1 receptors (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24671517
Cannabinoid receptor type 1 receptors on GABAergic vs. glutamatergic neurons differentially gate sex-dependent social interest in mice (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24698342
Fenitrothion action at the endocannabinoid system leading to spermatotoxicity in Wistar rats (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24998969
Type 2 cannabinoid receptor contributes to the physiological regulation of
spermatogenesis (full–2015)  http://www.fasebj.org/content/early/2015/12/15/fj.15-279034.long
Anandamide Reduces the Ejaculatory Threshold of Sexually Sluggish Male Rats: Possible Relevance for Human Lifelong Delayed Ejaculation Disorder (abst–2015)  http://www.ncbi.nlm.nih.gov/pubmed/25808995
Biphasic effects of anandamide on behavioural responses: emphasis on copulatory behaviour (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26226145
Anandamide acts via kisspeptin in the regulation of testicular activity of the frog, Pelophylax esculentus (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26586207
Biphasic effects of anandamide on behavioural responses: emphasis on copulatory behaviour (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26226145
top
Effects of Neuroendocrine CB1 Activity on Adult Leydig Cells (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4891325/
Characterization of non-olfactory GPCRs in human sperm with a focus on GPR18 (full–2016) http://www.nature.com/articles/srep32255
Progesterone and Endocannabinoid Interaction Alters Sperm Activation (full–2016) http://www.biolreprod.org/content/95/1/9.long
Sexual dysfunction in men diagnosed as substance use disorder (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26940022
Unconventional endocannabinoid signaling governs sperm activation via sex hormone progesterone (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26989199
PnPP-19, a spider toxin peptide, induces peripheral antinociception through opioid and cannabinoid receptors and inhibition of neutral endopeptidase (abst–2016) http://onlinelibrary.wiley.com/doi/10.1111/bph.13448/abstract
2-arachidonoylglycerol levels are increased in leukocytospermia and correlate with seminal macrophages (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27863106
Intra-VTA anandamide infusion produces dose-based biphasic effects on male rat sexual behavior expression (abst–2016) http://www.sciencedirect.com/science/article/pii/S0091305716302258
Developmental Patterns of Adolescent Marijuana and Alcohol Use and Their Joint Association with Sexual Risk Behavior and Outcomes in Young Adulthood (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28083726


MARFAN SYNDROME
Regarding Marfan Syndrome (forum post–2010) http://forum.grasscity.com/medical-marijuana-usage-applications/708198-regarding-marfan-syndrome.html


MASSAGE
Care and Feeding of the Endocannabinoid System: A Systematic Review of Potential Clinical Interventions that Upregulate the Endocannabinoid System (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3951193/
Endocannabinoids and related lipids in blood plasma following touch massage: a randomised, crossover study (full–2015) http://bmcresnotes.biomedcentral.com/articles/10.1186/s13104-015-1450-z


MAST CELLS
Systemic mastocytosis and medical marijuana (case report- undated) http://cannabisclinicians.org/view-all-case-reports/entry/645/
Acute administration of cannabidiol in vivo suppresses ischaemia-induced cardiac arrhythmias and reduces infarct size when given at reperfusion (full–2010)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2936031/?tool=pubmed
Cannabidiol Reduces Intestinal Inflammation through the Control of Neuroimmune Axis (full–2011) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0028159
Cannabinoid receptor-2 (CB2) agonist ameliorates colitis in IL-10(-/-) mice by attenuating the activation of T cells and promoting their apoptosis (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4117838/
New cannabinoid-like chromane and chromene derivatives from Rhododendron anthopogonoides (full–2011) https://www.jstage.jst.go.jp/article/cpb/59/11/59_11_1409/_pdf
CB1 receptors mediate rimonabant-induced pruritic responses in mice: investigation of locus of action (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3606913/
Effects of palmitoylethanolamide on release of mast cell peptidases and neurotrophic factors after spinal cord injury (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21354467
Endocannabinoids inhibit release of nerve growth factor by inflammation-activated mast cells (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21601562
Mast cell-glia axis in neuroinflammation and therapeutic potential of the anandamide congener palmitoylethanolamide (full-2012) http://rstb.royalsocietypublishing.org/content/367/1607/3312.long
top
Inhibitory effect of topical adelmidrol on antigen-induced skin wheal and mast cell behavior in a canine model of allergic dermatitis (full–2012) http://www.biomedcentral.com/1746-6148/8/230
Endocannabinoids limit excessive mast cell maturation and activation in human skin (full–2012) http://www.jacionline.org/article/S0091-6749%2811%2901796-9/fulltext
Amyotrophic lateral sclerosis treatment with ultramicronized palmitoylethanolamide: a case report (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22998138
The Role of Cannabinoids In Inflammatory Modulation of Allergic Respiratory Disorders, Inflammatory Pain and Ischemic Stroke (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22420307
Palmitoylethanolamide reduces early renal dysfunction and injury caused by experimental ischemia and reperfusion in mice (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22772472
Cannabinoid receptor type 1 and 2 expression in the skin of healthy dogs and dogs with atopic dermatitis (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22738050
Treatment of chronic regional pain syndrome type 1 with palmitoylethanolamide and topical ketamine cream: modulation of nonneuronal cells (full-2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3643547/
Cannabinoid receptor 1 controls human mucosal-type mast cell degranulation and maturation in situ (full–2013) http://www.jacionline.org/article/S0091-6749%2813%2900057-2/fulltext
The Dual Effect of Cannabinoid Receptor-1 Deficiency on the Murine Postoperative Ileus (full–2013) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0067427
New insights in mast cell modulation by palmitoylethanolamide (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23394523
Non-neuronal cell modulation relieves neuropathic pain: efficacy of the endogenous lipid palmitoylethanolamide (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23394519
Glia and Mast Cells as Targets for Palmitoylethanolamide, an Anti-inflammatory and Neuroprotective Lipid Mediator (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23813098
Vestibulodynia: synergy between palmitoylethanolamide + transpolydatin and transcutaneous electrical nerve stimulation (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23343704
Palmitoylethanolamide is a new possible pharmacological treatment for the inflammation associated with trauma (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/22697514
top
Increased levels of palmitoylethanolamide and other bioactive lipid mediators and enhanced local mast cell proliferation in canine atopic dermatitis (full–2014) http://www.biomedcentral.com/1746-6148/10/21
Characterization of endocannabinoid-mediated induction of myeloid-derived suppressor cells involving mast cells and MCP-1 (full–2014) http://www.jleukbio.org/content/95/4/609.long
Palmitoylethanolamide regulates development of intestinal radiation injury in a mast celldependent manner (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24848354
Targeting inflammation: new therapeutic approaches in chronic kidney disease (CKD) (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24602801
Palmitoylethanolamide inhibits rMCP-5 expression by regulating MITF activation in rat chronic granulomatous inflammation (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24440533
Palmitoylethanolamide, a naturally occurring disease-modifying agent in neuropathic pain (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24178954
Life Threatening Idiopathic Recurrent Angioedema Responding to Cannabis (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26257969
Cannabinoid receptor-specific mechanisms to ameliorate pain in sickle cell anemia via inhibition of mast cell activation and neurogenic inflammation (link to PDF–2015) http://www.haematologica.org/content/early/2015/12/21/haematol.2015.136523.long
Critical Role of Mast Cells and Peroxisome Proliferator-Activated Receptor γ in the Induction of Myeloid-Derived Suppressor Cells by Marijuana Cannabidiol In Vivo (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25917103
Critical Role of Mast Cells and Peroxisome Proliferator-Activated Receptor γ in the Induction of Myeloid-Derived Suppressor Cells by Marijuana Cannabidiol In Vivo (full–2015) http://www.jimmunol.org/content/194/11/5211.long
Selective Cannabinoid Receptor-1 Agonists Regulate Mast Cell Activation in an Oxazolone-Induced Atopic Dermatitis Model (full–2016) http://anndermatol.org/DOIx.php?id=10.5021/ad.2016.28.1.22
Palmitoylethanolamide reduces inflammation and itch in a mouse model of contact allergic dermatitis (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27720681


MEDICAL MARIJUANA-STUDIES
MEDICINAL USE OF CANNABIS: HISTORY AND CURRENT STATUS (full–undated) http://www.parl.gc.ca/content/sen/committee/371/ille/presentation/kalant-e.htm
Indian hemp and the dope fiends of Old England (article-undated) http://www.idmu.co.uk/indian.htm
Medical Marijuana and the Law (full-2010) http://content.nejm.org/cgi/content/full/362/16/1453?maxtoshow=&hits=80&RESULTFORMAT=&fulltext=cannabinoid&searchid=1&FIRSTINDEX=2080&resourcetype=HWCIT
DEA Listing of Approved Drug Products Containing Dronabinol in Schedule III (full–2010) http://www.deadiversion.usdoj.gov/fed_regs/rules/2010/fr1101.htm
Necessity or nastiness? The hidden law denying cannabis for medical use (full/news–2010) http://profdavidnutt.wordpress.com/2010/12/13/necessity-or-nastiness-the-hidden-law-denying-cannabisfor-medicinal-use/
Illicit and Nonmedical Drug Use Among Older Adults: A Review (link to PDF–2010) http://journals.sagepub.com/doi/abs/10.1177/0898264310386224
Accommodating the medical use of marijuana: surveying the differing legal approaches in Australia, the United States and Canada (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20329455
Denial of hepatic transplantation on the basis of smoking: is it ethical? (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20154621
Medical Marijuana Laws, Traffic Fatalities, and Alcohol Consumption (full–2011) http://ftp.iza.org/dp6112.pdf
top
An Analysis of Applicants Presenting to a Medical Marijuana Specialty Practice in California (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3673028/
The prevalence of cannabis-involved driving in California (full–2011) http://www.sciencedirect.com/science/article/pii/S0376871611004741
Medical marijuana: medical necessity versus political agenda (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3628147/
“But my Doctor Recommended Pot”: Medical Marijuana and the Patient-Physician Relationship (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3208453/
Popular intoxicants: what lessons can be learned from the last 40 years of alcohol and cannabis regulation? (full–2011) http://www.lufg.com.au/files/media/Popular_intoxicants_what_lessons_can_be_learned.pdf
The intersection between cannabis and cancer in the United States (full–2011) http://www.croh-online.com/article/S1040-8428(11)00231-9/fulltext
Examining the Health and Drug Exposures among Canadian Children Residing in Drug Producing Homes (abst–2011) http://www.jpeds.com/article/S0022-3476%2811%2900522-1/abstract
Medical cannabis: the opportunity versus the temptation (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/22352284
Assessment of hospice health professionals’ knowledge, views, and experience with medical marijuana (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/22077541
The Rhode Island medical marijuana program: an exploratory study (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21511683
High on Life? Medical Marijuana Laws and Suicide (full–2012) http://ftp.iza.org/dp6280.pdf
Medical Marijuana Laws and Teen Marijuana Use (full–2012) http://ftp.iza.org/dp6592.pdf
The medicalisation of revolt: a sociological analysis of medical cannabis users (full–2012) http://onlinelibrary.wiley.com/doi/10.1111/j.1467-9566.2012.01476.x/full
Clinical Service Desires of Medical Cannabis Patients (full–2012) http://www.harmreductionjournal.com/content/pdf/1477-7517-9-12.pdf
Blurred Boundaries: The Therapeutics and Politics of Medical Marijuana (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3538401/
Societal images of Cannabis use: comparing three countries (full–2012) http://www.harmreductionjournal.com/content/pdf/1477-7517-9-21.pdf
Exploring the ecological association between crime and medical marijuana dispensaries (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3364319/
Medical marijuana laws in 50 states: Investigating the relationship between state legalization of medical marijuana and marijuana use, abuse and dependence (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3251168/
Medical marijuana: the supremacy clause, federalism, and the interplay between state and federal laws (full–2012) http://fas.org/sgp/crs/misc/R42398.pdf
It can’t hurt to ask; a patient-centered quality of service assessment of health Canada’s medical cannabis policy and program (full–2012) http://www.harmreductionjournal.com/content/9/1/2
Cannabis as a substitute for alcohol and other drugs: A dispensary-based survey of substitution effect in Canadian medical cannabis patients (full–2012) https://philippelucasvictoria.files.wordpress.com/2012/12/rx-mj-as-a-substitute-for-aod-addiction-researchand-theory-2012-in-press.pdf
top
Do medical marijuana laws increase marijuana use? Replication study and extension (full–2012) http://www.annalsofepidemiology.org/article/S1047-2797%2811%2900372-3/fulltext
Cannabis—A Valuable Drug That Deserves Better Treatment (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3498425/ P
Prospectively Surveying Health-Related Quality of Life and Symptom Relief in a Lot Based Sample of Medical Cannabis-Using Patients in Urban Washington State Reveals Managed Chronic Illness and Debility (full–2012) http://journals.sagepub.com/doi/full/10.1177/1049909112454215
The medicalisation of revolt: a sociological analysis of medical cannabis users (link to PDF–2012) http://www.stcm.ch/en/files/paper_pedersen—sandberg.pdf
The New Politics of Marijuana Legalization: Why Opinion is Changing (full–2013) http://www.brookings.edu/research/papers/2013/05/29-politics-marijuana-legalization-galston-dionne
Medical Marijuana and Related Legal Aspects (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3875249/
Colorado family physicians’ attitudes toward medical marijuana (full–2013) http://www.jabfm.org/content/26/1/52.long
The pharmacologic and clinical effects of medical cannabis (full–2013) http://onlinelibrary.wiley.com/doi/10.1002/phar.1187/full
Legalization of medical marijuana and marijuana use among youths (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3638722/
Availability of tobacco products associated with use of marijuana cigars (blunts) (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3883305/
Effects of State Medical Marijuana Laws on Adolescent Marijuana Use (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4007871/
Cannabis for therapeutic purposes: Patient characteristics, access, and reasons for use (full–2013) http://www.ijdp.org/article/S0955-3959%2813%2900135-7/fulltext
The economic geography of medical cannabis dispensaries in California (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4162636/
Establishing expertise: Canadian community-based medical cannabis dispensaries as embodied health movement organisations (full–2013) http://www.ijdp.org/article/S0955-3959%2813%2900232-6/fulltext
Using cannabis to help you sleep: Heightened frequency of medical cannabis use among those with PTSD (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3929256/
Evaluation of trends in marijuana toxicosis in dogs living in a state with legalized medical marijuana: 125 dogs (2005-2010) (full–2013) http://onlinelibrary.wiley.com/doi/10.1111/j.1476-4431.2012.00818.x/full
The role of child protection in cannabis grow-operations (full–2013) http://www.canorml.org/child.welfare.pdf
Clinical decisions. Medicinal use of marijuana-polling results (article–2013) http://www.nejm.org/doi/full/10.1056/NEJMclde1305159
Medical Marijuana Coverage Still Lost in the Legal Weeds (article–2013) http://www.managedcaremag.com/linkout/2013/1/23
Integrating Cannabis Into Clinical Care (article–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3875042/
(Re)introducing medicinal cannabis (article–2013) https://www.mja.com.au/journal/2013/199/11/reintroducing-medicinal-cannabis
Medicinal Cannabis and Painful Sensory Neuropathy (editorial–2013) http://virtualmentor.ama-assn.org/2013/05/oped1-1305.html
top
Cannabis and the Lung: No More Smoking Gun? (editorial–2013) http://www.atsjournals.org/doi/abs/10.1513/AnnalsATS.201302-034ED?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed&
Correspondence (letter to the editor): Cannabis Therapy (letter–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3601285/
Anticipated Medical Effects on Children From Legalization of Marijuana in Colorado and Washington State (1st page–2013) http://archpedi.jamanetwork.com/article.aspx?articleid=1691419&resultClick=3
A review of the cultivation and processing of cannabis (Cannabis sativa L.) for production of prescription medicines in the UK (full–2013) http://onlinelibrary.wiley.com/doi/10.1002/dta.1531/full
Effects of Schedule I drug laws on neuroscience research and treatment innovation (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23756634
From 32 ounces to zero: a medical geographic study of dispensing a cultivated batch of “plum” cannabis flowers to medical marijuana patients in Washington State (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23909002
Characteristics of adults seeking medical marijuana certification (abst-2013) http://www.ncbi.nlm.nih.gov/pubmed/23683791
The medicinal use of cannabis and cannabinoids–an international cross-sectional survey on administration forms (abst–2013) http://www.unboundmedicine.com/medline/citation/24175484/The_medicinal_use_of_cannabis_and_cannabinoids–an_international_cross-sectional_survey_on_administration_forms.
Still Dazed and Confused: Midlife Marijuana Use by the Baby Boom Generation (abst–2013) http://www.tandfonline.com/doi/abs/10.1080/01639625.2014.889994
Prescribing smoked cannabis for chronic noncancer pain: Preliminary recommendations (full–2014) http://www.cfp.ca/content/60/12/1083.long
The Effect of Medical Marijuana Laws on Crime: Evidence from State Panel Data, 1990-2006 (full–2014)  http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0092816
Physicians, Medical Marijuana, and the Law (full–2014) http://journalofethics.ama-assn.org/2014/09/hlaw1-1409.html
The DEA: Four Decades of Impeding And Rejecting Science (full–2014) http://www.drugpolicy.org/sites/default/files/DPA-MAPS_DEA_Science_Final.pdf
2012 Division of Medicinal Chemistry Award Address: Trekking the Cannabinoid Road: A Personal Perspective (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4064474/
PTSD symptom reports of patients evaluated for the New Mexico Medical Cannabis Program (full–2014)  http://www.tandfonline.com/doi/full/10.1080/02791072.2013.873843#tabModule
Rheumatologists lack confidence in their knowledge of cannabinoids pertaining to the management of rheumatic complaints (full–2014)  http://www.biomedcentral.com/content/pdf/1471-2474-15-258.pdf
top
Does the legalization of medical marijuana increase completed suicide? (full–2014) http://informahealthcare.com/doi/full/10.3109/00952990.2014.910520
Health Poll – Legalizing Marijuana (full–2014) http://truvenhealth.com/Portals/0/NPR-Truven-HealthPoll/TRU_13728_0414_NPRPulseMarijuanaStudy.pdf
The Impact of State Medical Marijuana Legislation on Adolescent Marijuana Use (full–2014) http://www.jahonline.org/article/S1054-139X%2814%2900107-4/pdf
Political and medical views on medical marijuana and its future (full–2014) http://www.tandfonline.com/doi/full/10.1080/19371918.2013.821351
Words Can Be Deceiving: A Review of Variation Among Legally Effective Medical Marijuana Laws in the United States (full–2014)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4314612/
Physicians as gatekeepers in the use of medical marijuana (full–2014) http://www.jaapl.org/content/39/4/460.long
Medical Cannabis Laws and Opioid Analgesic Overdose Mortality in the United States, 1999-2010 (full–2014) http://archinte.jamanetwork.com/article.aspx?articleid=1898878
Medical marijuana: more questions than answers (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4243838/
High-Intensity Cannabis Use and Adherence to Antiretroviral Therapy Among People Who Use Illicit Drugs in a Canadian Setting (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4289662/
Positive posttraumatic stress disorder screens among first-time medical cannabis patients: Prevalence and association with other substance use (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4299455/
The Medicinal Cannabis Treatment Agreement: Providing Information to Chronic Pain Patients via a Written Document (full–2014) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4417655/
Cannabis Use and its Effects on Health, Education and Labor Market Success (link to PDF-2014) http://papers.ssrn.com/sol3/papers.cfm?abstract_id=2414469
Pharmacological management of chronic neuropathic pain: Revised consensus statement from the Canadian Pain Society (full–2014) http://tinyurl.com/p7ugyjf
Marijuana Resource Center: State Laws Related to Marijuana (article–2014) http://www.whitehouse.gov/ondcp/state-laws-related-to-marijuana
Up in smoke: A neurologist’s approach to “medical marijuana” (article–2014) http://onlinelibrary.wiley.com/doi/10.1002/ana.24327/full
Medical marijuana: 4 experts on benefits vs. risks (article–2014) https://www.elsevier.com/connect/medical-marijuana-4-experts-on-benefits-vs-risks
A Review and Critique of Dr. Sanjay Gupta’s Weed 2: Cannabis Madness on CNN (article–2014) http://cms.herbalgram.org/heg/volume11/04April/CNNGupataWEED2critique.html
Medical Marijuana Laws and Suicides by Gender and Age (abst–2014) http://ajph.aphapublications.org/doi/abs/10.2105/AJPH.2013.301612?journalCode=ajph
Self-reported cannabis use characteristics, patterns and helpfulness among medical cannabis users (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24205805
Therapeutic Satisfaction and Subjective Effects of Different Strains of Pharmaceutical Grade Cannabis (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24747979
The Effect of Medical Marijuana Laws on Marijuana, Alcohol, and Hard Drug Use (abst–2014) http://www.nber.org/papers/w20085#fromrss
Assessing Marijuana Use in Bariatric Surgery Candidates: Should It Be a Contra-indication? (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24913244
top
Barriers to access for Canadians who use cannabis for therapeutic purposes (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24947993
Medical use of cannabis in Australia: “medical necessity” defences under current Australian law and avenues for reform (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25087368
Growing medicine: Small-scale cannabis cultivation for medical purposes in six different countries (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25123694
Legalising medical use of cannabis in South Africa: Is the empirical evidence sufficient to support policy shifts in this direction? (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25214244
Prevalence of medical marijuana use in California, 2012. (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/25255903
Use and medicalization of marihuana in cancer patients (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25508539
Re-branding cannabis: the next generation of chronic pain medicine? (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25537695
Medical marijuana and children (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25647865
Patterns of medical marijuana use among individuals sampled from medical marijuana dispensaries in los angeles (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25188696
Therapeutic Potential of Cannabinoids—Perspectives for the Future (abst–2014)
http://www.ingentaconnect.com/search/article?option1=tka&value1=cannabinoid&sortDescending=true&sortField=prism_publicationDate&pageSize=10&index=120
The Impact of Marijuana Policies on Youth: Clinical, Research, and Legal Update (full–2015) http://pediatrics.aappublications.org/content/early/2015/01/20/peds.2014-4147.long
Medical marijuana: Policy topic for 2015 APhA House of Delegates (full–2015) http://japha.org/article.aspx?articleid=2090052
Illegal drugs laws: clearing a 50-year-old obstacle to research (full–2015) http://journals.plos.org/plosbiology/article?id=10.1371/journal.pbio.1002047
Cannabis in medicine: a national educational needs assessment among Canadian physicians (full–2015) http://www.molecularneurodegeneration.com/content/pdf/s13024-015-0012-0.pdf
High prevalence of cannabis use among Aka foragers of the Congo Basin and its possible relationship to helminthiasis (full–2015) http://onlinelibrary.wiley.com/doi/10.1002/ajhb.22740/full
top
Use of Prescription Pain Medications Among Medical Cannabis Patients: Comparisons of Pain Levels, Functioning, and Patterns of Alcohol and Other Drug Use (full–2015) http://ssw.umich.edu/sites/default/files/documents/news/use-of-prescription-pain-medications-amongmedical-cannabis-patients.pdf
The cannabis conundrum: Thinking outside the THC box (full–2015) http://onlinelibrary.wiley.com/doi/10.1002/jcph.511/full
Medical marijuana laws and adolescent marijuana use in the USA from 1991 to 2014: results from annual, repeated cross-sectional surveys (full–2015) http://press.thelancet.com/AdolescentMarijuana.pdf
Current Status and Future of Cannabis Research (full–2015) http://cannabisclinicians.org/wp-content/uploads/2015/05/Russo-et-al-Current-status-and-future-ofcannabis-research-Clin-Researcher-2015.pdf
Levels of selected metals in leaves of Cannabis sativa L. cultivated in Ethiopia (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4503701/
Stigma among California’s Medical Marijuana Patients (full–2015) http://www.ncbi.nlm.nih.gov/pubmed/25715067
PROGRESS REPORT Compassionate Use of Medical Cannabis Pilot Program Act July 1, 2014 through June 30, 2015 (full–2015) http://dph.illinois.gov/sites/default/files/publications/publicationohpmmedical-cannabis-annual-report-2015.pdf
Cannabis – the Israeli perspective (full–2015) http://www.degruyter.com/view/j/jbcpp.ahead-of-print/jbcpp-2015-0091/jbcpp-2015-0091.xml
Plant derived substances with anti-cancer activity: from folklore to practice (full–2015) http://journal.frontiersin.org/article/10.3389/fpls.2015.00799/full
Small Molecules from Nature Targeting G-Protein Coupled Cannabinoid Receptors: Potential Leads for Drug Discovery and Development (full–2015)
http://www.hindawi.com/journals/ecam/2015/238482/
Human rights, public health and medicinal cannabis use (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4662098/
Prevalence and determinants of cannabinoid prescription for the management of chronic noncancer pain: a postal survey of physicians in the Abitibi-Témiscamingue region of Quebec (full–2015) http://cmajopen.ca/content/3/2/E251.full?sid=139f05c1-b441-476b-99ff-addf8c918e1a
Cannabinoids for Medical Use A Systematic Review and Meta-analysis (full–2015) http://jama.jamanetwork.com/article.aspx?articleid=2338251&resultClick=24
Narrative review of the safety and efficacy of marijuana for the treatment of commonly state-approved medical and psychiatric disorders (full–2015)
http://ascpjournal.biomedcentral.com/articles/10.1186/s13722-015-0032-7
Public opinion and medical cannabis policies: examining the role of underlying beliefs and national medical cannabis policies (full–2015) http://harmreductionjournal.biomedcentral.com/articles/10.1186/s12954-015-0082-x
Medical marijuana’s public health lessons-implications for retail marijuana in Colorado (full–2015) http://www.nejm.org/doi/full/10.1056/NEJMp1500043
Medical marijuana: review of the science and implications for developmental-behavioral pediatric practice (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4318349/
top
Cannabinoids for Medical Use: A Systematic Review and Meta-analysis (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26103030
Cannabinoids for Medical Use: A Systematic Review and Meta-analysis (full–2015) http://jama.jamanetwork.com/article.aspx?articleid=2338251
U.S. Policy Responses to Calls for the Medical Use of Cannabis (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4553645/
Medicinal cannabis (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4674028/ Medical Marijuana for Treatment of Chronic Pain and Other Medical and Psychiatric Problems: A Clinical Review (full–2015) http://jama.jamanetwork.com/article.aspx? articleid=2338266
Marijuana Legalization: Impact on Physicians and Public Health (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4900958/
Medical Marijuana: Is the Cart Before the Horse? (1st page–2015) http://jama.jamanetwork.com/article.aspx?articleid=2338230
Sequelae of Cannabis as Medicine (full–2015) http://painmedicine.oxfordjournals.org/content/16/7/1447
Responsible and controlled use: Older cannabis users and harm reduction (full–2015) http://www.ijdp.org/article/S0955-3959(15)00075-4/fulltext
Overcoming the Bell-Shaped Dose-Response of Cannabidiol by Using Cannabis Extract Enriched in Cannabidiol (full–2015) http://file.scirp.org/Html/5-2500582_53912.htm
THE EFFECT OF MEDICAL MARIJUANA LAWS ON BODY WEIGHT (full–2015) http://www.os-extra.cannabisclinicians.org/wp-content/uploads/2016/03/MMJ_laws_Body-weight.pdf
An Overview of Products and Bias in Research (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4604179/
ADOLESCENTS’ USE OF MEDICAL MARIJUANA: A SECONDARY ANALYSIS OF MONITORING THE FUTURE DATA (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4514911/
Marijuana: A Time-Honored but Untested Treatment for Epilepsy (full–2015) https://www.cambridge.org/core/journals/canadian-journal-of-neurological-sciences/article/divclasstitlemarijuana-a-time-honored-but-untested-treatment-forepilepsydiv/DDEDDD9EAA09918D3D69CC7CA047AE5C/core-reader
Clinical perspectives on medical marijuana (cannabis) for neurologic disorders (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4549715/
Cannabis microbiome sequencing reveals several mycotoxic fungi native to dispensary grade Cannabis flowers (link to PDF–2015) http://r.search.yahoo.com/_ylt=AwrTcdRexG1XgyoAtagnnIlQ;_ylu=X3oDMTEyanRsZ2RrBGNvbG8DZ3 ExBHBvcwMxBHZ0aWQDQjIyNzRfMQRzZWMDc3I-/RV=2/RE=1466840287/RO=10/RU=http%3a%2f%2fbiorxiv.org%2fcontent%2fbiorxiv%2fearly%2f2015%2f11%2f06%2f030775.full.pdf/RK=0/RS=7LyvwyweD2gvwo06N_0cEX_XySE
Assessment of Israeli Physicians’ Knowledge, Experience and Attitudes towards Medical Cannabis: A Pilot Study (link to PDF–2015)
http://www.ima.org.il/IMAJ/ViewArticle.aspx?year=2015&month=07&page=437
Do Medical Marijuana Laws Reduce Addictions and Deaths Related to Pain Killers? (link to download-2015) http://r.search.yahoo.com/_ylt=AwrTccLI7odYEssAkR4nnIlQ;_ylu=X3oDMTByb2lvbXVuBGNvbG8DZ3ExBHBvcwMxBHZ0aWQDBHNlYwNzcg–/RV=2/RE=1485332296/RO=10/RU=https%3A%2F%2Fwww.rand.org%2Fcontent%2Fdam%2Frand%2Fpubs%2Fworking_papers%2FWR1100%2FWR1130%2FRAND_WR1130.pdf/RK=0/RS=v_T.FuIJoKWJPpRei74N4FbbEQ0-
Ending the U.S. government’s war on medical marijuana research (report–2015) https://www.brookings.edu/research/ending-the-u-s-governments-war-on-medical-marijuana-research/
Veterans Health Administration Policy on Cannabis as an Adjunct to Pain Treatment with Opiates (article–2015) http://journalofethics.ama-assn.org/2015/06/pfor2-1506.html
Marijuana gears up for production high in US labs (article–2015) http://www.nature.com/news/marijuana-gears-up-for-production-high-in-us-labs-1.17129
Marijuana Research with Human Subjects (article–2015) http://www.fda.gov/newsevents/publichealthfocus/ucm421173.htm
Marijuana’s role in optometry and beyond (article–2015) http://optometrytimes.modernmedicine.com/optometrytimes/news/marijuana-s-role-optometry-andbeyond?utm_source=TrendMD&utm_medium=cpc&utm_campaign=Optometry_Times_TrendMD_1
Peaceful feeling, or up in smoke? Medical marijuana in medicolegal context (article–2015) http://www.mdedge.com/currentpsychiatry/article/102099/practice-management/peaceful-feeling-orsmoke-medical-marijuana
The entourage effect: Synergistic actions of plant cannabinoids (letter–2015) http://www.researchgate.net/publication/273330402_The_entourage_effect_Synergistic_actions_of_plant_cannabinoids
Profiles of medicinal cannabis patients attending compassion centers in rhode island (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25715068
Is cannabis an illicit drug or a medicine? A quantitative framing analysis of Israeli newspaper coverage (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25661483
(1)H NMR and HPLC/DAD for Cannabis sativa L. chemotype distinction, extract profiling and specification (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26048837
Cannabis species and cannabinoid concentration preference among sleep-disturbed medicinal cannabis users (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26151582
Do Cannabinoid Receptor Agonists Have A Role In The Intensive Care Unit? … Totally Dude! (abst–2015) http://www.atsjournals.org/doi/abs/10.1164/ajrccm-conference.2015.191.1_MeetingAbstracts.A1657
From badness to illness: Medical cannabis and self-diagnosed attention deficit hyper-activity disorder (abst–2015) http://informahealthcare.com/doi/abs/10.3109/16066359.2014.954556
Polypharmacology Shakes Hands with Complex Aetiopathology. (abst – 2015) http://www.cell.com/trends/pharmacological-sciences/abstract/S0165-6147(15)00171-6
Substituting cannabis for prescription drugs, alcohol and other substances among medical cannabis patients: The impact of contextual factors (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26364922
The prescription of medical cannabis by a transitional pain service to wean a patient with complex pain from opioid use following liver transplantation : a case report (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26507533
Medicinal Cannabis: A Survey Among Health Care Providers in Washington State (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26377551
Medicinal Cannabis: A Survey Among Health Care Providers in Washington State (full–2015) http://journals.sagepub.com/doi/full/10.1177/1049909115604669
In the weeds: a baseline view of cannabis use among legalizing states and their neighbours (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26687431
Prevalence of Marijuana and Other Substance Use Before and After Washington State’s Change from Legal Medical Marijuana to Legal Medical and Non-Medical Marijuana: Cohort Comparisons in a Sample of Adolescents (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26252354
Substituting cannabis for prescription drugs, alcohol and other substances among medical cannabis patients: The impact of contextual factors (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26364922
Cannabis species and cannabinoid concentration preference among sleep-disturbed medicinal cannabis users (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26151582
An Overview of Products and Bias in Research (abst–2015) http://link.springer.com/article/10.1007/s13311-015-0370-x
Medical Marijuana and Chronic Pain: a Review of Basic Science and Clinical Evidence (abst–2015) http://link.springer.com/article/10.1007/s11916-015-0524-x
Prescribing medical cannabis in Canada: Are we being too cautious? (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26451996
Cannabis and cancer: reality or pipe dream? (abst–2015) http://www.thelancet.com/journals/lanonc/article/PIIS1470-2045%2815%2900302-2/abstract
Medical Cannabis in Arizona: Patient Characteristics, Perceptions, and Impressions of Medical Cannabis Legalization (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26317379
Proving personal use: the admissibility of evidence negating intent to distribute marijuana (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26030944
Medical education on cannabis and cannabinoids: Perspectives, challenges, and opportunities (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25728558
Merck Manual – Marijuana (Cannabis) Professional version (full–2016) http://www.merckmanuals.com/professional/special-subjects/recreational-drugs-and-intoxicants/marijuanacannabis Merck Manual – Marijuana (Cannabis) Consumer version (full–2016) http://www.merckmanuals.com/home/special-subjects/recreational-drugs-and-intoxicants/marijuana
Cannabis and Cannabinoids (PDQ®)Health Professional Version (full–2016) https://www.ncbi.nlm.nih.gov/books/NBK65755/
Effects of Medical Marijuana on Migraine Headache Frequency in an Adult Population (full–2016) http://onlinelibrary.wiley.com/doi/10.1002/phar.1673/full
top
A collaboration investigating endocannabinoid signalling in brain and bone (full–2016) http://www.degruyter.com/view/j/jbcpp.ahead-of-print/jbcpp-2015-0125/jbcpp-2015-0125.xml
Cannabinoids for pediatric epilepsy? Up in smoke or real science? (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4729003/
Cannabis sativa: The Plant of the Thousand and One Molecules (full–2016) http://journal.frontiersin.org/article/10.3389/fpls.2016.00019/full
Medical marijuana programs – Why might they matter for public health and why should we better understand their impacts? (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4721313/
The Role of Medicinal Cannabis in Clinical Therapy: Pharmacists’ Perspectives (full–2016) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0155113
Legal regulated markets have the potential to reduce population levels of harm associated with cannabis use (full–2016) http://onlinelibrary.wiley.com/doi/10.1111/add.13390/full Medicinal cannabis in Australia: the missing links (full–2016) https://www.mja.com.au/journal/2016/204/10/medicinal-cannabis-australia-missing-links
Evaluating the Effects of Gamma-Irradiation for Decontamination of Medicinal Cannabis (full–2016) http://journal.frontiersin.org/article/10.3389/fphar.2016.00108/full
Medicinal Use of Marijuana: What School Nurses Need to Know (full–2016) http://nas.sagepub.com/content/31/3/170.long Attitudes of Israeli Rheumatologists to the Use of Medical Cannabis as Therapy for Rheumatic Disorders (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4839539/
Is the medical use of cannabis a therapeutic option for children? (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4758425/
Prevalence of marijuana use does not differentially increase among youth after states pass medical marijuana laws: Commentary on and reanalysis of US National Survey on Drug Use in Households data 2002-2011 (full–2016) http://www.ijdp.org/article/S0955-3959(16)00038-4/fulltext
Model Guidelines for the Recommendation of Marijuana in Patient Care (full–2016) http://www.fsmb.org/Media/Default/PDF/BRD_RPT_16-2_Marijuana_Model_Guidelines.pdf
Tracking Dabbing Using Search Query Surveillance: A Case Study in the United States (full–2016) http://www.jmir.org/2016/9/e252/
Splendor in the Grass? A Pilot Study Assessing the Impact of Medical Marijuana on Executive Function (full–2016) http://journal.frontiersin.org/article/10.3389/fphar.2016.00355/full
Medical cannabis use in Canada: vapourization and modes of delivery (full–2016) https://harmreductionjournal.biomedcentral.com/articles/10.1186/s12954-016-0119-9 Federal barriers to Cannabis research (full–2016) http://science.sciencemag.org/content/352/6290/1182.1.long
Preparation and Distribution of Cannabis and Cannabis-Derived Dosage Formulations for Investigational and Therapeutic Use in the United States (full–2016) http://journal.frontiersin.org/article/10.3389/fphar.2016.00285/full#B14
Dietary fats and pharmaceutical lipid excipients increase systemic exposure to orally administered cannabis and cannabis-based medicines (full–2016) http://www.ajtr.org/files/ajtr0030292.pdf
Current Therapeutic Cannabis Controversies and Clinical Trial Design Issues (full–2016) http://journal.frontiersin.org/article/10.3389/fphar.2016.00309/full
Marijuana – How Safe is it Really? (full–2016) https://journals.mcmaster.ca/iScientist/article/download/1104/991
Minnesota Pharmacists and Medical Cannabis: A Survey of Knowledge, Concerns, and Interest Prior to Program Launch (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5083080/
Establishment of a New Drug Code for Marihuana Extract. Final rule (full–2016) https://www.federalregister.gov/documents/2016/12/14/2016-29941/establishment-of-a-new-drug-code-formarihuana-extract
Marijuana: Views on Its Medical Use Recorded at the Slovak Social Network (full–2016) http://journals.sagepub.com/doi/full/10.1177/0047237916646442
Opinions of Hospital Pharmacists in Canada Regarding Marijuana for Medical Purposes (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4853179/
Medical Marijuana Laws Reduce Prescription Medication Use In Medicare Part D (full– 2016) http://content.healthaffairs.org/content/35/7/1230.long
Preparation and Distribution of Cannabis and Cannabis-Derived Dosage Formulations for Investigational and Therapeutic Use in the United States (full–2016) http://journal.frontiersin.org/article/10.3389/fphar.2016.00285/full#B14
Metagenomic analysis of medicinal Cannabis samples; pathogenic bacteria, toxigenic fungi, and beneficial microbes grow in culture-based yeast and mold tests (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5089129/
Therapeutic Use of Cannabis in Inflammatory Bowel Disease (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5193087/
A user’s guide to cannabinoid therapies in oncology (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5176373/
Establishment of a New Drug Code for Marihuana Extract (full–2016) https://www.federalregister.gov/documents/2016/12/14/2016-29941/establishment-of-a-new-drug-code-formarihuana-extract
David Casarett’s Stoned: A Doctor’s Case for Medical Marijuana (full–book review-2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4938260/
Endocannabinoid system: Role in depression, reward and pain control (Review) (link to PDF–2016) https://www.spandidos-publications.com/10.3892/mmr.2016.5585
Tackling the Pharmaceutical Frontier: Regulation of Cannabinoid-Based Medicines in Postwar Japan (link to PDF–2016) http://online.liebertpub.com/doi/full/10.1089/can.2015.0011
COMPREHENSIVE MEDICAL MARIJUANA PATIENT STUDY (link to PDF–2016) https://www.hellomd.com/medical-marijuana-patient-survey
Medical experts warn Australia’s understanding of medicinal cannabis lacking (link to PDF-2016) http://apo.org.au/resource/medical-experts-warn-australias-understanding-medicinal-cannabis-lacking
Use of marijuana for medical purposes (click “full Text Links” for download–2016) http://www.ncbi.nlm.nih.gov/pubmed/27660881
Applications To Become Registered Under the Controlled Substances Act To Manufacture Marijuana To Supply Researchers in the United States. Policy statement (click “Link out” for download–2016) http://www.ncbi.nlm.nih.gov/pubmed/27529905
Cannabis Legalization: Focusing on Patient Needs: Five Recommendations on Access, Affordability, and Research (report–2016) http://cfamm.ca/patient-recommendations/ Cannabis in the United States (report–2016) http://self.gutenberg.org/article/WHEBN0020566488/Cannabis%20in%20the%20United%20States
Dose of Reality: The Effect of State Marijuana Legalizations (report–2016) http://www.cato.org/publications/policy-analysis/dose-reality-effect-state-marijuana-legalizations#full Evidence for Medicinal Use of Cannabis (article–2016) http://www.physio-pedia.com/Evidence_for_Medicinal_Use_of_Cannabis
Why I chose to use cannabis (article–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4791147/ Cannabis and Dr Piffard-A Century Ahead of the Curve (article–2016) http://archderm.jamanetwork.com/article.aspx?articleid=2547236
Opioids Out, Cannabis In (1st page – 2016) http://jamanetwork.com/journals/jama/article-abstract/2576617 Cannabis and Cannabinoids (1st page–2016) http://jamanetwork.com/journals/jama/article-abstract/2592497
Expectations for Physicians Prescribing Marijuana (1st page–2016) http://jamanetwork.com/journals/jama/article-abstract/2592491
Farming medical ganja in Jamaica. (click ELSEVIER for 1st page – 2016) http://www.ncbi.nlm.nih.gov/pubmed/27296757 The Effect of Medical Marijuana on Sickness Absence (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27416978
A cost-effectiveness model for the use of a cannabis-derived oromucosal spray for the treatment of spasticity in multiple sclerosis (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26750641
Medical use of cannabis products : Lessons to be learned from Israel and Canada (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26767992
Dental treatment planning considerations for patients using cannabis: A case report (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26768516
Marijuana: Medical Applications, Recreational Use and Substance Abuse Disorders (abst–2016) http://www.sciencedirect.com/science/article/pii/B9780123970459001336
Chapter 2 – Biosynthesis and Pharmacology of Phytocannabinoids and Related Chemical Constituents (abst–2016) http://www.sciencedirect.com/science/article/pii/B9780128046463000023
Chapter 3 – Medical Cannabis Formulations (abst–2016) http://www.sciencedirect.com/science/article/pii/B9780128046463000035
Chapter 4 – Analytical Methods in Formulation Development and Manufacturing (abst–2016) http://www.sciencedirect.com/science/article/pii/B9780128046463000047
Chapter 6 – The Roles of Research and Regulation (abst–2016) http://www.sciencedirect.com/science/article/pii/B9780128046463000060
Chapter 7 – The Future of Cannabinoid Therapeutics (abst–2016) http://www.sciencedirect.com/science/article/pii/B9780128046463000072
Medical cannabis: considerations for the anesthesiologist and pain physician (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26850063
The Changing Drug Culture: Medical and Recreational Marijuana (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26881768
Cannabinoids: Medical implications (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26912385
Cannabis – Position Paper of the German Respiratory Society (DGP) (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26935046
Cannabis in Pain Treatment: Clinical & Research Considerations (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26961090
Smoking, vaping, eating: Is legalization impacting the way people use cannabis? (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26992484
Weeding Out the Truth: Adolescents and Cannabis (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26985645
The Effect of Medicinal Cannabis on Pain and Quality of Life Outcomes in Chronic Pain: A Prospective Open-label Study (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26889611
Medical cannabis associated with decreased opiate medication use in retrospective crosssectional survey of chronic pain patients (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27001005
ENDOCANNABINOID SYSTEM: A multi-facet therapeutic target (abst–2016) http://www.eurekaselect.com/141330/article
“Those edibles hit hard”: Exploration of Twitter data on cannabis edibles in the U.S. (abst–2016) http://www.drugandalcoholdependence.com/article/S0376-8716%2816%2930056-4/abstract
Pain, Cannabis Species, and Cannabis Use Disorders (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27172585
MEDICAL CANNABIS (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27215115
The Use of Medical Marijuana in Cancer (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27215434 Need for Methods to Investigate Endocannabinoid Signaling (abst–2016) http://link.springer.com/protocol/10.1007%2F978-1-4939-3539-0_1
Medicinal cannabis: Principal cannabinoids concentration and their stability evaluated by a high performance liquid chromatography coupled to diode array and quadrupole time of flight mass spectrometry method (abst–2016) http://www.sciencedirect.com/science/article/pii/S0731708516302722
Current Status and Prospects for Cannabidiol Preparations as New Therapeutic Agents (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27285147
Comparing adults who use cannabis medically with those who use recreationally: Results from a national sample (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27262964 MEDICINAL CANNABIS LAW REFORM IN AUSTRALIA (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27323630
Pediatric oncology providers and use of medical marijuana in children with cancer (abst–2016) http://meetinglibrary.asco.org/content/170798-176
Problematic Use of Prescription Opioids and Medicinal Cannabis Among Patients Suffering from Chronic Pain (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27346885
Agitation in Alzheimer Disease as a Qualifying Condition for Medical Marijuana in the United States (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27389672
Qualitative research in Spanish cannabis social clubs: “The moment you enter the door, you are minimising the risks” (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27461986
Early Survey Results from the Minnesota Medical Cannabis Program (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27464390
Factors associated with having a medical marijuana card among Veterans with recent substance use in VA outpatient treatment (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27475408
Evidence-based policy? The re-medicalization of cannabis and the role of expert committees in the UK, 1972-1982 (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27477790
Role of nurses in the managements of symptoms associated with spasticity in patients with multiple sclerosis (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27492746 Targeting the endocannabinoid system: future therapeutic strategies (abst–2016) http://www.sciencedirect.com/science/article/pii/S1359644616302926
The Dangerous Drugs Act Amendment in Jamaica: Reviewing goals, implementation, and challenges (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27596698
Clinical trials of medicinal cannabis for appetite-related symptoms from advanced cancer: A survey of preferences, attitudes and beliefs among patients willing to consider participation (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27530738
State Medical Marijuana Laws and the Prevalence of Opioids Detected Among Fatally Injured Drivers (abst–2016) http://ajph.aphapublications.org/doi/abs/10.2105/AJPH.2016.303426?journalCode=ajph
Medical Marijuana: Just the Beginning of a Long, Strange Trip? (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27660328
Efficacy, tolerability, and safety of cannabinoids in gastroenterology: A systematic review (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/26809974
Cannabis: A Treasure Trove or Pandora’s Box? (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27719666
Clearing the haze: the complexities and challenges of research on state marijuana laws (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27723946
Prevalence and correlates of “Vaping” as a route of cannabis administration in medical cannabis patients (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27770657
Pseudo-Underage Assessment of Compliance With Identification Regulations at Retail Marijuana Outlets in Colorado (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27797687
Pros and cons of medical cannabis use by people with chronic brain disorders (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27804883
The Impact of Medical Marijuana Laws on the Labor Supply and Health of Older Adults: Evidence from the Health and Retirement Study (abst–2016) http://www.nber.org/papers/w22688
Survey of herbal cannabis (marijuana) use in rheumatology clinic attenders with a rheumatologist confirmed diagnosis (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27842047
Medical Cannabis – another piece in the mosaic of autoimmunity? (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27859024
Understanding and learning from the diversification of cannabis supply laws (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27891693
Attitudes to cannabis and patterns of use among Canadians with multiple sclerosis (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27919478
Phytocannabinoids: a growing family of plant natural products with increasing pharmacological and clinical importance (abst–2016) https://www.thieme-connect.com/DOI/DOI?10.1055/s-0036-1596088
Cannabinoids – a new weapon against cancer? (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/28100841
Stakeholders’ Views on Barriers to Research on Controversial Controlled Substances (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/28001138
Substance Use, Health, and Functioning Characteristics of Medical Marijuana Program Participants Compared to the General Adult Population in Ontario (Canada) (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/28001910
Storage and disposal of medical cannabis among patients with cancer: Assessing the risk of diversion and unintentional digestion (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27420392
Tasty THC: Promises and Challenges of Cannabis Edibles (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/28127591
US Traffic Fatalities, 1985–2014, and Their Relationship to Medical Marijuana Laws (abst–2016) http://ajph.aphapublications.org/doi/abs/10.2105/AJPH.2016.303577
Marijuana Could Help Treat Drug Addiction and Mental Health Problems (news & abst–2016) http://neurosciencenews.com/addiction-mental-health-marijuana-5536/
Migraine Frequency Decreased by Medical Marijuana (news & abst–2016) http://neurosciencenews.com/medical-marijuana-migraine-3440/
Irish general practitioner attitudes toward decriminalisation and medical use of cannabis: results from a national survey (full–2017) https://harmreductionjournal.biomedcentral.com/articles/10.1186/s12954-016-0129-7 Cannabinoid concentrations in Canada’s regulated medical cannabis industry (full–2017) http://onlinelibrary.wiley.com/doi/10.1111/add.13738/full
Cannabis use in persons with traumatic spinal cord injury in Denmark (link to PDF-2017) https://www.medicaljournals.se/jrm/content/abstract/10.2340/16501977-2105
Cannabis: high time for evidence-based policies (editorial–2017) http://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(16)30642-8/fulltext Rocky Mountain High: Preventing Cannabis-Related Injuries (1st page–2017) http://www.jenonline.org/article/S0099-1767(16)30339-7/abstract
Experts’ Perspectives on the Role of Medical Marijuana in Oncology: a semi-structured interview study (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28040884
Historical perspective on the medical use of cannabis for epilepsy: Ancient times to the 1980s (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28089286
Medicinal versus recreational cannabis use: Patterns of cannabis use, alcohol use, and cued-arousal among veterans who screen positive for PTSD (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28088054
Do recreational cannabis users, unlicensed and licensed medical cannabis users form distinct groups? (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28107687 Phytochemistry of Cannabis sativa L. (abst–2017) http://link.springer.com/chapter/10.1007%2F978-3-319-45541-9_1
Traditional uses of medicinal plants reported by the indigenous communities and local herbal practitioners of Bajaur Agency, Federally Administrated Tribal Areas, Pakistan (abst–2017) http://www.sciencedirect.com/science/article/pii/S037887411730197
Social factors in marijuana use for medical and recreational purposes (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28132734


MENINGITIS
Cannabidiol reduces host immune response and prevents cognitive impairments in Wistar rats submitted to pneumococcal meningitis (full–2012) http://www.sciencedirect.com/science/article/pii/S0014299912008485
A systematic review of the effect of cannabidiol on cognitive function: Relevance to schizophrenia (abst–2016) http://www.sciencedirect.com/science/article/pii/S0149763416304390


MENOPAUSE/OVARIECTOMY
The relationship between plasma levels of the endocannabinoid, anandamide, sex steroids, and gonadotrophins during the menstrual cycle (full-2010) http://www.fertstert.org/article/S0015-0282%2808%2904739-0/fulltext
The effects of Cannabis sativa L. seed (hemp seed) in the ovariectomized rat model of menopause (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/21069097
The type 2 cannabinoid receptor protects against age-related bone loss and ovariectomy induced bone loss by stimulating bone formation (abst–2010) http://www.thebonejournal.com/article/S8756-3282%2810%2900619-8/abstract
The Type 2 Cannabinoid Receptor Regulates Bone Mass and Ovariectomy-Induced Bone Loss by Affecting Osteoblast Differentiation and Bone Formation (full–2011) http://press.endocrine.org/doi/full/10.1210/en.2010-0930
Are endocannabinoid type 1 receptor gene (CNR1) polymorphisms associated with obesity and metabolic syndrome in postmenopausal Polish women? (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/20838400
Endocannabinoid type 1 receptor gene (CNR1) polymorphisms (rs806381, rs10485170, rs6454674, rs2023239) and cardiovascular risk factors in postmenopausal women (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21480765
top
Circulating endocannabinoids in insulin sensitive vs Insulin resistant obese post-menopausal women. A MONET group study (full–2013) http://onlinelibrary.wiley.com/doi/10.1002/oby.20498/full
New insights into the physiology of bone regulation: the role of neuro-hormones (full–2014) http://www.biomed.cas.cz/physiolres/pdf/prepress/932668.pdf
Cannabinoid receptor gene polymorphisms and bone mineral density in Korean postmenopausal women (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25268406
Dose-response estrogen promotes osteogenic differentiation via GPR40 (FFAR1) in murine BMMSCs (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25576830
Effects of CB1 receptor agonism and antagonism on behavioural fear and physiological stress responses in adult intact, ovariectomized, and estradiol-replaced female rats (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26311003
Ovariectomy Alters Gene Expression of the Hippocampal Formation in Middle-Aged Rats (link to PDF–2016) http://press.endocrine.org/doi/10.1210/en.2016-1516?url_ver=Z39.88-2003&rfr_id=ori%3Arid %3Acrossref.org&rfr_dat=cr_pub%3Dpubmed&
Circulating levels of endocannabinoids and oxylipins altered by dietary lipids in older women are likely associated with previously identified gene targets (abst–2016) http://www.sciencedirect.com/science/article/pii/S1388198116302013


METABOLIC SYNDROME
G1359A polymorphism in the cannabinoid receptor-1 gene is associated with metabolic syndrome in the Chinese Han population (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20851297
385 C/A polymorphism of the fatty acid amide hydrolase gene is associated with metabolic syndrome in the Chinese Han population (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3258756/
Acipimox reduces circulating levels of insulin and associated neutrophilic inflammation in metabolic syndrome (full–2011) http://ajpendo.physiology.org/content/300/4/E681.long
Are endocannabinoid type 1 receptor gene (CNR1) polymorphisms associated with obesity and metabolic syndrome in postmenopausal Polish women? (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/20838400
The potential use of cannabidiol in the therapy of metabolic syndrome (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22430005
The serine hydrolase ABHD6 Is a critical regulator of the metabolic syndrome (full–2013) http://www.cell.com/cell-reports/fulltext/S2211-1247%2813%2900507-X
Novel effects of the cannabinoid inverse agonist AM 251 on parameters related to metabolic syndrome in obese Zucker rats (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23932644
CNR1 Gene and Risk of the Metabolic Syndrome in Patients With Schizophrenia (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23422373
Impaired hypotensive responses induced by intrathecally injected drugs in fructose-fed rats (abst–2013) https://www.ncbi.nlm.nih.gov/pubmed/23499700
The effects of obesity, diabetes and metabolic syndrome on the hydrolytic enzymes of the endocannabinoid system in animal and human adipocytes (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3995979/
Development and validation of an HPLC-MS method for the simultaneous quantification of key oxysterols, endocannabinoids, and ceramides: variations in metabolic syndrome (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26563111
top
Approaches for the development of drugs for treatment of obesity and metabolic syndrome (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26648466
Metabolic Syndrome Among Marijuana Users in the United States: An Analysis of National Health and Nutrition Examination Survey Data (abst–2016) http://www.sciencedirect.com/science/article/pii/S0002934315010244
Endocannabinoids in Feeding Behavior and Energy Homeostasis (full–2016) http://themedicalbiochemistrypage.org/endocannabinoids.php
Exposure to a Highly Caloric Palatable Diet during the Perinatal Period Affects the Expression of the Endogenous Cannabinoid System in the Brain, Liver and Adipose Tissue of Adult Rat Offspring (full–2016) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0165432
Metabolic syndrome in people with a psychotic illness: is cannabis protective? (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26965714
Endocannabionoid System in Neurological Disorders (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27364363
Cannabimimetic phytochemicals in the diet – an evolutionary link to food selection and metabolic stress adaptation? (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27891602


METHODS OF USE-CAPSULES
Getting high on the endocannabinoid system (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3997295/
Population Pharmacokinetic Model of THC Integrates Oral, Intravenous, and Pulmonary Dosing and Characterizes Short- and Long-term Pharmacokinetics (abst–2015) http://link.springer.com/article/10.1007/s40262-014-0195-5
Free and Glucuronide Whole Blood Cannabinoids’ Pharmacokinetics after Controlled Smoked, Vaporized, and Oral Cannabis Administration in Frequent and Occasional Cannabis Users: Identification of Recent Cannabis Intake (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27899456
Evaluation of divided attention psychophysical task performance and effects on pupil sizes following smoked, vaporized and oral cannabis administration (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28138971


METHODS OF USE-‘DABS’/HASH OIL/CONCENTRATES
A new method of cannabis ingestion: The dangers of dabs? (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24930049
The Dabbing Dilemma: A Call for Research on Butane Hash Oil and Other Alternate Forms of Cannabis Use (full–2015) https://www.researchgate.net/publication/280691408_The_Dabbing_Dilemma_A_Call_for_Research_on_Butane_Hash_Oil_and_Other_Alternate_Forms_of_Cannabis_Use
“Time for dabs”: Analyzing Twitter data on marijuana concentrates across the U.S. (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26338481
“Time for dabs”: Analyzing Twitter data on marijuana concentrates across the U.S. (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4581982/
Butane Hash Oil Burns Associated with Marijuana Liberalization in Colorado (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4675612/
Understanding dabs: contamination concerns of cannabis concentrates and cannabinoid transfer during the act of dabbing (link to PDF–2015)
https://www.jstage.jst.go.jp/article/jts/40/6/40_797/_article
Dabble With Danger: A Case Of Severe Respiratory Failure Following Inhalation Of Butane Hash Oil (abst–2015) http://www.atsjournals.org/doi/abs/10.1164/ajrccm-conference.2015.191.1_MeetingAbstracts.A4596
Displays of dabbing marijuana extracts on YouTube (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26347408
Tracking Dabbing Using Search Query Surveillance: A Case Study in the United States (full–2016) http://www.jmir.org/2016/9/e252/
Current Therapeutic Cannabis Controversies and Clinical Trial Design Issues (full–2016) http://journal.frontiersin.org/article/10.3389/fphar.2016.00309/full
Establishment of a New Drug Code for Marihuana Extract. Final rule (full–2016) https://www.federalregister.gov/documents/2016/12/14/2016-29941/establishment-of-a-new-drug-code-formarihuana-extract
A Case of Butane Hash Oil (Marijuana Wax)-Induced Psychosis (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26820171
Exploring Butane Hash Oil Use: A Research Note (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26800050
Cannabis-induced psychosis associated with high potency “wax dabs” (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26876313
A content analysis of tweets about high-potency marijuana (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27402550
top


METHODS OF USE-DECARBOXYLATION
Decarboxilation (article–undated) http://theweedscene.com/recipe/decarboxilation/
How-to: Paleo’s Potent Decarboxylated Cannabis Oil (Edibles Technique) (forum post–2011) http://boards.cannabis.com/recipes/194281-how-paleos-potent-decarboxylated-cannabis-oil-ediblestechnique.html
Controlled cannabis decarboxylation – Patent US2012046352 (A1) ― 2012-02-23 (full–2012) http://worldwide.espacenet.com/publicationDetails/description?CC=US&NR=2012046352A1&KC=A1&FT&ND=3&date=20120223&DB=EPODOC&locale=en_EP
Potency 101 (printable card set–2015) (good info!) http://greenstyleconsulting.com/potency-101/
Medicinal Cannabis: In Vitro Validation of Vaporizers for the Smoke-Free Inhalation of Cannabis (link to PDF–2016) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0147286


METHODS OF USE-E-CIGARETTES
High School Students’ Use of Electronic Cigarettes to Vaporize Cannabis (full–2015) http://pediatrics.aappublications.org/content/136/4/611.long
E-Cigarettes: A Review of New Trends in Cannabis Use (full–2015) http://www.mdpi.com/1660-4601/12/8/9988
Vaping cannabis (marijuana): parallel concerns to e-cigs? (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26264448
Confirmation of the trials and tribulations of vaping (article–2015) http://onlinelibrary.wiley.com/doi/10.1111/add.13155/full
Electronic cigarettes and cannabis: an exploratory study (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25613866
How beneficial is vaping cannabis to respiratory health compared to smoking? (article–2015) http://onlinelibrary.wiley.com/doi/10.1111/add.13075/full
Electronic cigarettes and cannabis: an exploratory study (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25613866
Evaluation of Two Commercially Available Cannabidiol Formulations for Use in Electronic Cigarettes (full–2016) http://journal.frontiersin.org/article/10.3389/fphar.2016.00279/full Tracking Dabbing Using Search Query Surveillance: A Case Study in the United States (full–2016) http://www.jmir.org/2016/9/e252/
Medical cannabis use in Canada: vapourization and modes of delivery (full–2016) https://harmreductionjournal.biomedcentral.com/articles/10.1186/s12954-016-0119-9 Analysis of a commerical marijuana e-cigarette formulation (abst–2016) (This article has a delayed release and will be available in PMC on June 1, 2017) https://www.ncbi.nlm.nih.gov/pubmed/27059691
Analysis of a Commercial Marijuana e-Cigarette Formulation (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27059691
Prevalence of Use of Electronic Nicotine Delivery Systems (ENDS) to Vape Recreational Drugs by Club Patrons in South London (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27599520
Prevalence and Correlates of Vaping Cannabis in a Sample of Young Adults (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27631612


METHODS OF USE-EDIBLES (GENERAL)
Cannabis as a Unique Functional Food (full–2011) http://apothecary-genetics.spruz.com/gfile/75r4!-!HLKELE!-!svyr5/cannabis_as_a_unique_functional_food.pdf
US Patent Application 20110097283 – CHEWING GUM COMPOSITIONS COMPRISING CANNABINOIDS (full–2011) http://www.google.com/patents/US20110097283
Simultaneous determination of delta-9-tetrahydrocannabinol cannabidiol and cannabinol in edible oil using ultra performance liquid chromatography-tandem mass spectrometry (abst–2011) http://tinyurl.com/p8rv8ug
Accidental cannabis poisoning in children: report of four cases in a tertiary care center from southern Spain (abst–2011) http://www.unboundmedicine.com/medline/ebm/record/21283933/abstract/%5BAccidental_cannabis_poisoning_in_children:_report_of_four_cases_in_a_tertiary_care_center_from_southern_Spain%5D_
top
Prolonged coma in a child due to hashish ingestion with quantitation of THC metabolites in urine (abst–2011) http://www.unboundmedicine.com/medline/ebm/record/20634020/abstract/Prolonged_coma_in_a_child_due_to_hashish_ingestion_with_quantitation_of_THC_metabolites_in_urine_
Evaluation of trends in marijuana toxicosis in dogs living in a state with legalized medical marijuana: 125 dogs (2005-2010) (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23216842
“Disease Modifying Nutricals” for multiple sclerosis (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25435020
Notes from the Field: Death Following Ingestion of an Edible Marijuana Product – Colorado, March 2014 (full–2015) http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6428a6.htm
Implications of Marijuana Decriminalization on the Practice of Pulmonary, Critical Care, and Sleep Medicine. A Report of the American Thoracic Society Marijuana Workgroup (full–2015) http://www.atsjournals.org/doi/full/10.1513/AnnalsATS.201504-195AR#.Vo20QFJwtSE
Cluster of Acute Toxicity from Ingestion of Synthetic Cannabinoid-Laced Brownies (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25967137
With education, nurses can help to bridge the marijuana gap (article–2015) http://cannabistoday.bangordailynews.com/2015/07/09/home/with-education-nurses-can-help-to-bridgethe-marijuana-gap/
Half-Baked — The Retail Promotion of Marijuana Edibles (article–2015) http://www.nejm.org/doi/full/10.1056/NEJMp1416014
Cannabinoid Dose and Label Accuracy in Edible Medical Cannabis Products (letter–2015) http://jama.jamanetwork.com/article.aspx?articleid=2338239
Potency 101 (printable card set–2015) (good info!) http://greenstyleconsulting.com/potency-101/
When Weed Is The Cure: A Doctor’s Case for Medical Marijuana (interview–2015) http://www.npr.org/sections/health-shots/2015/07/14/422876973/when-weed-is-the-cure-a-doctors-casefor-medical-marijuana?utm_medium=RSS&utm_campaign=authorinterviews
Effects of Medical Marijuana on Migraine Headache Frequency in an Adult Population (full–2016) http://onlinelibrary.wiley.com/doi/10.1002/phar.1673/full
Identification of Psychoactive Degradants of Cannabidiol in Simulated Gastric and Physiological Fluid (full–2016) http://online.liebertpub.com/doi/10.1089/can.2015.0004 High on Cannabis and Calcineurin Inhibitors: A Word of Warning in an Era of Legalized Marijuana (full–2016) https://www.hindawi.com/journals/crit/2016/4028492/
Dietary fats and pharmaceutical lipid excipients increase systemic exposure to orally administered cannabis and cannabis-based medicines (full–2016) http://www.ajtr.org/files/ajtr0030292.pdf
A user’s guide to cannabinoid therapies in oncology (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5176373/
The use of medical-grade cannabis in patients non-responders to Nabiximols (1st page–2016) http://www.jns-journal.com/article/S0022-510X(16)30472-5/abstract
Smoking, vaping, eating: Is legalization impacting the way people use cannabis? (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26992484
“Those edibles hit hard”: Exploration of Twitter data on cannabis edibles in the U.S. (abst–2016) http://www.drugandalcoholdependence.com/article/S0376-8716%2816%2930056-4/abstract
Medicinal cannabis: Principal cannabinoids concentration and their stability evaluated by a high performance liquid chromatography coupled to diode array and quadrupole time of flight mass spectrometry method (abst–2016) http://www.sciencedirect.com/science/article/pii/S0731708516302722
Edible Cannabis Products: It is Time for FDA Oversight (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27270959
Cannabinoid disposition in oral fluid after controlled smoked, vaporized, and oral cannabis administration (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27647820
Accidental cannabis poisoning in the elderly (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27900531
Tasty THC: Promises and Challenges of Cannabis Edibles (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/28127591
Evaluation of divided attention psychophysical task performance and effects on pupil sizes following smoked, vaporized and oral cannabis administration (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28138971


METHODS-EDIBLES (BEVERAGES, OTHER)
How Is Hemp Seed Milk Made? (article–2010) http://www.ehow.com/about_6724476_hemp-seed-milk-made_.html
top


METHODS-EDIBLES (FOODS)
Recreational use and overdose of ingested processed cannabis (Majoon Birjandi) in the eastern Iran (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22751199
Cannabis Oil : chemical evaluation of an upcoming cannabis based medicine (full–2013) http://www.cannabis-med.org/data/pdf/en_2013_01_1.pdf
Cannabinoids for Medical Use A Systematic Review and Meta-analysis (full–2015) http://jama.jamanetwork.com/article.aspx?articleid=2338251&resultClick=24
Half-Baked – The Retail Promotion of Marijuana Edibles (article– 2015) http://www.nejm.org/doi/full/10.1056/NEJMp1416014
Cannabinoid Dose and Label Accuracy in Edible Medical Cannabis Products (letter–2015) http://jama.jamanetwork.com/article.aspx?articleid=2338239
Stability of Tetrahydrocannabinol and Cannabidiol in Prepared Quality Control Medible Brownies (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27798074


METHODS-EDIBLES (RAW UNHEATED CANNABIS JUICE)
Cannabis as a Unique Functional Food (full-2011) http://apothecary-genetics.spruz.com/gfile/75r4!-!HLKELE!-!svyr5/cannabis_as_a_unique_functional_food.pdf
No Heat ACTIVE cannabis smoothie recipe…this is real. Experience report (forum post–2015) http://forum.grasscity.com/incredible-edible-herb/1369180-no-heat-active-cannabis-smoothie-recipethisreal-experience-report.html


METHODS-EDIBLES (RECIPES)
Holi Recipes » Bhang Recipes (recipe–undated) http://www.holifestival.org/bhang-recipes.html
Bhang Recipes for Holi (collection- undated) http://www.indiankitchenfood.com/bhang-recipes-holi/
Recipes from “Onlinepot” (collection-undated) http://www.onlinepot.org/recipes.htm
Hemp Seed Recipes (collection-undated) http://manitobaharvest.com/recipes.html
{{Easy}} How to prepare Bhang Receipes at home Easily (collection- undated) http://www.theholi.com/2015/03/how-to-prepare-bhang-receipes.html
Edible Marijuana Recipes (collection-undated) http://theweedscene.com/edible-recipes/
The Stoner’s Cookbook (collection-undated) http://www.thestonerscookbook.com/
Alice B. Toklas brownies: the recipe! (recipe–1994) http://www.straightdope.com/columns/read/880/alice-b-toklas-brownies-the-recipe
Cannabis Recipes (forum thread/collection–2004) http://www.icmag.com/ic/showthread.php?t=7602&highlight=elixer
Cannabutter In 7 Easy Steps! (forum thread/ recipe-2005) http://www.icmag.com/ic/showthread.php?t=12895
Cooking with Cannabis (article–2008) http://www.papakief.com/2010/09/cooking-with-cannabis.html
IC Recipe Guide (forum thread/collection–2008) http://www.icmag.com/ic/showthread.php?t=78074
Cannabis Cooking Tips From Uncle Buck (article–2010) http://beyondchronic.com/2010/12/cannabis-cooking-tips-uncle-buck/
top
Cannabis Cooking Oil (recipe–2010) http://www.thecannabischef.com/content/cannabis-cooking-oil
Majoon Recipe (recipe–2010) http://goodandbaked.com/recipes/desserts/majoon-recipe/
Recipes that can make some lives easier; Cannabis Barbeque Sauce (recipe–2010) http://www.examiner.com/chef-about-town-in-seattle/recipes-that-can-make-some-lives-easier-cannabisbarbeque-sauce
Ask Old Hippie: What Can I Do With Marijuana Cooking Oil? (article–2010) http://beyondchronic.com/2011/09/ask-old-hippie-marijuana-cooking-oil/
Anchovy red wine vinegarette with or without cannabis oil (recipe–2011) http://www.examiner.com/chef-about-town-in-seattle/recipes-that-make-lives-easier-anchovy-red-winevinegarette-with-or-wi
BadKat’s CannaPharm: Canna Caps, UV Reactive GLOWING Hash Candy, Canna ‘Bombs’ & more (forum post/collection–2011) http://forum.grasscity.com/incredible-edible-herb/742831-badkats-cannapharm-canna-caps-uv-reactiveglowing-hash-candy-canna-bombs-more.html
Cannabis Decarboxylation – THC Preparation for Unheated Edibles (news–2012) http://www.weedist.com/2012/07/cannabis-decarboxylation-weed-preparation-for-unheated-edibles/
How To Blast Off With Nutella Firecrackers (recipe–2012) http://beyondchronic.com/2012/01/how-to-blast-off-nutella-firecrackers/
Pineapple Express Upside Down Cake (recipe–2012) http://www.foodrepublic.com/recipes/pineapple-express-upside-down-cake/
So You Want To Make Some Cannabutter? (recipe-2012) http://www.foodrepublic.com/recipes/so-you-want-to-make-some-cannabutter/
Kitchen Kush: The best cannabutter in America? Yep, in just 7 easy steps (news–2013) http://www.thecannabist.co/2013/12/27/kitchenweed/1244/
How To Make Cannabis Infused Sweet Potatoes That Are Vegan, Gluten-free (recipe–2013) http://www.medicaljane.com/2014/12/01/how-to-make-vegan-gluten-free-cannabis-infused-sweet-potatoes/
Stoner Sundae: How to Make Weed Ice Cream (news–2013) http://www.thefader.com/2013/07/03/stoner-sundae-how-to-make-weed-ice-cream/
One Bunch of Fresh Cannabis Leaves (Underground Pop-Up Weed-Dinner Green Congee) (news/recipe–2013) http://www.newyorker.com/culture/culture-desk/one-bunch-of-fresh-cannabis-leaves
Cooking with Cannabis: How to Make Weed Butter (recipe–2014) http://gizmodo.com/cooking-with-cannabis-how-to-make-weed-butter-1500453696
Cooking With Cannabis: 8 Delicious Marijuana Recipes (collection–2014) http://www.mainstreet.com/article/lifestyle/food-drink/cooking-cannabis-8-delicious-marijuanarecipes?puc=yahoo&cm_ven=YAHOO
How-To Make A Cannabis Infused Blueberry Banana Smoothie (news–2014) http://www.medicaljane.com/2014/11/13/cannabis-how-to-making-the-canserve-cannabluenana-smoothie/
Marijuana Spa Products You Can Make at Home (news–2014) https://www.mainstreet.com/article/marijuana-spa-products-you-can-make-home-0
How to Make Non-Psychoactive Cannabis & Carrot Juice (news–2015) http://www.medicaljane.com/2015/01/14/non-psychoactive-cannabis-carrot-juice-recipe/
top
Bhang Recipe (news–2015) https://www.whaxy.com/learn/bhang-recipe
Cannapple Ginger Juice (news–2015) http://twicebakedinwashington.com/2015/01/01/cannapple-ginger-juice/
Medicated Coffee Creamer Recipe (forum post–2015) http://forum.grasscity.com/incredible-edible-herb/1362946-medicated-coffee-creamer-recipe.html
Not Your Mother’s Pot Brownie (news–2015) http://hereandnow.wbur.org/2015/05/25/pot-ediblesrecipes?utm_medium=RSS&utm_campaign=storiesfromnpr
Spice up Your Coffee with Cannabis (news–2015) http://www.buydutchseeds.com/blog/spice-up-your-coffee-with-cannabis.html
Cannabis Infused Sugar Cookies: Recipe (news/recipe–2015) https://www.hellomd.com/health-wellness/cannabis-infused-sugar-cookies-recipe 12 Delicious Bhang Recipes That You Should Definitely Try Out This Holi (collection–2016) https://www.scoopwhoop.com/bhang-recipes-for-holi/
Make your own cannabutter in seven easy steps [PHOTOS] (news/recipe–2016) http://www.denverpost.com/2016/05/26/cannabutter-marijuana-infused-butter/ Cannabis-Infused Dark Chocolate Coconut Balls (news/recipe–2016) http://www.marijuana.com/blog/news/2016/05/cannabis-infused-dark-chocolate-coconut-balls/
Ask a Stoner: How Can I Have a Merryjuana Christmas? (news / recipe – 2016) http://www.houstonpress.com/news/ask-a-stoner-how-can-i-have-a-merryjuana-christmas-9040585


METHODS OF USE–HASHISH
Prolonged coma in a child due to hashish ingestion with quantitation of THC metabolites in urine (abst–2011) http://www.unboundmedicine.com/medline/ebm/record/20634020/abstract/Prolonged_coma_in_a_child_due_to_hashish_ingestion_with_quantitation_of_THC_metabolites_in_urine_
Some features of teenage beer alcoholism combined with hashish addiction (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21322145
Water pipe smoking and psychoactive substances (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23421061
Extraction of high quality DNA from seized moroccan cannabis resin (hashish) (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3790795/
Chemical profiling of different hashish seizures by gas chromatography-mass spectrometry and statistical methodology: a case report (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24008198
What are young adults smoking in their hookahs? A latent class analysis of substances smoked (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4091668/
Hashish revival in Morocco (full–2014) http://www.ijdp.org/article/S0955-3959%2814%2900003-6/fulltext
Hashish as cash in a post-Soviet Kyrgyz village (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24594222
Etno-territorial prevalence of hashishism in some Siberian areas (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25403303
Prevalence and correlates of hashish use in a national sample of high school seniors in the United States (full–2015) http://www.tandfonline.com/doi/full/10.3109/00952990.2015.1011745
Are Moroccan cannabis growers able to adapt to recent European market trend? (full–2015) http://www.ijdp.org/article/S0955-3959%2814%2900336-3/fulltext
Do consumers substitute opium for hashish? An economic analysis of simultaneous cannabinoid and opiate consumption in a legal regime (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26455552
False hashish without cannabis resin (abst–2015) http://www.ingentaconnect.com/search/article?option1=tka&value1=cannabinoid&sortDescending=true&sortField=prism_publicationDate&pageSize=10&index=24
Traditional marijuana, high-potency cannabis and synthetic cannabinoids: increasing risk for psychosis (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5032490/ Hashish in Morocco and Lebanon: A comparative study (abst–2016) http://www.ijdp.org/article/S0955-3959(16)30056-1/abstract
top


METHODS OF USE-INHALERS
US Patent Application 20100012118 – Medicament dosage for inhaler (full–2010) http://www.freepatentsonline.com/y2010/0012118.html
Clinical experiences with cannabinoids in spasticity management in multiple sclerosis (full–2013) http://zl.elsevier.es/en/revista/neurologia-495/articulo/clinical-experiences-with-cannabinoids-in-90328787
Cannabidiol reduces cigarette consumption in tobacco smokers: Preliminary findings (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23685330
The Pharmacokinetics, Efficacy, Safety, and Ease of Use of a Novel Portable Metered Dose Cannabis Inhaler in Patients With Chronic Neuropathic Pain: A Phase 1a Study (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25118789
Efficacy of Inhaled Cannabis on Painful Diabetic Neuropathy (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25843054


METHODS OF USE-INJECTION
The safety of studies with intravenous Δ(9)-tetrahydrocannabinol in humans, with case histories (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21845389
Dose-Related Modulation of Event-Related Potentials to Novel and Target Stimuli by Intravenous Δ(9)-THC in Humans (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3358754/
Naltrexone does not attenuate the effects of intravenous Δ9-tetrahydrocannabinol in healthy humans (full–2012) http://ijnp.oxfordjournals.org/content/15/9/1251.long
Cannabis in the arm: what can we learn from intravenous cannabinoid studies? (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22716141
N-Palmitoylethanolamine depot injection increased its tissue levels and those of other acylethanolamide lipids (full–2013) http://www.ncbi.nlm.nih.gov/pubmed/23976843
How Cannabis Causes Paranoia: Using the Intravenous Administration of Δ9-Tetrahydrocannabinol (THC) to Identify Key Cognitive Mechanisms Leading to Paranoia (full–2014) http://schizophreniabulletin.oxfordjournals.org/content/early/2014/07/01/schbul.sbu098.long
A Vapourized Δ9-Tetrahydrocannabinol (Δ9-THC) Delivery System Part I: Development and Validation of a Pulmonary Cannabinoid Route of Exposure for Experimental Pharmacology Studies in Rodents (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24973534
A Vapourized Δ9-Tetrahydrocannabinol (Δ9-THC) Delivery System Part II: Comparison of Behavioural Effects of Pulmonary Versus Parenteral Cannabinoid Exposure in Rodents (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24956154
Involvement of central and peripheral cannabinoid receptors on antinociceptive effect of tetrahydrocannabinol in muscle pain (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25446925
top
Population Pharmacokinetic Model of THC Integrates Oral, Intravenous, and Pulmonary Dosing and Characterizes Short- and Long-term Pharmacokinetics (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25316574
Intravenous Delta-9-Tetrahydrocannabinol to Prevent Postoperative Nausea and Vomiting: A Randomized Controlled Trial (abst–2015) http://www.ingentaconnect.com/search/article?option1=tka&value1=cannabinoid&sortDescending=true&sortField=prism_publicationDate&pageSize=10&index=23
Population Pharmacokinetic Model of THC Integrates Oral, Intravenous, and Pulmonary Dosing and Characterizes Short- and Long-term Pharmacokinetics (abst–2015) http://link.springer.com/article/10.1007/s40262-014-0195-5
Distribution of Synthetic cannabinoids JWH-210, RCS-4 and ∆ 9-Tetrahydrocannabinol After Intravenous Administration to Pigs (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27834143


METHODS OF USE-NANOPLATFORMS/NANOPARTICLES Etc
NANOENCAPSULATED DELTA-9-TETRAHYDROCANNABINOL – Patent US2012052119 (A1) ― 2012-03-01 (full–2012) http://tinyurl.com/oc2mnzc
Engineering of Δ9-tetrahydrocannabinol delivery systems based on surface modified PLGA nanoplatforms (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25262411
Lipid nanoparticles as an emerging platform for cannabinoid delivery: physicochemical optimization and biocompatibility (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25996463
The Use of Styrene Maleic Acid Nanomicelles Encapsulating the Synthetic Cannabinoid Analog WIN55,212-2 for the Treatment of Cancer (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26254360
Encapsulation of cannabinoid drugs in nanostructured lipid carriers (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26952905
Mesoporous Silica Particles as a Multifunctional Delivery System for Pain Relief in Experimental Neuropathy (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27028159 Application of carbon nanotubes as the carriers of the cannabinoid, 2- arachidonoylglycerol: Towards a novel treatment strategy in colitis (abst–2016) http://www.sciencedirect.com/science/article/pii/S002432051630666X


METHODS OF USE-NASAL SPRAYS
Cannabidiol bioavailability after nasal and transdermal application: effect of permeation enhancers (abst-2010) http://www.ncbi.nlm.nih.gov/pubmed/20545522
Bioavailability of Δ⁹-tetrahydrocannabinol following intranasal administration of a mucoadhesive gel spray delivery system in conscious rabbits (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21244195
Nasal administration of drugs as a new non-invasive strategy for efficient treatment of multiple sclerosis (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23517929
top


METHODS OF USE-RSO/RICK SIMPSON’S OIL/HEMP OIL/PHOENIX OIL
Harm Reduction: Alcohol Use Disorder, Cannabis-induced Psychotic Disorder and a tale of two Hemp Oils, in a Patient diagnosed with a Cluster A & B Personality Disorders in Long Term Behavior Therapy (case report–undated) http://cannabisclinicians.org/view-all-case-reports/entry/601/?pagenum=2
Cannabis extract treatment for terminal acute lymphoblastic leukemia with a Philadelphia chromosome mutation (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3901602/
Cannabis Oil : chemical evaluation of an upcoming cannabis based medicine (full–2013) http://www.cannabis-med.org/data/pdf/en_2013_01_1.pdf
The Comprehensive Report on the Cannabis Extract Movement and the Use of Cannabis Extracts to Treat Diseases (report–2014) http://www.slideshare.net/TheHempSolution/comprehensive-report-on-the-cannabis-extract-movement
Integrating cannabis into clinical cancer care (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4791148/ Establishment of a New Drug Code for Marihuana Extract. Final rule (full–2016) https://www.federalregister.gov/documents/2016/12/14/2016-29941/establishment-of-a-new-drug-code-formarihuana-extract
Safety and Efficacy of Medical Cannabis Oil for Behavioral and Psychological Symptoms of Dementia: An-Open Label, Add-On, Pilot Study (abst-2016) http://www.ncbi.nlm.nih.gov/pubmed/26757043
Review of Various Herbal Supplements as Complementary Treatments for Oral Cancer (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26863913
Limitations to the Dutch cannabis toleration policy: Assumptions underlying the reclassification of cannabis above 15% THC (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27471078


METHODS OF USE-SECOND-HAND SMOKE
Evaluating the athlete’s claim of an unintentional positive urine drug test (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/23531893
Non-smoker exposure to secondhand cannabis smoke I: Urine screening and confirmation results (full–2015) http://jat.oxfordjournals.org/content/39/1/1.long
Non-smoker exposure to secondhand cannabis smoke II: Effect of room ventilation on the physiological, subjective, and behavioral/cognitive effects (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25957157
Nonsmoker Exposure to Secondhand Cannabis Smoke III: Oral Fluid and Blood Drug Concentrations and Corresponding Subjective Effects (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26139312
Finding cannabinoids in hair does not prove cannabis consumption (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4595642/
Analysis of Cannabinoids and Their Metabolites in Human Urine (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26411292
Detecting biomarkers of secondhand marijuana smoke in young children (link to PDF– 2016) http://www.nature.com/pr/journal/vaop/naam/abs/pr2016261a.html
A systematic review of passive exposure to cannabis (abst–2016) http://www.fsijournal.org/article/S0379-0738(16)30493-5/abstract


METHODS OF USE-SMOKING
Smoked cannabis for chronic neuropathic pain: a randomized controlled trial (full-2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2950205/?toolmcentrez
Opioid antagonism enhances marijuana’s effects in heavy marijuana smokers (full-2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2923559/pdf/nihms201310.pdf
Does cannabis use predispose to chronic airflow obstruction? (full-2010) http://erj.ersjournals.com/content/35/1/3.full?ijkey=d1405bb2fc0ed2aff675335858f284f7f470fbbc&keytype2=tf_ipsecsha
top
Impact of cannabidiol on the acute memory and psychotomimetic effects of smoked cannabis: naturalistic study (full-2010) http://bjp.rcpsych.org/content/197/4/285.long
Disposition of smoked cannabis with high Delta(9)-tetrahydrocannabinol content: A kinetic model (abst–2010) http://www.unboundmedicine.com/medline/ebm/record/20450927/abstract/Disposition_of_smoked_cannabis_with_high_Delta_9__tetrahydrocannabinol_content:_A_kinetic_model_
Effects of smoking cannabis on lung function (full–2011) http://www.expert-reviews.com/doi/pdf/10.1586/ers.11.40
Drug-Intake Methods and Social Identity: The Use of Marijuana in Blunts Among South-east Asian Adolescents and Emerging Adults (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3193281/?toolubmed
Quantification and comparison of marijuana smoking practices: blunts, joints, and pipes (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3025094/
Characterizing smoking topography of cannabis in heavy users (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3641906/
Odor Elimination Filters, Devices and Methods (full–2011) http://www.google.com/patents/EP2560512A1?cl=en
US Patent EP 2560512 A1 – Smoke and Odor Elimination Filters, Devices and Methods (full–2011) http://www.google.com/patents/EP2560512A1?cl=en
Prevalence and co-use of marijuana among young adult cigarette smokers: An anonymous online national survey (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3507655/
Patterns of blunt use among rural young adult african-american men (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3244685/
The dose effects of short-term dronabinol (oral THC) maintenance in daily cannabis users (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3546149/
Can oral fluid cannabinoid testing monitor medication compliance and/or cannabis smoking during oral THC and oromucosal Sativex administration? (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3612560/
The changing demographic of blunt smokers across birth cohorts (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23201173
Water pipe smoking and psychoactive substances (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23421061
Availability of tobacco products associated with use of marijuana cigars (blunts) (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3883305/
Statistics on cannabis users skew perceptions of cannabis use (full–2013) http://journal.frontiersin.org/article/10.3389/fpsyt.2013.00138/full
Marijuana’s dose-dependent effects in daily marijuana smokers (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4547548/ Determination of Pesticide Residues in Cannabis Smoke (full–2013) https://www.hindawi.com/journals/jt/2013/378168/
Cannabis and the Lung: No More Smoking Gun? (editorial–2013) http://www.atsjournals.org/doi/abs/10.1513/AnnalsATS.201302-034ED?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed&
top
Comparison of cannabinoid concentrations in oral fluid and whole blood between occasional and regular cannabis smokers prior to and after smoking a cannabis joint (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24202191
Smoking mull: a grounded theory model on the dynamics of combined tobacco and cannabis use among adult men (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24168742
Getting high on the endocannabinoid system. (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3997295/
What are young adults smoking in their hookahs? A latent class analysis of substances smoked (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4091668/
Inhaled medicinal cannabis and the immunocompromised patient (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25216851
Inhaled medicinal cannabis and the immunocompromised patient (full–2014) MASSC
Oral fluid cannabinoids in chronic frequent cannabis smokers during ad libitum cannabis smoking (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25220020
Oral fluid cannabinoids in chronic frequent cannabis smokers during ad libitum cannabis smoking (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4362971/
Does cannabis smoking predispose to lung bulla formation? (full–2014) http://aan.sagepub.com/content/22/1/65.long
Cross-sectional and prospective relation of cannabis potency, dosing and smoking behaviour with cannabis dependence: an ecological study (full-2014) http://onlinelibrary.wiley.com/doi/10.1111/add.12508/full
The co-use of tobacco and cannabis among adolescents over a 30-year period (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24443776
Experiences of marijuana-vaporizer users (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24821347
Just say ‘know’: how do cannabinoid concentrations influence users’ estimates of cannabis potency and the amount they roll in joints? (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24894801
Population Pharmacokinetic Model of THC Integrates Oral, Intravenous, and Pulmonary Dosing and Characterizes Short- and Long-term Pharmacokinetics (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25316574
Alcohol Versus Cannabinoids: A Review of Their Opposite Neuro-Immunomodulatory
Effects and Future Therapeutic Potentials (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4607066/
Implications of Marijuana Decriminalization on the Practice of Pulmonary, Critical Care, and Sleep Medicine. A Report of the American Thoracic Society Marijuana Workgroup (full–2015) http://www.atsjournals.org/doi/full/10.1513/AnnalsATS.201504-195AR#.Vo20QFJwtSE
Marijuana use in hepatitis C infection does not affect liver biopsy histology or treatment outcomes (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4144456/
Cannabis, Cigarettes, and Their Co-Occurring Use: Disentangling Differences in Gray Matter Volume (full–2015) http://ijnp.oxfordjournals.org/content/18/10/pyv061
Cannabis problem experiences among users of the tobacco-cannabis combination known as blunts (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25746234
The use of illicit drugs as self-medication in the treatment of cluster headache: Results from an Italian online survey (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25903763
How beneficial is vaping cannabis to respiratory health compared to smoking? (article–2015) http://onlinelibrary.wiley.com/doi/10.1111/add.13075/full
top
Subjective and behavioral effects of marijuana the morning after smoking (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/2315429
Oral Cannabidiol does not Alter the Subjective, Reinforcing or Cardiovascular Effects of Smoked Cannabis (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26708108
Combined effects of HIV and marijuana use on neurocognitive functioning and immune status (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26694807
Are users’ most recent drug purchases representative? (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25008105
Population Pharmacokinetic Model of THC Integrates Oral, Intravenous, and Pulmonary Dosing and Characterizes Short- and Long-term Pharmacokinetics (abst–2015) http://link.springer.com/article/10.1007/s40262-014-0195-5
Prescribing medical cannabis in Canada: Are we being too cautious? (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26451996
Behavioral Characterization of the Effects of Cannabis Smoke and Anandamide in Rats (full–2016) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0153327
No Smoke without Tobacco: A Global Overview of Cannabis and Tobacco Routes of Administration and Their Association with Intention to Quit (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4933835/
Current Therapeutic Cannabis Controversies and Clinical Trial Design Issues (full–2016) http://journal.frontiersin.org/article/10.3389/fphar.2016.00309/full
Medical cannabis use in Canada: vapourization and modes of delivery (full–2016) https://harmreductionjournal.biomedcentral.com/articles/10.1186/s12954-016-0119-9
A user’s guide to cannabinoid therapies in oncology (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5176373/
Comparison of Cannabinoid Concentrations in Plasma, Oral Fluid and Urine in Occasional Cannabis Smokers After Smoking Cannabis Cigarette (link to download–2016) https://ejournals.library.ualberta.ca/index.php/JPPS/article/view/28326/20877
Working on a Standard Joint Unit: A pilot test (link to download in English–2016) Descargar el archivo PDF
Smoking, vaping, eating: Is legalization impacting the way people use cannabis? (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26992484
Bayesian inference for the distribution of grams of marijuana in a joint (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27346327
Alveolar haemorrhage following a cannabis water pipe (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27421143
Alterations in taste perception due to recreational drug use are due to smoking a substance rather than ingesting it (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27426619 Acute effects of cannabis on breath-holding duration (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27454678
Limitations to the Dutch cannabis toleration policy: Assumptions underlying the reclassification of cannabis above 15% THC (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27471078
A review of the additive health risk of cannabis and tobacco co-use (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27476751
Does marijuana “blunt” smoking contribute to nicotine exposure?: Preliminary product testing of nicotine content in wrappers of cigars commonly used for blunt smoking (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27639129
Cannabinoid disposition in oral fluid after controlled smoked, vaporized, and oral cannabis administration (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27647820
Free and Glucuronide Whole Blood Cannabinoids’ Pharmacokinetics after Controlled Smoked, Vaporized, and Oral Cannabis Administration in Frequent and Occasional Cannabis Users: Identification of Recent Cannabis Intake (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27899456
Thermolytic degradation of synthetic cannabinoids: chemical exposures and pharmacological consequences (link to download–2017) http://jpet.aspetjournals.org/content/early/2017/01/13/jpet.116.238717.long
Evaluation of divided attention psychophysical task performance and effects on pupil sizes following smoked, vaporized and oral cannabis administration (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28138971


METHODS OF USE-SUPPOSITORIES/RECTAL USE
Topical and Systemic Cannabidiol Improves Trinitrobenzene Sulfonic Acid Colitis in Mice (full–2012) http://content.karger.com/produktedb/produkte.asp?DOI=000336871&typ=pdf


METHODS OF USE-TINCTURES
Marijuana Tincture (article & video–2010) http://patients4medicalmarijuana.wordpress.com/medical-use-of-cannabis-video/marijuana-tincture/
WildWill’s Glycerin Tincture HOW-TO (forum thread–2010) http://forum.grasscity.com/incredible-edible-herb/655899-wildwills-glycerin-tincture-how.html
Heat Exposure of Cannabis sativa Extracts Affects the Pharmacokinetic and Metabolic Profile in Healthy Male Subjects (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22411724
Optimisation and characterisation of marihuana extracts obtained by supercritical fluid extraction and focused ultrasound extraction and retention time locking GC-MS (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23505258
Establishment of a New Drug Code for Marihuana Extract. Final rule (full–2016) https://www.federalregister.gov/documents/2016/12/14/2016-29941/establishment-of-a-new-drug-code-formarihuana-extract
Why I chose to use cannabis (article–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4791147/
Medicinal cannabis: Principal cannabinoids concentration and their stability evaluated by a high performance liquid chromatography coupled to diode array and quadrupole time of flight mass spectrometry method (abst–2016) http://www.sciencedirect.com/science/article/pii/S0731708516302722
Quality Control of Traditional Cannabis Tinctures: Pattern, Markers, and Stability (full–2017) http://www.mdpi.com/2218-0532/84/3/567/htm
top


METHODS OF USE-TOPICAL OINTMENTS
Local application of the endocannabinoid hydrolysis inhibitor URB597 reduces nociception in spontaneous and chemically induced models of osteoarthritis (abst-2010) http://www.unboundmedicine.com/medline/ebm/record/21185649/abstract/Local_application_of_the_endocannabinoid_hydrolysis_inhibitor_URB597_reduces_nociception_in_spontaneous_and_chemically_induced_models_of_osteoarthritis_
Comparative topical anti-inflammatory activity of cannabinoids and cannabivarins (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20450962
Topical Cannabis Healing Salve (recipe–2010) http://patients4medicalmarijuana.wordpress.com/2010/04/30/topical-cannabis-healing-salve/
The Faces Of Medical Marijuana: An Interview With Sarah Lovering (interview–2010) http://the420times.com/2010/04/the-faces-of-medical-marijuana/
Balm from canna roots (forum thread–2010) http://www.greenpassion.org/showthread.php?t=20879
US Patent Application 20110052694 – USE OF CANNABIDIOL PRODRUGS IN TOPICAL AND TRANSDERMAL ADMINISTRATION WITH MICRONEEDLES (full–2011) http://www.google.com/patents/US20110052694
Medical Marijuana Topical Balm Recipe for Eczema, Sore Joints, PMS Cramps (recipe–2011) http://ommplady.blogspot.com/2011/03/medical-marijuana-topical-balm-recipe.html
Topical Compositions with Cannabis Extracts United States Patent Application 20120264818 (full–2012) http://www.freepatentsonline.com/y2012/0264818.html
Treatment of chronic regional pain syndrome type 1 with palmitoylethanolamide and topical ketamine cream: modulation of nonneuronal cells (full-2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3643547/
Anti-inflammatory activity of topical THC in DNFB-mediated mouse allergic contact dermatitis independent of CB1 and CB2 receptors (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23889474
A new formulation of cannabidiol in cream shows therapeutic effects in a mouse model of experimental autoimmune encephalomyelitis (full–2015) http://darujps.biomedcentral.com/articles/10.1186/s40199-015-0131-8
Transdermal cannabidiol reduces inflammation and pain-related behaviours in a rat model of arthritis (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26517407
Jesus & Cannabis (article/ recipe–2015) https://patients4medicalmarijuana.wordpress.com/marijuana-info/marijuana-in-the-bible/jesus-cannabis/
top
Topical cannabinoid receptor 1 agonist attenuates the cutaneous inflammatory responses in oxazolone-induced atopic dermatitis model (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26095080
The safety and efficacy of 3% Cannabis seeds extract cream for reduction of human cheek skin sebum and erythema content (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/26142529
Hot Tired Feet at #BEA15? My Sorry-It’s-Not-Legal-Yet-In-NY Lemon Mint Cold Cannabis Salve Recipe (news/recipe–2015) http://www.hempista.com/2015/hot-tired-feet-at-bea15-my-sorry-its-not-legal-yet-in-ny-lemon-mint-coldcannabis-salve-recipe/
Selective Cannabinoid Receptor-1 Agonists Regulate Mast Cell Activation in an Oxazolone-Induced Atopic Dermatitis Model (full–2016) http://anndermatol.org/DOIx.php?id=10.5021/ad.2016.28.1.22
Establishment of a New Drug Code for Marihuana Extract. Final rule (full–2016) https://www.federalregister.gov/documents/2016/12/14/2016-29941/establishment-of-a-new-drug-code-formarihuana-extract
Medical Cannabis in the Palliation of Malignant Wounds—A Case Report (article–2017) http://www.jpsmjournal.com/article/S0885-3924(16)30328-1/abstract


METHODS OF USE-TRANSDERMAL PATCH
Cannabidiol bioavailability after nasal and transdermal application: effect of permeation enhancers (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20545522
US Patent Application 20110052694 – USE OF CANNABIDIOL PRODRUGS IN TOPICAL AND TRANSDERMAL ADMINISTRATION WITH MICRONEEDLES (full–2011) http://www.google.com/patents/US20110052694
TRANSDERMAL DELIVERY OF CANNABINOIDS – Patent US2012034293 (A1)― 2012-02-09 (full–2012) http://worldwide.espacenet.com/publicationDetails/description?CC=US&NR=2012034293A1&KC=A1&FT&ND=3&date=20120209&DB=EPODOC&locale=en_EP
Transdermal delivery of cannabidiol attenuates binge alcohol-induced neuro-degeneration in a rodent model of an alcohol use disorder (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24012796
Transdermal delivery of cannabidiol attenuates binge alcohol-induced neuro-degeneration in a rodent model of an alcohol use disorder (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4096899/
top


METHODS OF USE-VAPORIZERS
Pulmonary function in cannabis users: Support for a clinical trial of the vaporizer (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20451365
Low-Dose Vaporized Cannabis Significantly Improves Neuropathic Pain (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3566631/
Simple Method: Isolating & Extracting INDIVIDUAL Cannabinoids … from BadKittySmiles (forum post–2012) http://forum.grasscity.com/incredible-edible-herb/1051569-simple-method-isolating-extracting-individualcannabinoids-badkittysmiles.html
Cannabis and the Lung: No More Smoking Gun? (editorial–2013) http://www.atsjournals.org/doi/abs/10.1513/AnnalsATS.201302-034ED?url_ver=Z39.88-2003&rfr_idri:rid:crossref.org&rfr_dat=cr_pub%3dpubmed&
Therapeutic benefits of cannabis: a patient survey (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3998228/
Getting high on the endocannabinoid system (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3997295/
A protocol for the delivery of cannabidiol (CBD) and combined CBD and [increment]9-tetrahydrocannabinol (THC) by vaporisation (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4274767/
Experiences of marijuana-vaporizer users (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24821347
A Vapourized Δ9-Tetrahydrocannabinol (Δ9-THC) Delivery System Part I: Development and Validation of a Pulmonary Cannabinoid Route of Exposure for Experimental Pharmacology Studies in Rodents (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24973534
Controlled Cannabis Vaporizer Administration: Blood and Plasma Cannabinoids with and without Alcohol (full–2015) http://www.clinchem.org/content/61/6/850.long
Implications of Marijuana Decriminalization on the Practice of Pulmonary, Critical Care, and Sleep Medicine. A Report of the American Thoracic Society Marijuana Workgroup (full–2015) http://www.atsjournals.org/doi/full/10.1513/AnnalsATS.201504-195AR#.Vo20QFJwtSE
Mull it over: cannabis vaporizers and harm reduction (full–2015) http://onlinelibrary.wiley.com/doi/10.1111/add.13139/full
No smoke, no fire: What the initial literature suggests regarding vapourized cannabis and respiratory risk (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4456813/
Confirmation of the trials and tribulations of vaping (article–2015) http://onlinelibrary.wiley.com/doi/10.1111/add.13155/full
How beneficial is vaping cannabis to respiratory health compared to smoking? (article-2015) http://onlinelibrary.wiley.com/doi/10.1111/add.13075/full
Electronic cigarettes and cannabis: an exploratory study (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25613866
In the weeds: a baseline view of cannabis use among legalizing states and their neighbours (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26687431
Online survey characterizing vaporizer use among cannabis users (abst–2015) http://www.drugandalcoholdependence.com/article/S0376-8716%2815%2901835-9/abstract
top
Prescribing medical cannabis in Canada: Are we being too cautious? (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26451996
Vaping cannabis (marijuana): parallel concerns to e-cigs? (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26264448
Medicinal Cannabis: In Vitro Validation of Vaporizers for the Smoke-Free Inhalation of Cannabis (link to PDF–2016) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0147286
Drug vaping applied to cannabis: Is “Cannavaping” a therapeutic alternative to marijuana? (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4881394/
No Smoke without Tobacco: A Global Overview of Cannabis and Tobacco Routes of Administration and Their Association with Intention to Quit (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4933835/
Tracking Dabbing Using Search Query Surveillance: A Case Study in the United States (full-2016) http://www.jmir.org/2016/9/e252/
A user’s guide to cannabinoid therapies in oncology (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5176373/
Cannabis Legalization: Focusing on Patient Needs: Five Recommendations on Access, Affordability, and Research (report–2016) http://cfamm.ca/patient-recommendations/
Smoking, vaping, eating: Is legalization impacting the way people use cannabis? (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26992484
An Exploratory Human Laboratory Experiment Evaluating Vaporized Cannabis in the Treatment of Neuropathic Pain from Spinal Cord Injury and Disease (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27286745
Inhaled delivery of Δ9-tetrahydrocannabinol (THC) to rats by e-cigarette vapor technology (abst–2016) http://www.sciencedirect.com/science/article/pii/S002839081630226X
A review of the additive health risk of cannabis and tobacco co-use (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27476751
Cannabinoid disposition in oral fluid after controlled smoked, vaporized, and oral cannabis administration (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27647820
Prevalence and correlates of “Vaping” as a route of cannabis administration in medical cannabis patients (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27770657
Medical cannabis use in Canada: vapourization and modes of delivery (full–2016) https://harmreductionjournal.biomedcentral.com/articles/10.1186/s12954-016-0119-9
Free and Glucuronide Whole Blood Cannabinoids’ Pharmacokinetics after Controlled Smoked, Vaporized, and Oral Cannabis Administration in Frequent and Occasional Cannabis Users: Identification of Recent Cannabis Intake (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27899456
Thermolytic degradation of synthetic cannabinoids: chemical exposures and pharmacological consequences (link to download–2017) http://jpet.aspetjournals.org/content/early/2017/01/13/jpet.116.238717.long
Medical Cannabis in the Palliation of Malignant Wounds—A Case Report (article–2017) http://www.jpsmjournal.com/article/S0885-3924(16)30328-1/abstract
Evaluation of divided attention psychophysical task performance and effects on pupil sizes following smoked, vaporized and oral cannabis administration (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28138971


METHODS OF USE-VARIOUS/OTHER
Information for Health Care Professionals- Marihuana (marijuana, cannabis) dried plant for administration by ingestion or other means (Health Canada) (full-2010) http://www.hc-sc.gc.ca/dhp-mps/marihuana/med/infoprof-eng.php
Dosage & Routes of Cannabis and Cannabinoid Administration (article/forum repost-2010) http://www.420magazine.com/forums/methods-use-various/173948-dosage-routes-cannabis-cannabinoidadministration.html
Scientific Opinion on the safety of hemp (Cannabis genus) for use as animal feed (full-2011) (deceptive title) http://www.hanf-info.ch/info/en/IMG/pdf/EIHA-11-05-31_EIHA-Statement_on_THC_in_feed.pdf
The medicinal use of cannabis and cannabinoids: an international survey on methods of intake (abst-2011) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=482
Medical Marijuana: Clearing Away the Smoke (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3358713/
Cannabinoid derivate-loaded PLGA nanocarriers for oral administration: formulation, characterization, and cytotoxicity studies (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3511186/
Cannabis Oil : chemical evaluation of an upcoming cannabis based medicine (full-2013) http://www.cannabis-med.org/data/pdf/en_2013_01_1.pdf
Integrating Cannabis Into Clinical Care (article–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3875042/
Getting high on the endocannabinoid system (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3997295/
Responsible and controlled use: Older cannabis users and harm reduction (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/25911027
In the weeds: a baseline view of cannabis use among legalizing states and their neighbours (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/26687431
Legal regulated markets have the potential to reduce population levels of harm associated with cannabis use (full – 2016) http://onlinelibrary.wiley.com/doi/10.1111/add.13390/full Medical cannabis use in Canada: vapourization and modes of delivery (full–2016) https://harmreductionjournal.biomedcentral.com/articles/10.1186/s12954-016-0119-9
A user’s guide to cannabinoid therapies in oncology (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5176373/
COMPREHENSIVE MEDICAL MARIJUANA PATIENT STUDY (link to PDF–2016) https://www.hellomd.com/medical-marijuana-patient-survey
Chapter 3 – Medical Cannabis Formulations (abst-2016) http://www.sciencedirect.com/science/article/pii/B9780128046463000035
top
Clinical trials of medicinal cannabis for appetite-related symptoms from advanced cancer: A survey of preferences, attitudes and beliefs among patients willing to consider participation (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27530738
Medical Marijuana: Just the Beginning of a Long, Strange Trip? (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27660328
Evaluation of divided attention psychophysical task performance and effects on pupil sizes following smoked, vaporized and oral cannabis administration (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28138971


MIDLIFE ADULT USE
Prevalences of illicit drug use in people aged 50 years and over from two surveys (full–2012) http://ageing.oxfordjournals.org/content/41/4/553.long
Still Dazed and Confused: Midlife Marijuana Use by the Baby Boom Generation (abst–2013) http://www.tandfonline.com/doi/abs/10.1080/01639625.2014.889994
Association Between Lifetime Marijuana Use and Cognitive Function in Middle Age: The Coronary Artery Risk Development in Young Adults (CARDIA) Study (full–2016) http://archinte.jamanetwork.com/article.aspx?articleid=2484906
National Estimates of Marijuana Use and Related Indicators — National Survey on Drug Use and Health, United States, 2002–2014 (full–2016) http://www.cdc.gov/mmwr/volumes/65/ss/ss6511a1.htm?s_cid=ss6511a1_e
The Effect of Medical Marijuana on Sickness Absence (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27416978
Marijuana use in adults admitted to a Canadian epilepsy monitoring unit (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27568641
Prevalence and correlates of “Vaping” as a route of cannabis administration in medical cannabis patients (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27770657
A longitudinal examination of the relationship between cannabis use and cognitive function in mid-life adults (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27810656
From adolescent to elder rats: Motivation for palatable food and cannabinoids receptors (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27935269
Persistent cannabis dependence and alcohol dependence represent risks for midlife economic and social problems: A longitudinal cohort study (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/28008372
Association Between Use of Cannabis in Adolescence and Weight Change into Midlife (link to download–2017) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0168897


MIGRAINE/HEADACHE
The endocannabinoid system and migraine (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20353780
Alterations of the endocannabinoid system in an animal model of migraine: Evaluation in cerebral areas of rat (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/19515121
Effects of anandamide in migraine: data from an animal model (full-2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3072518/
Migraines, Marijuana, and Chocolate (article-2011) http://www.psychologytoday.com/blog/your-brain-food/201109/migraines-marijuana-and-chocolate
The Use of Marijuana or Synthetic Cannabinoids for the Treatment of Headache (1st page-2011) http://onlinelibrary.wiley.com/doi/10.1111/j.1526-4610.2011.01848.x/abstract
Interictal Type 1 Cannabinoid Receptor Binding is Increased in Female Migraine Patients (abst-2011) http://www.ncbi.nlm.nih.gov/pubmed/22077199
Hallucinogens and cannabinoids for headache (abst-2012) http://www.ncbi.nlm.nih.gov/pubmed/23030539
Use of cannabis among 139 cluster headache sufferers (abst-2012) http://www.ncbi.nlm.nih.gov/pubmed/23197349
Acute reduction of anandamide-hydrolase (FAAH) activity is coupled with a reduction of nociceptive pathways facilitation in medication-overuse headache subjects after withdrawal treatment (abst-2012) http://www.ncbi.nlm.nih.gov/pubmed/22670561?dopt=Abstract
Irritable Bowel Syndrome and Migraine: Bystanders or Partners? (full-2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3714407/
Endocannabinoids in the Brainstem Modulate Dural Trigeminovascular Nociceptive Traffic via CB1 and “Triptan” Receptors: Implications in Migraine (full-2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3771033/
Effect of Cannabinoid Receptor Activation on Spreading Depression (full-2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3586901/
Activation of CB2 receptors as a potential therapeutic target for migraine: evaluation in an animal model (full–2014) http://www.thejournalofheadacheandpain.com/content/pdf/1129-2377-15-14.pdf
Exposure to Bisphenol A Exacerbates Migraine-Like Behaviors in a Multibehavior Model of Rat Migraine (abst–2014) http://toxsci.oxfordjournals.org/content/137/2/416.abstract?
Intraganglionic injection of a nitric oxide donator induces afferent mechanical sensitization that is attenuated by palmitoylethanolamide (abst–2014) http://cep.sagepub.com/content/34/9/686.abstract
Intraganglionic injection of a nitric oxide donator induces afferent mechanical sensitization that is attenuated by palmitoylethanolamide (full–2014) http://journals.sagepub.com/doi/full/10.1177/0333102414521510
Nocebo and placebo modulation of hypobaric hypoxia headache involves the cyclooxygenase-prostaglandins pathway (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24462931
Discriminating the effects of Cannabis sativa and Cannabis indica: a web survey of medical cannabis users (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25191852sid=8056cec7-005f-4140-9293-0c57afd8aea8
Discriminating the effects of Cannabis sativa and Cannabis indica: a web survey of medical cannabis users (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25191852
Clinical endocannabinoid deficiency (CECD) revisited: Can this concept explain the therapeutic benefits of cannabis in migraine, fibromyalgia, irritable bowel syndrome and other treatment-resistant conditions? (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24977967
Clinical endocannabinoid deficiency (CECD) revisited: Can this concept explain the
therapeutic benefits of cannabis in migraine, fibromyalgia, irritable bowel syndrome and other treatment-resistant conditions? (full–2014) http://tinyurl.com/hss39v9
top
Chronic Adolescent Marijuana Use as a Risk Factor for Physical and Mental Health Problems in Young Adult Men (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26237286
Study finds no link between teen marijuana use, mental health issues (news–2015) http://www.foxnews.com/health/2015/08/04/study-finds-no-link-between-teen-marijuana-use-mentalhealth-issues/
Teen marijuana use not linked to later depression, lung cancer, other health problems, study finds (news–2015) http://www.sciencedaily.com/releases/2015/08/150804093718.htm
Effects of peripheral FAAH blockade on NTG-induced hyperalgesia-evaluation of URB937 in an animal model of migraine (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25608877
Diet-induced changes in n-3 and n-6 derived endocannabinoids and reductions in headache pain and psychological distress (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4522350/
The modulatory effect of anandamide on nitroglycerin-induced sensitization in the trigeminal system of the rat (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26512068
The modulatory effect of anandamide on nitroglycerin-induced sensitization in the trigeminal system of the rat (full–2015) http://journals.sagepub.com/doi/full/10.1177/0333102415613766
Osler on Migraine (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25721175
Inhibition of FAAH reduces nitroglycerin-induced migraine-like pain and trigeminal neuronal hyperactivity in mice (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25910421
Comprehensive Review of Medicinal Marijuana, Cannabinoids, and Therapeutic Implications in Medicine and Headache: What a Long Strange Trip It’s Been … (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26015168
Effects of Medical Marijuana on Migraine Headache Frequency in an Adult Population (full–2016) http://onlinelibrary.wiley.com/doi/10.1002/phar.1673/full
The use of illicit drugs as self-medication in the treatment of cluster headache: Results from an Italian online survey (abst–2015)  http://www.ncbi.nlm.nih.gov/pubmed/25903763
Diet-induced changes in n-3 and n-6 derived endocannabinoids and reductions in headache pain and psychological distress (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25958314
top
Effects of Medical Marijuana on Migraine Headache Frequency in an Adult Population (full–2016) http://onlinelibrary.wiley.com/doi/10.1002/phar.1673/full
Endovanilloids are potential activators of the trigeminovascular nocisensor complex (full–2016) http://thejournalofheadacheandpain.springeropen.com/articles/10.1186/s10194-016-0644-7
Childhood Maltreatment in the Migraine Patient (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27194425
Variants in the CNR1 gene predispose to headache with nausea in the presence of life stress (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27762084
Antagonism of cannabinoid receptor 1 attenuates the anti-inflammatory effects of electroacupuncture in a rodent model of migraine (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27834685


MILITARY and CANNABINOIDS
Survey on the use of psychotropic drugs by twelve military police units in the municipalities of Goiânia and Aparecida de Goiânia, state of Goiás, Brazil (full–2010) http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-44462010000400012&lng=en&nrm=iso&tlng=en
Survey of alcohol, tobacco, and cannabis use in the French army (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20390703
Cannabis use among military veterans after residential treatment for posttraumatic stress disorder (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21261407
Prevalence of Cannabis Use Disorder Diagnoses Among Veterans in 2002, 2008, and 2009 (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22564034
The underdiagnosis of cannabis use disorders and other Axis-I disorders among military veterans within VHA (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22808884
Spice: a new “legal” herbal mixture abused by young active duty military personnel (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22489593
Synthetic Cannabinoid and Cathinone Use Among US Soldiers (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23007932
Spice, bath salts, and the U.S. military: the emergence of synthetic cannabinoid receptor agonists and cathinones in the U.S. Armed Forces (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23025133
Alcohol and cannabis consumption in the French Army: determination of consumer profiles to focus on prevention and care (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22128723
Cognitive ability in early adulthood as a predictor of habitual drug use during later military service and civilian life: the Vietnam Experience Study (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22520690
Substance use disorders in the U.S. Armed Forces, 2000-2011 (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23231051
The accuracy of self-reported data concerning recent cannabis use in the French armed forces (full–2013) http://eurpub.oxfordjournals.org/content/23/2/328.long
Correspondence (letter to the editor): Cannabis Therapy (letter–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3601285/
Synthetic Cannabinoid Overdose in a 20-Year-Old Male US Soldier (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23327506
Is serving in the armed forces associated with tobacco or cannabis initiation? A study of onset sequences before and after joining the French armed forces (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23685331
Poor sleep quality as a risk factor for lapse following a cannabis quit attempt (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23098380
Posttraumatic stress disorder and cannabis use characteristics among military veterans with cannabis dependence (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23617872 Urinary prevalence, metabolite detection rates, temporal patterns and evaluation of suitable LC-MS/MS targets to document synthetic cannabinoid intake in US military urine specimens (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25263309
Spicing up the military: Use and effects of synthetic cannabis in substance abusing army personnel (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24727109
Prevalence of psychotropic drug use in military police units (full–2015) http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1413-81232015000601843&lng=en&nrm=iso&tlng=en
Veterans Health Administration Policy on Cannabis as an Adjunct to Pain Treatment with Opiates (article–2015) http://journalofethics.ama-assn.org/2015/06/pfor2-1506.html
Use and effects of cannabinoids in military veterans with posttraumatic stress disorder (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26195653
Difficulties in emotion regulation are associated with panic symptom severity following a quit attempt among cannabis dependent veterans (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25034429
Cannabis use among Navy personnel in Sri Lanka: a cross sectional study (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4794863/
Associations of Posttraumatic Stress Disorder Symptoms With Marijuana and Synthetic Cannabis Use Among Young Adult U.S. Veterans: A Pilot Investigation (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27172584
Factors associated with having a medical marijuana card among Veterans with recent substance use in VA outpatient treatment (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27475408
Medicinal versus recreational cannabis use: Patterns of cannabis use, alcohol use, and cued-arousal among veterans who screen positive for PTSD (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28088054


MISCELLANEOUS STUFF–STUDIES
VICTOR LICATA : A RUSH TO JUDGEMENT (ebook–undated) http://reefermadnessmuseum.org/VictorLIcata/Chap00_Index.htm
Drug War Clock: Money Spent on the War On Drugs this Year (links to studies-undated) http://www.drugsense.org/cms/wodclock
Outline for a Marijuana Medical Handbook – Tod Mikuriya (undated) http://www.ukcia.org/medical/marijuanamedicalhandbook.php
THE LEGEND OF THE HOT TAMALE PEDDLER: What the Newspapers were saying: (news–undated) http://reefermadnessmuseum.org/chap11/NewsPaper.htm
Hemp Hurds As Paper Making Material: Bulletin 404, USDA 1916 (full–1916) http://www.gutenberg.org/files/17855/17855-h/17855-h.htm
Problems of modern hemp breeding, with particular reference to the breeding of varieties of hemp containing little or no hashish (full–1956) http://www.unodc.org/unodc/en/data-and-analysis/bulletin/bulletin_1956-01-01_3_page007.html
The Use of the Cannabis Drugs in India (full–1957) http://www.unodc.org/unodc/en/data-and-analysis/bulletin/bulletin_1957-01-01_1_page003.html
Suppressive Effects of 2-thiouracil on Differentiation and Flowering in Cannabis Sativa (abst–1960) http://www.ncbi.nlm.nih.gov/pubmed/13713898
Sweet v. Parsley and Public Welfare Offences (full–1969) http://onlinelibrary.wiley.com/doi/10.1111/j.1468-2230.1969.tb02306.x/epdf
Mr. X by Carl Sagan (article-1969) http://marijuana-uses.com/mr-x/
Effects of Chronic Smoking of Cannabis in Jamaica (download–1972) http://cifas.us/pdf/Comitas%20Pdf%20Files/Long%20Manuscripts/1972%20Effects%20of%20Chronic%20Smoking%20of%20Cannabis%20in%20Jamaica.pdf
Marijuana and Mutism (abst-1972) http://ajp.psychiatryonline.org/doi/abs/10.1176/ajp.129.4.475
Cannabinoid Profile and Elemental Uptake of Cannabis sativa L. as Influenced by Soil Characteristics (full-1975) http://www.votehemp.com/PDF/Cannabinoid_Profile_and_Elemental_Uptake_of_Cannabis_sativa_L._as_I nfluenced_by_Soil_Characteristics-1975.pdf
Kif in Morocco (abst–1975) http://www.ncbi.nlm.nih.gov/pubmed/1104494
Physical assessment of 30 chronic cannabis users and 30 matched controls (1st page–1976) http://onlinelibrary.wiley.com/doi/10.1111/j.1749-6632.1976.tb49895.x/abstract
A note on the cannabinoid content of Jamaican ganja (abst–1976) http://www.ncbi.nlm.nih.gov/pubmed/1051625
Marijuana – The First Twelve Thousand Years (book–1980) http://www.druglibrary.org/Schaffer/hemp/history/first12000/abel.htm
Sequential appearance of cannabinoids during seedling development (full–1980) https://www.realhemp.com/marihuana-84/
Ingestion of Hashish Oil-filled Condoms (abst–1980) http://www.ncbi.nlm.nih.gov/pubmed/7207349
Bias and the cannabis researcher (abst–1981) http://www.ncbi.nlm.nih.gov/pubmed/6271821
Structure, development and composition of glandular trichomes of Cannabis (link to PDF–1984) https://www.realhemp.com/mahlberg-cannabis-research/structure-development-and-composition-ofglandular-trichomes-of-cannabis/
Illicit traffic and abuse of cannabis in Canada (full–1985) http://www.unodc.org/unodc/en/data-and-analysis/bulletin/bulletin_1985-01-01_4_page006.html
Barba Jacob and the history of marihuana (abst–1986) http://www.ncbi.nlm.nih.gov/pubmed/3296662
Retrieving impacted cannabis resin with ear drops (full-1987) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1492799/?tool=pubmed
UV-B radiation effects on photosynthesis, growth and cannabinoid production of two Cannabis sativa chemotypes (abst–1987) http://onlinelibrary.wiley.com/doi/10.1111/j.1751-1097.1987.tb04757.x/abstract;jsessionid=E27DFF97974EDECC7DCDFFD1EED18D17.d03t03
UV-B radiation effects on photosynthesis, growth and cannabinoid production of two Cannabis sativa chemotypes (download–1987) DOWNLOAD PDF VERSION
The Business of Drug Dealing in Milwaukee (download–1988) http://cifas.us/analyses/dealing.pdf
Stability of Cannabinoids in Dried Samples of Cannabis Dating from Around 1896-1905 (abst–1990) http://www.ncbi.nlm.nih.gov/pubmed/2314109
The Intangible Rewards from Crime: The Case of Domestic Marijuana Cultivation (abst-1991) http://cad.sagepub.com/content/37/4/506.abstract?maxtoshow=&hits=80&RESULTFORMAT=&fulltext=marihuana&searchid=1&FIRSTINDEX=1840&resourcetype=HWCIT
From Ganja to Crack: Caribbean Participation in the Underground Economy in Brooklyn, 1976-1986. Part 1. Establishment of the Marijuana Economy (abst–1991) http://www.tandfonline.com/doi/abs/10.3109/10826089109058909
Flashback Following Use of Cannabis-a Review (abst–1991) http://www.ncbi.nlm.nih.gov/pubmed/1761271
The Effect of Marijuana Decriminalization on Hospital Emergency Room Drug Episodes: 1975–1978 (full–1993) http://www.drugpolicy.org/docUploads/model.pdf
Economics of Cannabis Legalization (article–1993) http://cifas.us/analyses/gieringer.htmlhttp://cifas.us/analyses/gieringer.html
Economics of Legalization (full–1994) http://norml.org/component/zoo/category/economics-of-cannabis-legalization
Preference for High- Versus Low-potency Marijuana (abst–1994) http://www.ncbi.nlm.nih.gov/pubmed/7862719
DRUG USE AND HUMAN RIGHTS: PRIVACY, VULNERABILITY, DISABILITY, AND HUMAN RIGHTS INFRINGEMENTS (article–1996) http://cifas.us/analyses/Gilmore1.html
Immunochemical localization of tetrahydrocannabinol (THC) in cryofixed glandular trichomes of Cannabis (Cannabaceae) (full–1997) http://www.amjbot.org/content/84/3/336.full.pdf+html
Cannabis Hemp: The Invisible Prohibition Revealed (link to PDF–1997) http://www.constitutionalcannabis.com/uploads/1/3/5/9/13590809/sots_web.pdf
Feasibility of Industrial Hemp Production in the United States Pacific Northwest (link to PDF–1998) https://catalog.extension.oregonstate.edu/sb681
Drugs in Prehistory: Chemical Analysis of Ancient Human Hair (abst–1998) http://www.fsijournal.org/article/S0379-0738%2899%2900204-2/abstract
Drugs in Prehistory: Chemical Analysis of Ancient Human Hair (link to download–1998) https://www.researchgate.net/publication/12579718_Drugs_in_prehistory_Chemical_analysis_of_ancient_ human_hair
Providing medical marijuana: the importance of cannabis clubs (abst–1998) http://www.ncbi.nlm.nih.gov/pubmed/9692380
Schedules of controlled substances: rescheduling of the Food and Drug Administration approved product containing synthetic dronabinol [(-) – [DELTA] less than 9 greater than – (trans)-tetrahydrocannabinol] in sesame oil and encapsulated in soft gelatin capsules from schedule II to schedule III. Department of Justice (DOJ), Drug Enforcement Administration (DEA) Final rule (full–1999) http://www.deadiversion.usdoj.gov/fed_regs/rules/1999/fr0702.htm
top
A Critical Look at the D.A.R.E. Program and Effective Youth Programs (3 articles-1999) https://web.stanford.edu/class/e297c/poverty_prejudice/ganginterv/criticallook.htm The Relationship between Research and Drug Policy in the United States (article–1999) http://cifas.us/analyses/laniel.html
Thujone exhibits low affinity for cannabinoid receptors but fails to evoke cannabimimetic responses (abst–1999) http://www.ncbi.nlm.nih.gov/pubmed/10080239
Project DARE: no effects at 10-year follow-up (abst–1999) http://www.ncbi.nlm.nih.gov/pubmed/10450631
The Science of Marijuana (book–2000) http://www.green215.com/sites/all/files/education_articles/Science%20Cannabis.pdf
Cannabinoid mimics in chocolate utilized as an argument in court (abst–2000) http://www.ncbi.nlm.nih.gov/pubmed/10876983
New Tropical Industrial Hemp (full–2001) http://www.hempreport.com/issues/17/australia16.html
Industrial Hemp (Cannabis sativa L.) as a Papermaking Raw Material in Minnesota: Technical, Economic, and Environmental Considerations (full–2001) http://www.votehemp.com/PDF/hemp.pdf
Cannabis: an environmentally and economically viable method for climate change mitigation (revised 2001) (thesis–2001) http://www.hempreport.com/issues/17/pdf/deeleythesis.pdf
Distortion of Teatree Stems by Twine As a Means to Determine the Number of Years That the Stems Have Been Used to Support Cannabis Plants (abst–2001) http://www.ncbi.nlm.nih.gov/pubmed/11451066
Cannabis-induced Koro in Americans (abst–2001) http://www.ncbi.nlm.nih.gov/pubmed/11784462
The economics of cannabis-cultivation in Europe (full-2002) http://www.cedro-uva.org/lib/jansen.economics.html
Chronic Cannabis Use in the Compassionate Investigational New Drug Program (abstract & comments-2002) http://www.letfreedomgrow.com/cmu/chronic_cannabis_use.htm
Chronic Cannabis Use in the Compassionate Investigational New Drug Program: An Examination of Benefits and Adverse Effects of Legal Clinical Cannabis (full–2002) http://proxy.baremetal.com/cannabiscoalition.ca/chronic.pdf
The endocannabinoid system in invertebrates (link to PDF – 2002) http://citeseerx.ist.psu.edu/viewdoc/summary? doi=10.1.1.724.8151&rank=69&q=cannabinoid&osm=&ossid=
The Ganja Complex: Rastafari and Marijuana (download–2002) http://cifas.us/pdf/Fieldwork%20and%20Research/Cannabis/Books/Hamid/2002_GanjaComplex_Hamid%202.pdf
Chronic Cannabis Use in the Compassionate Investigational New Drug Program: An Examination of Benefits and Adverse Effects of Legal Clinical Cannabis (summary – 2002) http://www.letfreedomgrow.com/cmu/chronic_cannabis_use.htm
Remediation of benzo[a]pyrene and chrysene-contaminated soil with industrial hemp (Cannabis sativa) (abst–2002) http://www.ncbi.nlm.nih.gov/pubmed/12655808
A Brief History of Cannabis Policies in Spain (1968–2003) (full–2003) http://jod.sagepub.com/content/34/3/623.full.pdf+html
Patent 6503492 – Antiperspirant or deodorant compositions (full–2003) http://www.google.com/patents/US6503492
Cannabis (marijuana) contamination of United States and foreign paper currency (full–2004) http://jat.oxfordjournals.org/content/28/6/439.long
California and U.S. Officials Conspired to Block Prop 215 (article – 2004) http://www.os-extra.cannabisclinicians.org/wp-content/uploads/2014/04/McCartney-Conspiracy-04.pdf
Burns from illegal drug manufacture: case series and management (abst–2004) http://www.ncbi.nlm.nih.gov/pubmed/15273473
A biological oil adsorption filter (abst–2004) http://www.ncbi.nlm.nih.gov/pubmed/15556187
God forbid! Substance use among religious and non-religious youth (full–2005) http://www.ncbi.nlm.nih.gov/pubmed/16262516
Cannabimimetic Effects of Osteopathic Manipulative Treatment (full–2005) http://jaoa.org/article.aspx?articleid=2093088&resultClick=1
Mother’s milk and the muffin man: grassroots innovations in medical marijuana delivery systems (abst–2005) http://www.ncbi.nlm.nih.gov/pubmed/16537333
Cultivation of Cannabis sativa L. in northern Morocco (abst–2005) http://www.ncbi.nlm.nih.gov/pubmed/21338017
Fibre crops as alternative land use for radioactively contaminated arable land (abst–2005) http://www.ncbi.nlm.nih.gov/pubmed/15795030
Waterborne Lead Exposure Affects Brain Endocannabinoid Content in Male but Not Female Fathead Minnows (Pimephales Promelas) (abst–2005) http://www.ncbi.nlm.nih.gov/pubmed/15527869
Strong increase in total delta-THC in cannabis preparations sold in Dutch coffee shops (abst–2005) http://www.ncbi.nlm.nih.gov/pubmed/16191670
Marijuana Production in the United States (full–2006) http://www.drugscience.org/Archive/bcr2/MJCropReport_2006.pdf
top
Explicit and Implicit Effects of Anti-marijuana and Anti-tobacco Tv Advertisements (abst–2006) http://www.sciencedirect.com/science/article/pii/S0306460306000955
Cannabis and Endocannabinoids: The Old Man and the Teenagers (full–2007) http://www.farm.ucl.ac.be/Full-texts-FARM/Lambert-2007-1.pdf
“Usual” cannabis abuse producing an unusual incident (abst–2007) (The Valsalva maneuver is performed by attempting to forcibly exhale while keeping the mouth and nose closed. Don’t do it!) http://www.ncbi.nlm.nih.gov/pubmed/17342632
Apparent increase in biomass and see productivity in hemp (Cannabis sativa) resulting from branch proliferation caused by the European corn borer (Ostrinia nubilalis) (abst–2007) http://www.agr.gc.ca/eng/abstract/?id=9561000000564
Detection method for the ability of hemp (Cannabis sativa L.) seed germination by the use of 2,3,5-triphenyl-2H-tetrazolium chloride (TTC) (full-2008) https://www.jstage.jst.go.jp/article/yakushi/128/11/128_11_1707/_pdf
The Army’s Conquest-by-Cannabinoid Fantasy (article–2008) http://www.beyondthc.com/wp-content/uploads/2014/06/Ketchum-THM-issue-color.pdf
Scheduling process at DEA – the example of cannabidiol (abst–2008) http://www.fasebj.org/cgi/content/meeting_abstract/22/1_MeetingAbstracts/711.1
N-arachidonoyl dopamine is a possible factor of the rate of tentacle formation in freshwater hydra (abst–2008) http://www.ncbi.nlm.nih.gov/pubmed/18409382
Fungal biotransformation of cannabinoids: potential for new effective drugs (abst–2009) http://www.ncbi.nlm.nih.gov/pubmed/19333876
Cannabinoids Excite Circadian Clock Neurons (full-2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2927117/?tool=pmcentrez
Tea catechins’ affinity for human cannabinoid receptors (full–2010) http://www.thefreelibrary.com/Tea+catechins%27+affinity+for+human+cannabinoid+receptors.-a0221094461
A Sociological Theory of Drug Sales, Gifts, and Frauds (full–2010) http://journals.sagepub.com/doi/full/10.1177/0011128710386199
Characteristics of Cannabis sativa L.: seed morphology, germination and growth characteristics, and distinction from Hibiscus cannabinus L (link to PDF–2010) https://www.jstage.jst.go.jp/article/yakushi/130/2/130_2_237/_article
Necessity or nastiness? The hidden law denying cannabis for medical use (full/news–2010) http://profdavidnutt.wordpress.com/2010/12/13/necessity-or-nastiness-the-hidden-law-denying-cannabisfor-medicinal-use/
Colonic perforation: a lethal consequence of cannabis body packing (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20569954
Stable isotope models to predict geographic origin and cultivation conditions of marijuana (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20470741
The results of an experimental indoor hydroponic Cannabis growing study, using the ‘Screen of Green’ (ScrOG) method-Yield, tetrahydrocannabinol (THC) and DNA analysis (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20462712
Potency trends of Δ9-THC and other cannabinoids in confiscated cannabis preparations from 1993 to 2008 (abst–2010) http://www.unboundmedicine.com/medline/ebm/record/20487147/abstract/Potency_trends_of_%CE%949_THC_and_other_cannabinoids_in_confiscated_cannabis_preparations_from_1993_to_2008_
The case for small-scale domestic cannabis cultivation (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20176465
top
The feasibility of converting Cannabis sativa L. oil into biodiesel (abst-2010) http://www.ncbi.nlm.nih.gov/pubmed/20624607
A Sociological Theory of Drug Sales, Gifts, and Frauds (abst–2010) http://cad.sagepub.com/content/60/7/1057.abstract
Effect of various concentrations of Crocus sativus and Cannabis sativa extracts on luminescent biosensor Escherichia coli SM10 S1 (full–2011) http://jjm.ajums.ac.ir/_jjm/documents/Issue%2012,%20S35-41MM.pdf
Bilateral testicular self-castration due to cannabis abuse: a case report (full–2011) (warning-graphic pictures) http://www.jmedicalcasereports.com/content/5/1/404
Cannabinoid CB2 Receptors Contribute to Upregulation of β-endorphin in Inflamed Skin Tissues by Electroacupuncture (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3281798/
Cannabinomimetic lipid from a marine cyanobacterium (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3325759/
High-performance sport, marijuana, and cannabimimetics (full–2011) http://jat.oxfordjournals.org/content/35/9/624.long
“But my Doctor Recommended Pot”: Medical Marijuana and the Patient-Physician Relationship (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3208453/
How well do international drug conventions protect public health? (abst-register free for full–2011) http://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2811%2961423-2/fulltext
Examining the Health and Drug Exposures among Canadian Children Residing in DrugProducing Homes (abst–2011) http://www.jpeds.com/article/S0022-3476%2811%2900522-1/abstract
Study on spectral reflectance characteristics of hemp canopies (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21322234
Attempted ignition of petrol vapour by lit cigarettes and lit cannabis resin joints (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21605828
Bioconversion of industrial hemp to ethanol and methane: the benefits of steam pre-treatment and co-production (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21111616
Cadmium Tolerance and Bioaccumulation of 18 Hemp Accessions (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21938417
Reported value of cannabis seizures in Australian newspapers: are they accurate? (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21219493
Molecular analysis of genetic fidelity in Cannabis sativa L. plants grown from synthetic (encapsulated) seeds following in vitro storage (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21805186
Investigations into the Hypothesis of Transgenic Cannabis (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/22211569
What can we learn from the Dutch cannabis coffeeshop system? (abst–2011) http://marijuana.researchtoday.net/archive/8/10/4840.htm
The Effect of Electrical Lighting Power and Irradiance on Indoor-Grown Cannabis Potency and Yield (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/22211717
Electroacupuncture reduces the expression of proinflammatory cytokines in inflamed skin tissues through activation of cannabinoid CB2 receptors (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/22337285
Cannabis use in a central region of Tunisia (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/22407249
top
EVALUATION ALLELOPATHIC EFFECT OF HEMP (CANNABIS SATIVA L.) ON GERMINATION AND GROWTH OF THREE KINDS OF WEEDS (abst–2011) http://en.journals.sid.ir/ViewPaper.aspx?ID=246119
High on Life? Medical Marijuana Laws and Suicide (full–2012) http://ftp.iza.org/dp6280.pdf
Medical Marijuana Laws and Teen Marijuana Use (full–2012) http://ftp.iza.org/dp6592.pdf
The medicalisation of revolt: a sociological analysis of medical cannabis users (full–2012) http://onlinelibrary.wiley.com/doi/10.1111/j.1467-9566.2012.01476.x/full
Clinical Service Desires of Medical Cannabis Patients (full–2012) http://www.harmreductionjournal.com/content/pdf/1477-7517-9-12.pdf
Societal images of Cannabis use: comparing three countries (full–2012) http://www.harmreductionjournal.com/content/pdf/1477-7517-9-21.pdf
The Relationship between Plants Used to Sustain Finches (Fringillidae) and Uses for Human Medicine in Southeast Spain (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3350861/?tool=pubmed
Nutritive quality of romanian hemp varieties (Cannabis sativa L.) with special focus on oil and metal contents of seeds (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3543203/
Is today’s marijuana more potent simply because it’s fresher? (full–2012) http://onlinelibrary.wiley.com/doi/10.1002/dta.1430/full
Using dopamine research to generate rational cannabinoid drug policy (full–2012) http://onlinelibrary.wiley.com/doi/10.1002/dta.1410/full
Cannabis sativa – An Important Subsistence Pollen Source for Apis mellifera (full–2012) http://iosrjournals.org/iosr-jpbs/papers/vol1-issue4/A0140103.pdf
Cannabis in the Media: Film Prespectives on the Least Illicit Schedule 1 Drug (full–2012) http://entheology.com/research/cannabis-in-the-media-film-perspectives-on-the-least-illicit-schedule-idrug/
Marine Cyanobacterial Fatty Acid Amides Acting on Cannabinoid Receptors (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3748600/
Antimicrobial Activity of Cannabis sativa L. (full–2012) http://file.scirp.org/Html/10-8801078_18123.htm
Prospectively Surveying Health-Related Quality of Life and Symptom Relief in a LotBased Sample of Medical Cannabis-Using Patients in Urban Washington State Reveals Managed Chronic Illness and Debility (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22887696
Prospectively Surveying Health-Related Quality of Life and Symptom Relief in a LotBased Sample of Medical Cannabis-Using Patients in Urban Washington State Reveals Managed Chronic Illness and Debility (full–2012) http://journals.sagepub.com/doi/full/10.1177/1049909112454215
Prevalence of Synthetic Cannabinoids in U.S. Athletes: Initial Findings (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22872465
Prevalence of Synthetic Cannabinoids in U.S. Athletes: Initial Findings (full–2012) https://academic.oup.com/jat/article-lookup/doi/10.1093/jat/bks066
Cannabinoid-like anti-inflammatory compounds from flax fiber (link to PDF–2012) http://link.springer.com/article/10.2478%2Fs11658-012-0023-6
The medicalisation of revolt: a sociological analysis of medical cannabis users (link to PDF–2012) http://www.stcm.ch/en/files/paper_pedersen—sandberg.pdf
Cannabis Genome Uncloaked: Commentary on the Scientific Implications (article–2012) http://tinyurl.com/zqfrpew
Is today’s marijuana more potent simply because it’s fresher? (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23169764
Cannabis – from cultivar to chemovar (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22362625
Evolution of the Content of THC and Other Major Cannabinoids in Drug-Type Cannabis Cuttings and Seedlings During Growth of Plants (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22390363
Cannabinoid-like anti-inflammatory compounds from flax fiber (abst–2012) http://link.springer.com/article/10.2478%2Fs11658-012-0023-6
Enzymatic accessibility of fiber hemp is enhanced by enzymatic or chemical removal of pectin (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22237172
Chemiluminescence detection of cannabinoids and related compounds with acidic potassium permanganate (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22461321
The Studies on the Preparation, Structure and Physical Properties of Rubber Composites Filled with Hemp Hurd Powder (abst–2012) http://www.dissertationtopic.net/doc/1482776
top
Poly-ε-caprolactone microspheres as a drug delivery system for cannabinoid administration: Development, characterization and in vitro evaluation of their anti-tumoral efficacy (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22580111
Left-handedness is statistically linked to lifetime experimentation with illicit drugs (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22594814
A survey of the potency of Japanese illicit cannabis in fiscal year 2010 (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22554871
Shiva, lord of bhang (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22742944
Prevalence of Cannabis Use Disorder Diagnoses Among Veterans in 2002, 2008, and 2009 (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22564034
Investigation of drugs of abuse and relevant metabolites in Dutch sewage water by liquid chromatography coupled to high resolution mass spectrometry (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22784865
An age–period–cohort analysis of cannabis use prevalence and frequency in Germany, 1990–2009 (abst–2012) http://jech.bmj.com/content/early/2011/10/20/jech-2011-200180
The underdiagnosis of cannabis use disorders and other Axis-I disorders among military veterans within VHA (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22808884
The prevalence of substance use among patients at a dental school clinic in Michigan (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22855903
Comparison of Random and Postaccident Urine Drug Tests in Southern Indiana Coal Miners (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22895464
Synthetic Cannabinoid and Cathinone Use Among US Soldiers (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23007932
Effects of parabolic flight and spaceflight on the endocannabinoid system in humans (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23023882
Why small-scale cannabis growers stay small: Five mechanisms that prevent small-scale growers from going large scale (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23036648
Profiles of illicit drug use during annual key holiday and control periods in Australia: wastewater analysis in an urban, a semi-rural and a vacation area (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23072541
Predictors of stigmatization towards use of various illicit drugs among emerging adults (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23061324
Analysis of cannabinoids in laser-microdissected trichomes of medicinal Cannabis sativa using LCMS and cryogenic NMR (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23280038
The New Politics of Marijuana Legalization: Why Opinion is Changing (full–2013) http://www.brookings.edu/research/papers/2013/05/29-politics-marijuana-legalization-galston-dionne
top
Harms and benefits associated with psychoactive drugs: findings of an international survey of active drug users (full-2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4107777/
The Global Epidemiology and Contribution of Cannabis Use and Dependence to the Global Burden of Disease: Results from the GBD 2010 Study (full–2013) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0076635
Perceptions of cannabis as a stigmatized medicine: a qualitative descriptive study (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3584982/
Electroacupuncture inhibition of hyperalgesia in rats with adjuvant arthritis: involvement of cannabinoid receptor 1 and dopamine receptor subtypes in striatum (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3677619/
Why should Cannabis be Considered Doping in Sports? (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3654312/
Effects of steam pretreatment and co-production with ethanol on the energy efficiency and process economics of combined biogas, heat and electricity production from industrial hemp (full–2013) http://www.biotechnologyforbiofuels.com/content/6/1/56
Identity Formation, Marijuana and “The Self”: A Study of Cannabis Normalization among University Students (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3847659/
Weeding out the information: an ethnographic approach to exploring how young people sense of the evidence on cannabis (full–2013) http://www.harmreductionjournal.com/content/10/1/34
“Body packers” in Israel: a case series (full–2013) http://www.ima.org.il/FilesUpload/IMAJ/0/65/32679.pdf
In planta imaging of Δ9-tetrahydrocannabinolic acid in Cannabis sativa L. with hyperspectral coherent anti-Stokes Raman scattering microscopy (full–2013) http://os.tnw.utwente.nl/publications/pdf/237.pdf
Extraction of high quality DNA from seized moroccan cannabis resin (hashish) (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3790795/
Viking and early Middle Ages northern Scandinavian textiles proven to be made with hemp (full–2013) http://www.nature.com/srep/2013/131018/srep02686/pdf/srep02686.pdf
Do societal wealth, family affluence and gender account for trends in adolescent cannabis use? A 30 country cross-national study (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3947129/
Statistics on cannabis users skew perceptions of cannabis use (full–2013) http://journal.frontiersin.org/article/10.3389/fpsyt.2013.00138/full
US Patent Application 20130251824 – Recycling cannabinoid extractor (full–2013) http://www.faqs.org/patents/app/20130251824
From “Social Supply” to “Real Dealing”: Drift, Friendship, and Trust in Drug-Dealing Careers (full–2013) http://jod.sagepub.com/content/43/4/392.full.pdf+html
The Future of Marijuana in the United States (thesis–2013) http://law.uoregon.edu/org/olr/volumes/91/2/documents/Duke.pdf
Synthetic cannabis: A comparison of patterns of use and effect profile with natural cannabis in a large global sample (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23291209
Cloud point extraction of Δ(9)-tetrahydrocannabinol from cannabis resin (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23354583
top
Lifetime prevalence of alcohol and substance use in egypt: a community survey (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23577901
The prevalence and incidence of medicinal cannabis on prescription in The Netherlands (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23588562
Is serving in the armed forces associated with tobacco or cannabis initiation? A study of onset sequences before and after joining the French armed forces (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23685331
Effects of Schedule I drug laws on neuroscience research and treatment innovation (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23756634
Cannabis use in a Swiss male prison: Qualitative study exploring detainees’ and staffs’ perspectives (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23773686
Life Cycle Assessment of Hemp Cultivation and Use of Hemp-Based Thermal Insulator Materials in Buildings (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23745970
Effect of reclassification of cannabis on hospital admissions for cannabis psychosis: A time series analysis (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23867051
Secondary Metabolites from Eupenicillium parvum and Their in Vitro Binding Affinity for Human Opioid and Cannabinoid Receptors (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24288291
Nematicidal activities of Cannabis sativa L. and Zanthoxylum alatum Roxb. against Meloidogyne incognita (abst–2013) http://www.sciencedirect.com/science/article/pii/S0926669012003494
Legalizing a market for cannabis for pleasure: Colorado, Washington, Uruguay and beyond (abst–2013) http://onlinelibrary.wiley.com/doi/10.1111/add.12355/abstract
Use of Silk Road, the online drug marketplace, in the UK, Australia and the USA (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24372954
LCMS Spectral Evidence of the Occurrence of Cannabinoid in Cannabis sativa Cell Cultures (abst–2013) https://www.thieme-connect.com/ejournals/abstract/10.1055/s-0033-1352335
The Future of Marijuana in the United States (thesis–2013) http://law.uoregon.edu/org/olr/volumes/91/2/documents/Duke.pdf
An Examination of Opinions Toward Marijuana Policies Among High School Seniors in the United States (full–2014) http://www.tandfonline.com/doi/full/10.1080/02791072.2014.962716#tabModule
Rheumatologists lack confidence in their knowledge of cannabinoids pertaining to the management of rheumatic complaints (full–2014) http://www.biomedcentral.com/content/pdf/1471-2474-15-258.pdf
Identification and quantification of synthetic cannabinoids in ‘spice-like’ herbal mixtures: A snapshot of the German situation in the autumn of 2012 (full–2014) http://onlinelibrary.wiley.com/doi/10.1002/dta.1499/full
Words Can Be Deceiving: A Review of Variation Among Legally Effective Medical Marijuana Laws in the United States (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4314612/
Hashish revival in Morocco (full–2014) http://www.ijdp.org/article/S0955-3959%2814%2900003-6/fulltext
top
Genetic identification of Cannabis sativa using chloroplast trnL-F gene (full–2014) http://www.fsigenetics.com/article/S1872-4973%2814%2900219-1/fulltext
Couples’ Marijuana Use Is Inversely Related to Their Intimate Partner Violence Over the First 9 Years of Marriage (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4282761/
Medical Cannabis Laws and Opioid Analgesic Overdose Mortality in the United States, 1999-2010 (full–2014) http://archinte.jamanetwork.com/article.aspx?articleid=1898878
Cannabinoid modulation of drug reward and the implications of marijuana legalization (full–2014) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4442758/ Prevalence of Cannabis Lifetime Use in Iranian High School and College Students: A Systematic Review, Meta-Analyses, and Meta-Regression (full–2014) http://journals.sagepub.com/doi/full/10.1177/1557988314546667
“A Little Dab Will Do Ya”: An Emergency Department Case Series Related to a New Form of “High-Potency” Marijuana Known as “Wax” (article–2014) http://www.annemergmed.com/article/S0196-0644%2814%2901025-7/fulltext
Identification and quantification of synthetic cannabinoids in ‘spice-like’ herbal mixtures : A snapshot of the German situation in the autumn of 2012 (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/23723183
Early phytocannabinoid chemistry to endocannabinoids and beyond (full–2014) http://www.nature.com/nrn/journal/v15/n11/full/nrn3811.html
Hashish as cash in a post-Soviet Kyrgyz village (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24594222
Behaviours of psychotropic substances in indoor and outdoor environments of Rome, Italy (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24705952
Therapeutic Satisfaction and Subjective Effects of Different Strains of Pharmaceutical Grade Cannabis (abst–2014)  http://www.ncbi.nlm.nih.gov/pubmed/24747979
Boosting accumulation of neutral lipids in Rhodosporidium kratochvilovae HIMPA1 grown on hemp (Cannabis sativa Linn) seed aqueous extract as feedstock for biodiesel production (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24746767
Ethanol production from industrial hemp: Effect of combined dilute acid/steam pre-treatment and economic aspects (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24821202
Just say ‘know’: how do cannabinoid concentrations influence users’ estimates of cannabis potency and the amount they roll in joints? (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24894801
Post-Soviet Central Asia: A summary of the drug situation (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24954816
Fifty years of ‘cannabinoid research’ and the need for a new nomenclature (abst–2014) http://onlinelibrary.wiley.com/doi/10.1002/9781118451281.ch8/summary
Interconnected carbon nanosheets derived from hemp for ultrafast supercapacitors with high energy (abst–2014) http://pubs.acs.org/doi/abs/10.1021/nn400731g
Effective Phytoextraction of Cadmium (Cd) with Increasing Concentration of Total Phenolics and Free Proline in Cannabis sativa (L) Plant Under Various Treatments of Fertilizers, Plant Growth Regulators and Sodium Salt (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25174425
Attitudes of cannabis growers to regulation of cannabis cultivation under a non-prohibition cannabis model (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25181993
Mooreamide A: A Cannabinomimetic Lipid from the Marine Cyanobacterium Moorea bouillonii (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25204580
Prevalence of Cannabis Lifetime Use in Iranian High School and College Students: A Systematic Review, Meta-Analyses, and Meta-Regression (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25147097
top
Production, perceptions, and punishment: Restrictive deterrence in the context of cannabis cultivation (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25223245
Urinary prevalence, metabolite detection rates, temporal patterns and evaluation of suitable LC-MS/MS targets to document synthetic cannabinoid intake in US military urine specimens (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25263309
Cannabinoid modulation of drug reward and the implications of marijuana legalization (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25463025
Omega-3 fatty acid production from enzyme saccharified hemp hydrolysate using a novel marine thraustochytrid strain (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25497057
Frequent electronic media communication with friends is associated with higher adolescent substance use (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25471077
Are cannabis laws used for political repression in the Arab Spring countries? (full–2015) http://onlinelibrary.wiley.com/doi/10.1111/add.13065/full
Using Web searches to track interest in synthetic cannabinoids (aka ‘herbal incense’) (full–2015) http://onlinelibrary.wiley.com/doi/10.1111/dar.12189/full
The globalisation of cannabis cultivation: A growing challenge (full–2015) http://www.ijdp.org/article/S0955-3959%2815%2900003-1/fulltext
Comparative risk assessment of alcohol, tobacco, cannabis and other illicit drugs using the margin of exposure approach (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4311234/
Cannabis in medicine: a national educational needs assessment among Canadian physicians (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4374299/
Global patterns of domestic cannabis cultivation: Sample characteristics and patterns of growing across eleven countries (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25582281
Global patterns of domestic cannabis cultivation: Sample characteristics and patterns of growing across eleven countries (full–2015) http://www.ijdp.org/article/S0955-3959%2814%2900363-6/fulltext
High prevalence of cannabis use among Aka foragers of the Congo Basin and its possible relationship to helminthiasis (full–2015) http://onlinelibrary.wiley.com/doi/10.1002/ajhb.22740/full
Levels of selected metals in leaves of Cannabis sativa L. cultivated in Ethiopia (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4503701/
Human rights, public health and medicinal cannabis use (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4662098/
Public opinion and medical cannabis policies: examining the role of underlying beliefs and national medical cannabis policies (full–2015) http://harmreductionjournal.biomedcentral.com/articles/10.1186/s12954-015-0082-x
Cannabis Mobile Apps: A Content Analysis (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4705020/
U.S. Policy Responses to Calls for the Medical Use of Cannabis (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4553645/
Enrichment and identification of Δ(9)-Tetrahydrocannabinolic acid synthase from Pichia pastoris culture supernatants (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4560726/
Are cannabis laws used for political repression in the Arab Spring countries? (full–2015) http://onlinelibrary.wiley.com/doi/10.1111/add.13065/full
Predicting Alcohol, Cigarette, and Marijuana Use From Preferential Music Consumption (full–2015) http://journals.sagepub.com/doi/full/10.1177/0047237915607283
Risk of emergency medical treatment following consumption of cannabis or synthetic cannabinoids in a large global sample (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25759401
Risk of emergency medical treatment following consumption of cannabis or synthetic cannabinoids in a large global sample (full–2015) http://journals.sagepub.com/doi/full/10.1177/0269881115574493
Marijuana gears up for production high in US labs (article–2015) http://www.nature.com/news/marijuana-gears-up-for-production-high-in-us-labs-1.17129
top
Marijuana Research with Human Subjects (article–2015) http://www.fda.gov/newsevents/publichealthfocus/ucm421173.htm
Detection of physiological activities of G protein-coupled receptor-acting pharmaceuticals in wastewater (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25556879
Assessing the harms of cannabis cultivation in Belgium (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25599596
“Should I Buy or Should I Grow?” How drug policy institutions and drug market transaction costs shape the decision to self-supply with cannabis in the Netherlands and the Czech Republic (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25655217
Is cannabis an illicit drug or a medicine? A quantitative framing analysis of Israeli newspaper coverage (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25661483
Stability of cosmetic emulsion containing different amount of hemp oil (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25704610
From substance use to homelessness or vice versa? (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25989002
UNGASS 2016: Insights from Europe on the development of global cannabis policy and the need for reform of the global drug policy regime (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26795703
Production of Δ9-tetrahydrocannabinolic acid from cannabigerolic acid by whole cells of Pichia (Komagataella) pastoris expressing Δ9-tetrahydrocannabinolic acid synthase from Cannabis sativa L. (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25994576
Δ9-Tetrahydrocannabinolicacid synthase production in Pichia pastoris enables chemical synthesis of cannabinoids (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26197418
Are the last grade medical students aware of the danger of synthetic cannabinoids? (abst–2015) http://www.jflmjournal.org/article/S1752-928X%2815%2900220-6/abstract
Phytoaccumulation of Heavy Metals in Natural Vegetation at the Municipal Wastewater Site in Abbottabad, Pakistan (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26366840
Status Report: Marijuana Legalization in Colorado After One Year of Retail Sales and Two Years of Decriminalization (full–2015) http://www.drugpolicy.org/sites/default/files/Colorado_Marijuana_Legalization_One_Year_Status_Report.pdf
Longitudinal Effects of School Drug Policies on Student Marijuana Use in Washington State and Victoria, Australia (abst–2015) http://ajph.aphapublications.org/doi/10.2105/AJPH.2014.302421
Merck Manual – Marijuana (Cannabis) Professional version (full–2016) http://www.merckmanuals.com/professional/special-subjects/recreational-drugs-and-intoxicants/marijuanacannabis
Merck Manual – Marijuana (Cannabis) Consumer version (full–2016) http://www.merckmanuals.com/home/special-subjects/recreational-drugs-and-intoxicants/marijuana
δ-Ctenitoxin-Pn1a, a Peptide from Phoneutria nigriventer Spider Venom, Shows Antinociceptive Effect Involving Opioid and Cannabinoid Systems, in Rats (full–2016) http://www.mdpi.com/2072-6651/8/4/106/htm
Evaluating the Effects of Gamma-Irradiation for Decontamination of Medicinal Cannabis (full–2016) http://journal.frontiersin.org/article/10.3389/fphar.2016.00108/full
High Time for Conservation: Adding the Environment to the Debate on Marijuana Liberalization (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4776720/ Indirect Modulation of the Endocannabinoid System by Specific Fractions of Nutmeg Total Extract (full–2016)  http://www.beyondthc.com/wp-content/uploads/2016/06/El-Alfy2016_nutmeg-endocannabinoid-system-FAAH-inhibitor.pdf
Beyond Cannabis: Plants and the Endocannabinoid System (full–2016) http://ge.tt/3Rgtrsa2
The US as an example of how not to legalize marijuana? (full–2016) http://onlinelibrary.wiley.com/doi/10.1111/add.13498/full
Highlights of the 2011 Drug Abuse Warning Network (DAWN) Findings on Drug Related Emergency Department Visits (full–2016) http://www.ncbi.nlm.nih.gov/books/NBK384680/
A spider derived peptide, PnPP-19, induces central antinociception mediated by opioid and cannabinoid systems (full–2016) https://jvat.biomedcentral.com/articles/10.1186/s40409-016-0091-6
Cannabis Legalization: Focusing on Patient Needs: Five Recommendations on Access, Affordability, and Research (report–2016) http://cfamm.ca/patient-recommendations/
Analysis of a commerical marijuana e-cigarette formulation (abst–2016) (This article has a delayed release and will be available in PMC on June 1, 2017) https://www.ncbi.nlm.nih.gov/pubmed/27059691
The Effect of Medical Marijuana on Sickness Absence (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27416978
Acute Neurologic Disorder from an Inhibitor of Fatty Acid Amide Hydrolase (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27806235
The effect of cannabis on regular cannabis consumers’ ability to ride a bicycle (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26739323
A Genetic Component to National Differences in Happiness (abst–2016) http://link.springer.com/article/10.1007/s10902-015-9712-y
Brain reactivity to alcohol and cannabis marketing during sobriety and intoxication (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26769333
Systematic review of the toxicological and radiological features of body packing (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26932867
Tightening the Dutch coffee shop policy: Evaluation of the private club and the residence criterion (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26944718
Age of Sexual Debut and Cannabis Use in the United States (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26881806
Cannabis policy and the uptake of treatment for cannabis-related problems (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27004985
Estimating the production, consumption and export of cannabis: The Dutch case (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27048853
Marijuana-Related Posts on Instagram (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27262456
Bayesian inference for the distribution of grams of marijuana in a joint (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27346327
Phytotoxic Effect of Fiber Hemp Essential Oil on Germination of Some Weeds and Crops (abst–2016) http://www.tandfonline.com/doi/abs/10.1080/0972060X.2015.1137236? journalCode=teop20
Potential therapeutic targets and the role of technology in developing novel cannabinoid drugs from cyanobacteria (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27416557
Determining Cannabis Use Status From a Photograph: An Assessment of the “Jay-dar” in Neuropsychologists (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27779445
top


MITOCHONDRIA
Cannabinoid receptor stimulation impairs mitochondrial biogenesis in mouse white adipose tissue, muscle, and liver: the role of eNOS, p38 MAPK, and AMPK pathways (full–2010) http://diabetes.diabetesjournals.org/content/59/11/2826.full.pdf+html
Protective effects of the synthetic cannabinoids CP55,940 and JWH-015 on rat brain mitochondria upon paraquat exposure (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20514518
The Cannabinoid WIN 55212-2 Mitigates Apoptosis and Mitochondrial Dysfunction After Hypoxia Ischemia (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21909954
Review article: Endocannabinoids in neuroendopsychology: multiphasic control of mitochondrial function (full–2012) http://rstb.royalsocietypublishing.org/content/367/1607/3342.full?sid=dd42995f-c629-4f8c-86a0-5e962e352fda
Mitochondrial CB(1) receptors regulate neuronal energy metabolism (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22388959
The JNK inhibitor D-JNKI-1 blocks apoptotic JNK signaling in brain mitochondria (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22206897
The endocannabinoid 2-arachidonoylglicerol decreases calcium induced cytochrome c release from liver mitochondria (abst–2012) http://www.springerlink.com/content/54jm40088728t0pn/
Direct modulation of the outer mitochondrial membrane channel, voltage-dependent anion channel 1 (VDAC1) by cannabidiol: a novel mechanism for cannabinoid-induced cell death (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3877544/
Acute and chronic administration of cannabidiol increases mitochondrial complex and creatine kinase activity in the rat brain (full–2013) http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-44462013000400380&lng=en&nrm=iso&tlng=en
Antibodies to cannabinoid type 1 receptor co-react with stomatin-like protein 2 in mouse brain mitochondria (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3902808/
Δ9-Tetrahydrocannabinol is protective through PPARγ dependent mitochondrial bio-genesis in a cell culture model of Parkinson’s Disease (abst-2013) http://jnnp.bmj.com/content/84/11/e2.58.abstract
Mitochondrial JNK phosphorylation as a novel therapeutic target to inhibit neuro-inflammation and apoptosis after neonatal ischemic brain damage (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23376684
Cannabidiol Normalizes Capase 3, Synatophsin, and Mitochondrial Fission Protein DNM1L Expression Levels in Rats with Brain Iron Overload: Implications for Neuro-protection (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23893294
Cannabinoid CB2 receptor (CB2R) stimulation delays rubrospinal mitochondrialdependent degeneration and improves functional recovery after spinal cord hemisection by ERK1/2 inactivation (full–2014) http://www.nature.com/cddis/journal/v5/n9/full/cddis2014364a.html
Involvement of cannabinoid receptor-1 activation in mitochondrial depolarizing effect of lipopolysaccharide in human spermatozoa (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24692267
Mitochondria: A Possible Nexus for the Regulation of Energy Homeostasis by the Endocannabinoid System? (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24801388
top
The Potential Therapeutic Effects of THC on Alzheimer’s Disease (abst–2014) http://iospress.metapress.com/content/8421pvx80144t354/?p=ff122a13e6cf4bf78324e26d253bd883&pi=8
Cannabinoid-induced changes in respiration of brain mitochondria (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25195527
Cannabinoid receptor agonists reduce the short-term mitochondrial dysfunction and oxidative stress linked to excitotoxicity in the rat brain (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25446347
The endocannabinoid anandamide induces apoptosis in cytotrophoblast cells: Involvement of both mitochondrial and death receptor pathways (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25465706
Cannabinoid CB2 receptor (CB2R) stimulation delays rubrospinal mitochondrialdependent degeneration and improves functional recovery after spinal cord hemisection by ERK1/2 inactivation (full–2014) http://www.nature.com/cddis/journal/v5/n9/full/cddis2014364a.html
The endocannabinoid anandamide induces apoptosis in cytotrophoblast cells: Involvement of both mitochondrial and death receptor pathways (full–2014) http://www.placentajournal.org/article/S0143-4004%2814%2900823-6/fulltext
Involvement of cannabinoid receptor-1 activation in mitochondrial depolarizing effect of lipopolysaccharide in human spermatozoa (full–2014) http://onlinelibrary.wiley.com/doi/10.1111/j.2047-2927.2014.00210.x/full
Mitochondria: A Possible Nexus for the Regulation of Energy Homeostasis by the Endocannabinoid System? (full–2014) http://ajpendo.physiology.org/content/ajpendo/307/1/E1.full.pdf
Cannabidiol Normalizes Capase 3, Synatophsin, and Mitochondrial Fission Protein DNM1L Expression Levels in Rats with Brain Iron Overload: Implications for Neuro-protection (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/23893294
The Potential Therapeutic Effects of THC on Alzheimer’s Disease (abst–2014) http://iospress.metapress.com/content/8421pvx80144t354/?p=ff122a13e6cf4bf78324e26d253bd883&pi=8
Cannabinoid-induced changes in respiration of brain mitochondria (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25195527
Cannabinoid receptor agonists reduce the short-term mitochondrial dysfunction and oxidative stress linked to excitotoxicity in the rat brain (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25446347
Cannabinoid Type 1 (CB1) Receptors on Sim1-Expressing Neurons Regulate Energy Expenditure in Male Mice (abst–2014) http://press.endocrine.org/doi/10.1210/en.2014-1437#sthash.9q1rpqPq.dpuf
Blockade of monoacylglycerol lipase inhibits oligodendrocyte excitotoxicity and prevents demyelination in vivo (full–2015) http://onlinelibrary.wiley.com/doi/10.1002/glia.22742/full
Motor, Visual and Emotional Deficits in Mice after Closed-Head Mild Traumatic Brain Injury Are Alleviated by the Novel CB2 Inverse Agonist SMM-189 (full–2015) http://www.mdpi.com/1422-0067/16/1/758/htm
top
Cannabidiol protects against doxorubicin-induced cardiomyopathy by modulating mitochondrial function and biogenesis (full–2015) http://static.smallworldlabs.com/molmedcommunity/content/pdfstore/14_261_Hao.pdf
Hypothalamic POMC neurons promote cannabinoid-induced feeding (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4496586/
Non-Selective Cannabinoid Receptor Antagonists, Hinokiresinols Reduce Infiltration of Microglia/Macrophages into Ischemic Brain Lesions in Rat via Modulating 2-Arachidonolyglycerol-Induced Migration and Mitochondrial Activity (full–2015) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0141600
Pharmacological Blockade of Cannabinoid CB1 Receptors in Diet-Induced Obesity Regulates Mitochondrial Dihydrolipoamide Dehydrogenase in Muscle (full–2015) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0145244
Mitochondrial CB1 receptor is involved in ACEA-induced protective effects on neurons and mitochondrial functions (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26215450
Mitochondrial CB1 receptor is involved in ACEA-induced protective effects on neurons and mitochondrial functions (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4516969/
Dissecting the cannabinergic control of behavior: The where matters (abst–2015) http://onlinelibrary.wiley.com/doi/10.1002/bies.201500046/abstract;jsessionid=222EC084D6C5E7ECF95BFF9D2752CFE4.f01t01
Cannabinoid-Induced Changes in the Activity of Electron Transport Chain Complexes of Brain Mitochondria (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25820672
Major urinary protein 1 interacts with cannabinoid receptor type 1 in fatty acid-induced hepatic insulin resistance in a mouse hepatocyte model (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25843798
6B.09: EFFECT OF CANNABINOID RECEPTOR ACTIVATION ON ABERRANT ITOCHONDRIAL BIO-ENERGETICS IN HYPERTROPHIED CARDIAC MYOCYTES (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26102932
The effect of WIN 55,212-2 suggests a cannabinoid-sensitive component in the early toxicity induced by organic acids accumulating in glutaric acidemia type I and in related disorders of propionate metabolism in rat brain synaptosomes (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26431622
Controlled downregulation of the cannabinoid CB1 receptor provides a promising approach for the treatment of obesity and obesity-derived type 2 diabetes (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26498013
Alteration of SLP2-like Immunolabeling in Mitochondria Signifies Early Cellular Damage in Developing and Adult Mouse Brain (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26547131
top
THC exerts neuroprotective effect in glutamate affected murine primary mesencephalic cultures and neuroblastoma N18TG2 cells (abst–2015) https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0035-1565754
Controlled downregulation of the cannabinoid CB1 receptor provides a promising approach for the treatment of obesity and obesity-derived type 2 diabetes (abst–2016) http://link.springer.com/article/10.1007/s12192-015-0653-5
Alteration of SLP2‐like immunolabeling in mitochondria signifies early cellular damage in developing and adult mouse brain (abst–2016) http://www.ingentaconnect.com/search/article;jsessionid=6lgm6ugmbhtmb.alice?option1=tka&value1=cannabinoid&sortDescending=true&sortField=prism_publicationDate&pageSize=20&index=11
Cannabinoid receptor type 1 mediates high-fat diet-induced insulin resistance by increasing forkhead box O1 activity in a mouse model of obesity (abst–2016) http://www.spandidos-publications.com/10.3892/ijmm.2016.2475
METABOLOMIC-DRIVEN ELUCIDATION OF SERUM DISTURBANCES ASSOCIATED WITH ALZHEIMER´S DISEASE AND MILD COGNITIVE IMPAIRMENT (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26825096


MORNING SICKNESS
Cannabinoid hyperemesis syndrome: an underreported entity causing nausea and vomiting of pregnancy (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21170540
Medical Marijuana: Can Pot Help Pregnant Women With Vomiting and Nausea? (article–2011) http://patients4medicalmarijuana.wordpress.com/2011/01/13/pregnancy-and-medical-marijuana-can-pothelp-pregnant-women-with-vomiting-and-nausea/
Plasma Anandamide and Related N-acylethanolamide Levels are not Elevated in Pregnancies Complicated by Hyperemesis Gravidarum (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24117326


MORTALITY RATES/DEATH
Does cannabis use increase the risk of death? Systematic review of epidemiological evidence on adverse effects of cannabis use (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20565525
An index of fatal toxicity for drugs of misuse (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20104506
A summary of the health harms of drugs – Section 5 Cannabis (full–2011) http://www.nta.nhs.uk/uploads/healthharmsfinal-v1.pdf
Annual Causes of Death in the United States (article–2011) http://drugwarfacts.org/cms/?q=node/30
High on Life? Medical Marijuana Laws and Suicide (full–2012) http://ftp.iza.org/dp6280.pdf
Alcohol and cannabis use and mortality in people with schizophrenia and related psychotic disorders (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3392453/
top
Cannabidiol exerts anti-convulsant effects in animal models of temporal lobe and partial seizures (full–2012) http://www.seizure-journal.com/article/S1059-1311%2812%2900057-X/fulltext
Cannabis misinterpretation and misadventure in a coroner’s court (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23155125
The Global Epidemiology and Contribution of Cannabis Use and Dependence to the Global Burden of Disease: Results from the GBD 2010 Study (full–2013) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0076635
The medical use of cannabis for reducing morbidity and mortality in patients with HIV/AIDS (full–2013) http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD005175.pub3/full
Expression of the cannabinoid type I receptor and prognosis following surgery in colorectal cancer (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3576207/
Evaluation of trends in marijuana toxicosis in dogs living in a state with legalized medical marijuana: 125 dogs (2005-2010) (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23216842
Evaluation of trends in marijuana toxicosis in dogs living in a state with legalized medical marijuana: 125 dogs (2005-2010) (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23216842
Diacylglycerol lipase regulates lifespan and oxidative stress response by inversely modulating TOR signaling in Drosophila and C. elegans (full–2014) http://www.ncbi.nlm.nih.gov/pubmed/?term=24889782
Medical Cannabis Laws and Opioid Analgesic Overdose Mortality in the United States, 1999-2010 (full–2014) http://archinte.jamanetwork.com/article.aspx?articleid=1898878
Plasma-Free Fatty Acids, Fatty Acid-Binding Protein 4, and Mortality in Older Adults (from the Cardiovascular Health Study) (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4162821/
The culpability of drivers killed in New Zealand road crashes and their use of alcohol and other drugs (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24636874
Effect of Marijuana Use on Outcomes in Traumatic Brain Injury (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25264643
Comparative risk assessment of alcohol, tobacco, cannabis and other illicit drugs using the margin of exposure approach (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25634572
Cannabinoids receptor type 2, CB2, expression correlates with human colon cancer progression and predicts patient survival (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4381706/
Notes from the Field: Death Following Ingestion of an Edible Marijuana Product – Colorado, March 2014 (full–2015) http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6428a6.htm
top
Cannabis conundrum: Evidence of harm?: Opposition to marijuana use is often rooted in arguments about the drug’s harm to children and adults, but the scientific evidence is seldom clear-cut (article–2015) http://onlinelibrary.wiley.com/doi/10.1002/cncy.21516/full
Point-of-care heart-type fatty acid binding protein versus high-sensitivity troponin T testing in emergency patients at high risk for acute coronary syndrome (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25666938
Case reports of synthetic cannabinoid XLR-11 associated fatalities (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25979131
Smoke Your Troubles Away: Exploring the Effects of Death Cognitions on Cannabis Craving and Consumption (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25950588
Maternal marijuana use and neonatal morbidity (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26026918
Do Medical Marijuana Laws Reduce Addictions and Deaths Related to Pain Killers? (abst–2015) http://www.nber.org/papers/w21345
Driving Under the Influence of Marijuana Versus Driving and Dying Under the Influence of Marijuana: A Comparison of Blood Concentrations of Δ9-Tetrahydrocannabinol, 11-Hydroxy-Δ9-Tetrahydrocannabinol, 11-Nor-9-Carboxy-Δ9-Tetrahydrocannabinol and Other Cannabinoids in Arrested Drivers Versus Deceased Drivers (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26378132
Evaluation of cannabinoid CB1 and CB2 receptors expression in mobile tongue
squamous cell carcinoma: associations with clinicopathological parameters and patients’ survival (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26459312
The effects of adolescent cannabinoid exposure on seizure susceptibility and lethality in adult male rats (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26711091
Association between marijuana use and adverse obstetrical and neonatal outcomes (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26401751
Synthetic cannabinoid drug use as a cause or contributory cause of death (abst–2016) http://www.sciencedirect.com/science/article/pii/S0379073816000049
Trends of novel psychoactive substances (NPSs) and their fatal cases (abst–2016) http://link.springer.com/article/10.1007/s11419-015-0286-5


MOTION SICKNESS
Motion Sickness, Stress and the Endocannabinoid System (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2873996/?toolmcentrez
Effects of parabolic flight and spaceflight on the endocannabinoid system in humans (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23023882
Dexamethasone alleviates motion sickness in rats in part by enhancing the endocannabinoid system (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24508383
top


MRSA/METHICILLIN-RESISTANT STAPHLOCOCCUS AUREUS
The Faces Of Medical Marijuana: An Interview With Sarah Lovering (interview–2010) http://the420times.com/2010/04/the-faces-of-medical-marijuana/
Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3165946/
Transcriptional Profiles of the Response of Methicillin-Resistant Staphylococcus aureus to Pentacyclic Triterpenoids (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3577688/
2-Arachidonoyl-glycerol- and arachidonic acid-stimulated neutrophils release antimicrobial effectors against E. coli, S. aureus, HSV-1, and RSV (full–2013) http://www.jleukbio.org/content/93/2/267.long
The herbal-derived honokiol and magnolol enhances immune response to infection with methicillin-sensitive Staphylococcus aureus (MSSA) and methicillin-resistant S. aureus (MRSA) (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25586586


MULTIPLE SCLEROSIS/MS
Standardized Cannabis in Multiple Sclerosis: A Case Report (full-2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2806860/?tool=pubmed
New approaches in the management of spasticity in multiple sclerosis patients: role of cannabinoids (full-2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2835560/?tool=pmcentrez
Cannabinoid-induced apoptosis in immune cells as a pathway to immunosuppression (full-2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3005548/?tool=pubmed
The Multiplicity of Action of Cannabinoids: Implications for Treating Neurodegeneration (full-2010) http://onlinelibrary.wiley.com/doi/10.1111/j.1755-5949.2010.00195.x/full
Meta-analysis of the efficacy and safety of Sativex (nabiximols), on spasticity in people with multiple sclerosis (link to download – 2010) http://journals.sagepub.com/doi/abs/10.1177/1352458510367462
Pharmacology and toxicology of Cannabis derivatives and endocannabinoid agonists (link to PDF–2010) http://www.eurekaselect.com/85221/article
Randomized controlled trial of Sativex to treat detrusor overactivity in multiple sclerosis (abst–2010) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=314
top
The endocannabinoid system in the inflammatory and neurodegenerative processes of multiple sclerosis and of amyotrophic lateral sclerosis (abst-2010) http://www.ncbi.nlm.nih.gov/pubmed/20353778
Anandamide inhibits Theiler’s virus induced VCAM-1 in brain endothelial cells and reduces leukocyte transmigration in a model of blood brain barrier by activation of CB1 receptors (full–2011) http://www.jneuroinflammation.com/content/pdf/1742-2094-8-102.pdf
Cannabidiol inhibits pathogenic T cells, decreases spinal microglial activation and ameliorates multiple sclerosis-like disease in C57BL/6 mice (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3165959/
Gadolinium-HU-308-incorporated micelles (full–2011) http://www.ncbi.nlm.nih.gov/books/NBK54067/pdf/CB2R-Gd-Micelles.pdf
Cannabinoid receptor signalling in neurodegenerative diseases: a potential role for membrane fluidity disturbance (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3165948/
Is lipid signaling through cannabinoid 2 receptors part of a protective system? (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3062638/
Identification of the synthetic cannabinoid R(+)WIN55,212-2 as a novel regulator of IFN regulatory factor 3 (IRF3) activation and IFN-{beta} expression: relevance to therapeutic effects in models of multiple sclerosis (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3060486/
Cannabinoids and B cells: emerging targets for treating progressive multiple sclerosis (full–2011) http://msj.sagepub.com/content/17/3/259.long
Emerging treatment options for spasticity in multiple sclerosis; clinical utility of cannabinoids (link to PDF–2011) http://www.dovepress.com/articles.php?article_id=7675
Role of cannabinoids in multiple sclerosis (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21323391
Role of Cannabinoids in Multiple Sclerosis (link to PDF-2011) http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.659.8269&rank=26
Acute and chronic cannabinoid extracts administration affects motor function in a CREAE model of multiple sclerosis (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21094240
The endocannabinoid anandamide downregulates IL-23 and IL-12 subunits in a viral model of multiple sclerosis: evidence for a cross-talk between IL-12p70/IL-23 axis and IL-10 in microglial cells (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21310228
Medical cannabis: the opportunity versus the temptation (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/22352284
Inhibitory Effect of Standardized Cannabis sativa Extract and Its Ingredient Cannabidiol on Rat and Human Bladder Contractility (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21310467
top
A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols* (Sativex(®), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis (abst–2011) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=322
Treating pain in multiple sclerosis (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21916786
THC and CBD oromucosal spray (Sativex®) in the management of spasticity associated with multiple sclerosis (abst-2011) http://www.unboundmedicine.com/medline/ebm/record/21456949/abstract/THC_and_CBD_oromucosal_spray__Sativex%C2%AE__in_the_management_of_spasticity_associated_with_multiple_sclerosis_
Endocannabinoid pathways and their role in multiple sclerosis-related muscular dysfunction (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21449854
FROM GHENNAB TO CANNABIS: HOPES TO FIND A CURE FOR MULTIPLE SCLEROSIS ARE FLOURISHING (abst–2011) http://en.journals.sid.ir/ViewPaper.aspx?ID=228000
The synthetic cannabinoid R(+)WIN55,212-2 augments interferon-β expression via peroxisome proliferator-activated receptor-α (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3408184/
Multiple Sclerosis and Extract of Cannabis: results of the MUSEC trial (full–2012) http://jnnp.bmj.com/content/83/11/1125.long
A placebo-controlled, parallel-group, randomized withdrawal study of subjects with symptoms of spasticity due to multiple sclerosis who are receiving long-term Sativex® (nabiximols) (full–2012) http://msj.sagepub.com/content/18/2/219.long
Evaluation of the Effects of Sativex (THC BDS: CBD BDS) on Inhibition of Spasticity in a Chronic Relapsing Experimental Allergic Autoimmune Encephalomyelitis: A Model of Multiple Sclerosis (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3423911/pdf/ISRN.NEUROLOGY2012-802649.pdf
Symptomatic therapy in multiple sclerosis: the role of cannabinoids in treating spasticity (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3437528/
Smoked cannabis for spasticity in multiple sclerosis: a randomized, placebo-controlled trial (full–2012) http://www.cmaj.ca/content/184/10/1143.long
The Therapeutic Potential of Cannabis and Cannabinoids (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3442177/
Cannabinoid modulation of neuroinflammatory disorders (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3386505/
Cannabidiol in humans-the quest for therapeutic targets (full–2012) http://www.ncbi.nlm.nih.gov/pubmed/24281562
Medical Marijuana: Clearing Away the Smoke (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3358713/
Multimodal stepped care approach with acupuncture and PPAR-α agonist
palmitoylethanolamide in the treatment of a patient with multiple sclerosis and central neuropathic pain (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22301508
Neuroprotective agents: cannabinoids (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/21420365
Multimodal stepped care approach with acupuncture and PPAR-α agonist
palmitoylethanolamide in the treatment of a patient with multiple sclerosis and central neuropathic pain (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22301508
Neuroprotective agents: cannabinoids (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/21420365
Cannabinoids ameliorate disease progression in a model of multiple sclerosis in mice, acting preferentially through CB(1) receptor-mediated anti-inflammatory effects (abst-2012) http://www.ncbi.nlm.nih.gov/pubmed/22342378
top
Cannabinoid receptor 2 agonists inhibit migration of activated dendritic cells via modulation of MMP-9 (abst–2012) http://www.jimmunol.org/content/188/1_Supplement/173.23.abstract?sid=919f9469-cb24-4dbd-9884-1985caa8604a
A questionnaire survey of patients and carers of patients prescribed Sativex as an unlicensed medicine (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22784399
Potential Control of Multiple Sclerosis by Cannabis and the Endocannabinoid System (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22583441
Evaluation of the safety and tolerability profile of Sativex: is it reassuring enough? (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22509986
Clinical efficacy and effectiveness of Sativex, a combined cannabinoid medicine, in multiple sclerosis-related spasticity (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22509985
Nabiximols in the treatment of spasticity, pain and urinary symptoms due to multiple sclerosis (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22954177
A Cannabigerol Quinone Alleviates Neuroinflammation in a Chronic Model of Multiple Sclerosis (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22971837
Treatment of spasticity in multiple sclerosis: new perspectives regarding the use of cannabinoids (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23011861
Cost Effectiveness of Oromucosal Cannabis-Based Medicine (Sativex®) for Spasticity in Multiple Sclerosis (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23072659
CD200-CD200R1 interaction contributes to neuroprotective effects of anandamide on experimentally induced inflammation (abst–2012) http://onlinelibrary.wiley.com/doi/10.1002/glia.22366/abstract
What place for cannabis extract in MS? (abst–2012) http://dtb.bmj.com/content/50/12/141.abstract
A double-blind, randomized, placebo-controlled, parallel-group study of THC/CBD oromucosal spray in combination with the existing treatment regimen, in the relief of central neuropathic pain in patients with multiple sclerosis (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23180178
The biology that underpins the therapeutic potential of cannabis-based medicines for the control of spasticity in multiple sclerosis (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/25876933
Treatment failure of intrathecal baclofen and supra-additive effect of nabiximols in multiple sclerosis-related spasticity: a case report (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3625014/
top
Genetic Background Can Result in a Marked or Minimal Effect of Gene Knockout (GPR55 and CB2 Receptor) in Experimental Autoimmune Encephalomyelitis Models of Multiple Sclerosis (full–2013) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0076907
Effects on Immune Cells of a New 1,8-Naphthyridin-2-One Derivative and Its Analogues as Selective CB2 Agonists: Implications in Multiple Sclerosis (full–2013) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0062511
Association between a Genetic Variant of Type-1 Cannabinoid Receptor and Inflammatory Neurodegeneration in Multiple Sclerosis (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3877004/
Multiple sclerosis and the blood-central nervous system barrier (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3562587/
Association of Expanded Disability Status Scale and Cytokines after Intervention with Co-supplemented Hemp Seed, Evening Primrose Oils and Hot-natured Diet in Multiple Sclerosis Patients (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3648912/
A review of the cultivation and processing of cannabis (Cannabis sativa L.) for production of prescription medicines in the UK (full–2013) http://onlinelibrary.wiley.com/doi/10.1002/dta.1531/full
Cannabidiol provides long-lasting protection against the deleterious effects of inflammation in a viral model of multiple sclerosis: A role for A2A receptors (full–2013) http://www.sciencedirect.com/science/article/pii/S0969996113001939
Clinical experiences with cannabinoids in spasticity management in multiple sclerosis (full–2013) http://zl.elsevier.es/en/revista/neurologia-495/articulo/clinical-experiences-with-cannabinoids-in-90328787
Association between a genetic variant of type-1 cannabinoid receptor and inflammatory neurodegeneration in multiple sclerosis (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3877004/
Control of spasticity in a multiple sclerosis model using central nervous system-excluded CB1 cannabinoid receptor agonists (full–2013) http://www.fasebj.org/content/28/1/117.long
Cannabinoids: Do they have the potential to treat the symptoms of multiple sclerosis? (full–2013) http://www.wjgnet.com/2218-6212/full/v3/i4/87.htm
Control of experimental spasticity by targeting the degradation of endocannabinoids using selective fatty acid amide hydrolase inhibitors. (full – 2013) http://journals.sagepub.com/doi/full/10.1177/1352458513485982
Effect of dronabinol on progression in progressive multiple sclerosis (CUPID): a randomised, placebo-controlled trial (link to PDF–2013) http://www.thelancet.com/journals/laneur/article/PIIS1474-4422%2813%2970159-5/abstract
Medicinal Cannabis and Painful Sensory Neuropathy (editorial–2013) http://journalofethics.ama-assn.org/2013/05/oped1-1305.html
Therapeutic potential of cannabinoid medicines (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24006213
Endocannabinoid system modulator use in everyday clinical practice in the UK and Spain (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23369054
Sativex long-term use: an open-label trial in patients with spasticity due to multiple sclerosis (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/22878432
Pharmacokinetic evaluation of nabiximols for the treatment of multiple sclerosis pain (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23621668
Therapeutic Potential of Cannabinoids in Neurodegenerative Disorders: A Selective Review (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23829360
Interplay of cannabinoid 2 (CB2) receptors with nitric oxide synthases, oxidative and nitrative stress, and cell death during remote neurodegeneration (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/22371074
A review of the cultivation and processing of cannabis (Cannabis sativa L.) for production of prescription medicines in the UK (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24115748
Cannabinoids Decrease the Th17 Inflammatory Autoimmune Phenotype (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23892791
Nasal administration of drugs as a new non-invasive strategy for efficient treatment of multiple sclerosis (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23517929
Advances in the management of multiple sclerosis spasticity: experiences from recent studies and everyday clinical practice (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24289844
top
Systematic review: Efficacy and safety of medical marijuana in selected neurologic disorders: Report of the Guideline Development Subcommittee of the American Academy of Neurology (full-2014) http://www.neurology.org/content/82/17/1556.long
Who Benefits Most from THC:CBD Spray? Learning from Clinical Experience (full–2014) http://www.karger.com/Article/FullText/357743
THC:CBD Spray and MS Spasticity Symptoms: Data from Latest Studies (full–2014) http://www.karger.com/Article/FullText/357742
Summary of evidence-based guideline: Complementary and alternative medicine in multiple sclerosis (full–2014) http://www.neurology.org/content/82/12/1083.full
Docosahexaenoyl ethanolamide improves glucose uptake and alters endocannabinoid system gene expression in proliferating and differentiating C2C12 myoblasts (full–2014) http://journal.frontiersin.org/Journal/10.3389/fphys.2014.00100/full
The endocannabinoid system: a putative role in neurodegenerative diseases (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4070159/
Current and future drugs for treatment of MS-associated bladder dysfunction (full–2014) http://www.sciencedirect.com/science/article/pii/S187706571401728X
CB1 receptor affects cortical plasticity and response to physiotherapy in multiple sclerosis (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4268035/
Medical marijuana for cancer (full–2014) http://onlinelibrary.wiley.com/doi/10.3322/caac.21260/full
Regulation of cannabinoid receptor gene expression and endocannabinoid levels in lymphocyte subsets by IFN-β: a longitudinal study in multiple sclerosis patients (full–2014) http://onlinelibrary.wiley.com/doi/10.1111/cei.12443/full
top
Complementary and alternative medical therapies in multiple sclerosis-the american academy of neurology guidelines: a commentary (full–2014)
http://www.clinicaltherapeutics.com/article/S0149-2918%2814%2900684-5/fulltext
Advances in the management of multiple sclerosis spasticity: multiple sclerosis spasticity nervous pathways (full–2014) http://www.karger.com/Article/Pdf/367615
Endocannabinoid signalling and the deteriorating brain (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4471876/
Cannabis use by individuals with multiple sclerosis: effects on specific immune parameters (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4170074/
Report On Medical Cannabis Research, What the Science Says (article–2014) http://www.safeaccessnow.org/medical_cannabis_research_what_does_the_evidence_say
Clinical experience with THC:CBD oromucosal spray in patients with multiple sclerosis-related spasticity (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24392812
Nabiximols (THC/CBD Oromucosal Spray, Sativex®) in Clinical Practice – Results of a Multicenter, Non-Interventional Study (MOVE 2) in Patients with Multiple Sclerosis Spasticity (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24525548
Delta-9-Tetrahydrocannabinol/Cannabidiol (Sativex®): A Review of Its Use in Patients with Moderate to Severe Spasticity Due to Multiple Sclerosis (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24671907
Therapeutic Satisfaction and Subjective Effects of Different Strains of Pharmaceutical Grade Cannabis (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24747979
Long-Term Effectiveness and Safety of Nabiximols (Tetrahydrocannabinol/Cannabidiol Oromucosal Spray) in Clinical Practice (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24943098
Genome-wide microarray analysis identifies a potential role for striatal retrograde endocannabinoid signaling in the pathogenesis of experimental l-DOPA-induced dyskinesia (abst–2014) http://onlinelibrary.wiley.com/doi/10.1002/syn.21740/abstract
Delta-9-tetrahydrocannabinol + cannabidiol. A reasonable option for some patients with multiple sclerosis (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25121144
A Reversible and Selective Inhibitor of Monoacylglycerol Lipase Ameliorates Multiple Sclerosis (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25298214
Evaluation of the tolerability and efficacy of Sativex in multiple sclerosis (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25331416
top
There is evidence for the use of cannabinoids for symptomatic treatment of multiple sclerosis (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25350886
“Disease Modifying Nutricals” for multiple sclerosis (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25435020
Activity of liver enzymes in multiple sclerosis patients with Hot-nature diet and cosupplemented hemp seed, evening primrose oils intervention (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25453518
Sativex in the Management of Multiple Sclerosis-Related Spasticity: Role of the Corticospinal Modulation (full–2015) http://www.hindawi.com/journals/np/2015/656582/
Blockade of monoacylglycerol lipase inhibits oligodendrocyte excitotoxicity and prevents demyelination in vivo (full–2015) http://onlinelibrary.wiley.com/doi/10.1002/glia.22742/full
Nabilone as an Adjunctive to Gabapentin for Multiple Sclerosis-Induced Neuropathic Pain: A Randomized Controlled Trial (full–2015) http://onlinelibrary.wiley.com/doi/10.1111/pme.12569/full
Sativex in the Management of Multiple Sclerosis-Related Spasticity: Role of the Cortico-spinal Modulation (full–2015) http://www.hindawi.com/journals/np/2015/656582/
Effects of pro-inflammatory cytokines on cannabinoid CB1 and CB2 receptors in immune cells (full–2015) http://onlinelibrary.wiley.com/doi/10.1111/apha.12474/full
Cannabidiol, a non-psychoactive cannabinoid, leads to EGR2-dependent energy in activated encephalitogenic T cells (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4363052/
PROGRESS REPORT Compassionate Use of Medical Cannabis Pilot Program Act July 1, 2014 through June 30, 2015 (full–2015) http://dph.illinois.gov/sites/default/files/publications/publicationohpmmedical-cannabis-annual-report-2015.pdf
A new formulation of cannabidiol in cream shows therapeutic effects in a mouse model of experimental autoimmune encephalomyelitis (full–2015) http://darujps.biomedcentral.com/articles/10.1186/s40199-015-0131-8
Narrative review of the safety and efficacy of marijuana for the treatment of commonly state-approved medical and psychiatric disorders (full–2015) http://ascpjournal.biomedcentral.com/articles/10.1186/s13722-015-0032-7
Activation of Cannabinoid CB2 receptors Reduces Hyperalgesia in an Experimental Autoimmune Encephalomyelitis Mouse Model of Multiple Sclerosis (full–2015) http://onlinelibrary.wiley.com/doi/10.1111/cns.12349/full
HU-446 and HU-465, derivatives of the non-psychoactive cannabinoid cannabidiol, decrease the activation of encephalitogenic T cells (full–2015) http://onlinelibrary.wiley.com/doi/10.1111/cbdd.12637/full
The therapeutic potential of cannabinoids for movement disorders (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25649017
Cannabinoids and Tremor Induced by Motor-related Disorders: Friend or Foe? (full–2015) http://link.springer.com/article/10.1007%2Fs13311-015-0367-5
Medical Marijuana: Is the Cart Before the Horse? (full–2015) http://jama.jamanetwork.com/article.aspx?articleid=2338230
A sativex-like combination of phytocannabinoids as a disease-modifying therapy in a viral model of multiple sclerosis (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25857324
Clinical perspectives on medical marijuana (cannabis) for neurologic disorders (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26336632
Clinical Use of Cannabinoids for Symptom Control in Multiple Sclerosis (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26289248
Purified Cannabidiol, the main non-psychotropic component of Cannabis sativa, alone, counteracts neuronal apoptosis in experimental multiple sclerosis (link to PDF–2015) http://www.europeanreview.org/article/10049
The entourage effect: Synergistic actions of plant cannabinoids (letter – 2015) https://www.researchgate.net/publication/268878607_Medical_marijuana_in_neurology
Drug-resistant MS spasticity treatment with Sativex® add-on and driving ability (full–2015) http://onlinelibrary.wiley.com/doi/10.1111/ane.12287/full
top
Cannabinoid Signaling and Neuroinflammatory Diseases: A Melting pot for the Regulation of Brain Immune Responses (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25601726
Interaction between the protective effects of cannabidiol and palmitoylethanolamide in experimental model of multiple sclerosis in C57BL/6 mice (abst–2015) http://www.sciencedirect.com/science/article/pii/S0306452215000858
The role of cannabinoids and leptin in neurological diseases (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25880465
New quinolone- and 1,8-naphthyridine-3-carboxamides as selective CB2 receptor agonists with anticancer and immuno-modulatory activity (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25935384
Effect of Sativex on spasticity-associated symptoms in patients with multiple sclerosis (abst–2015) http://informahealthcare.com/doi/abs/10.1586/14737175.2015.1067607
Endocannabinoids in Multiple Sclerosis and Amyotrophic Lateral Sclerosis (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26408162
Use of Cannabinoids for Spasticity and Pain Management in MS (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26705757
Effectiveness and Tolerability of THC/CBD Oromucosal Spray for Multiple Sclerosis Spasticity in Italy: First Data from a Large Observational Study (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26571097
Sativex(®) and clinical-neurophysiological measures of spasticity in progressive multiple sclerosis (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26289497
Efficacy and safety of nabiximols (Sativex®) on multiple sclerosis spasticity in a real-life Italian monocentric study (abst–2015) http://link.springer.com/article/10.1007/s10072-015-2392-x
Alteration of delta-6-desaturase (FADS2), secretory phospholipase-A2 (sPLA2) enzymes by Hot-nature diet with co-supplemented hemp seed, evening primrose oils intervention in multiple sclerosis patients (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26365444
Neuroprotection in Experimental Autoimmune Encephalomyelitis and Progressive Multiple Sclerosis by Cannabis-Based Cannabinoids (abst–2015) http://link.springer.com/article/10.1007%2Fs11481-014-9575-8
Evidence for the efficacy and effectiveness of THC-CBD oromucosal spray in symptom management of patients with spasticity due to multiple sclerosis (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4710104/
Systematic Review of Pharmacological Properties of the Oligodendrocyte Lineage (full–2016) http://journal.frontiersin.org/article/10.3389/fncel.2016.00027/full
THC:CBD Observational Study Data: Evolution of Resistant MS Spasticity and Associated Symptoms (full–2016) http://www.karger.com/Article/FullText/444235
THC:CBD in Daily Practice: Available Data from UK, Germany and Spain (full–2016) http://www.karger.com/Article/FullText/444234
Oral Palmitoylethanolamide Treatment Is Associated with Reduced Cutaneous Adverse Effects of Interferon-β1a and Circulating Proinflammatory Cytokines in Relapsing Remitting Multiple Sclerosis (full–2016) http://link.springer.com/article/10.1007/s13311-016-0420-z/fulltext.html
Modulation of cellular redox homeostasis by the endocannabinoid system (full–2016) http://rsob.royalsocietypublishing.org/content/6/4/150276
Pathways and gene networks mediating the regulatory effects of cannabidiol, a nonpsychoactive cannabinoid, in autoimmune T cells (full–2016) http://jneuroinflammation.biomedcentral.com/articles/10.1186/s12974-016-0603-x
Efficacy and safety of cannabinoid oromucosal spray for multiple sclerosis spasticity (full–2016) http://jnnp.bmj.com/content/early/2016/05/08/jnnp-2015-312591.long
Interaction between interleukin-1β and type-1 cannabinoid receptor is involved in anxiety-like behavior in experimental autoimmune encephalomyelitis (full–2016) http://jneuroinflammation.biomedcentral.com/articles/10.1186/s12974-016-0682-8
The impact of drugs for multiple sclerosis on sleep (full–2016) http://journals.sagepub.com/doi/full/10.1177/1352458516664034
Target regulation of PI3K/Akt/mTOR pathway by cannabidiol in treatment of experimental multiple sclerosis (full–2016) http://www.sciencedirect.com/science/article/pii/S0367326X16304476
The use of medical-grade cannabis in patients non-responders to Nabiximols (1st page–2016) http://www.jns-journal.com/article/S0022-510X(16)30472-5/abstract
Cannabis and Cannabinoids (1st page–2016) http://jamanetwork.com/journals/jama/article-abstract/2592497
A cost-effectiveness model for the use of a cannabis-derived oromucosal spray for the treatment of spasticity in multiple sclerosis (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26750641
The emerging role of the cannabinoid receptor family in peripheral and neuro-immune interactions (abst–2016) http://www.eurekaselect.com/138448/article
Evaluating Sativex® in Neuropathic Pain Management: A Clinical and Neurophysiological Assessment in Multiple Sclerosis (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26764336
Medical use of cannabis products : Lessons to be learned from Israel and Canada (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26767992
Cannabinoids and autoimmune diseases: A systematic review (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26876387
Development and Pharmacological Characterization of Selective Blockers of 2- Arachidonoyl Glycerol Degradation with Efficacy in Rodent Models of Multiple Sclerosis and Pain (abst–2016) http://pubs.acs.org/doi/abs/10.1021/acs.jmedchem.5b01812
Cannabinoids: Medical implications (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26912385
The effect of cannabinoids on the stretch reflex in multiple sclerosis spasticity (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27003093
Toll-like receptor signalling as a cannabinoid target in Multiple Sclerosis (abst–2016) http://www.sciencedirect.com/science/article/pii/S0028390816301459
MEDICAL CANNABIS (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27215115
Chromenopyrazole, a Versatile Cannabinoid Scaffold with in Vivo Activity in a Model of Multiple Sclerosis (abst–2016) http://pubs.acs.org/doi/abs/10.1021/acs.jmedchem.6b00397
Influence of Previous Failed Antispasticity Therapy on the Efficacy and Tolerability of THC:CBD Oromucosal Spray for Multiple Sclerosis Spasticity (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27160412
Refractory trigeminal neuralgia responsive to nabiximols in a patient with multiple sclerosis (abst–2016) http://www.msard-journal.com/article/S2211-0348(16)30056-6/abstract
Role of nurses in the managements of symptoms associated with spasticity in patients with multiple sclerosis (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27492746
Modulation of monocytes by bioactive lipid anandamide in multiple sclerosis involves distinct Toll-like receptors (abst–2016) http://www.sciencedirect.com/science/article/pii/S1043661816309021
Cortical and spinal excitability in patients with multiple sclerosis and spasticity after oromucosal cannabinoid spray (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27772772
Potential Future Pharmacological Treatment of Bladder Dysfunction (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/26990140
Medical Cannabis – another piece in the mosaic of autoimmunity? (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27859024
Muscle elastography: a new imaging technique for multiple sclerosis spasticity measurement (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27904961
Attitudes to cannabis and patterns of use among Canadians with multiple sclerosis (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27919478
Potent immunomodulatory activity of a highly selective cannabinoid CB2 agonist on immune cells from healthy subjects and patients with multiple sclerosis (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/28041663
Cannabinoid Receptors in the Central Nervous System: Their Signaling and Roles in Disease (full–2017) http://journal.frontiersin.org/article/10.3389/fncel.2016.00294/full
Cannabinoids for treating neurogenic lower urinary tract dysfunction in patients with multiple sclerosis: a systematic review and meta-analysis (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28058780
Cannabinoids and Tremor Induced by Motor-related Disorders: Friend or Foe? (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26152606
There is evidence for the use of cannabinoids for symptomatic treatment of multiple sclerosis (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26535431
top


MULTIPLE SYSTEM ATROPHY
Loss of cannabinoid CB1 receptor expression in the 6-hydroxydopamine-induced nigrostriatal terminal lesion model of Parkinson’s disease in the rat (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3659808/


MUSCLES/MUSCLE RELAXANT
Cannabis Overdose (case report–undated) http://cannabisclinicians.org/view-all-case-reports/entry/96/?pagenum=3
Cannabinoid receptor stimulation impairs mitochondrial biogenesis in mouse white adipose tissue, muscle, and liver: the role of eNOS, p38 MAPK, and AMPK pathways (full–2010) http://diabetes.diabetesjournals.org/content/59/11/2826.full.pdf+html
The endocannabinoid signaling system: a marriage of PUFA and musculoskeletal health (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20934863
The cannabinoid receptor type 2 is time-dependently expressed during skeletal muscle wound healing in rats (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20535492
High levels of N-palmitoylethanolamide and N-stearoylethanolamide in microdialysate samples from myalgic trapezius muscle in women (full–2011) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0027257
Expression of the cannabinoid system in muscle: effects of a high fat diet and CB1 receptor blockade (full–2011) http://www.biochemj.org/content/433/1/175
Endocannabinoid pathways and their role in multiple sclerosis-related muscular dysfunction (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21449854
Peripheral effects of the endocannabinoid system in energy homeostasis: adipose tissue, liver and skeletal muscle (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21336842
Cannabinoid Receptor Antagonist-Induced Striated Muscle Toxicity and Ethylmalonic-Adipic Aciduria in Beagle Dogs (full–2012) http://toxsci.oxfordjournals.org/content/129/2/268.full
Hind limb suspension and long-chain omega-3 PUFA increase mRNA endocannabinoid system levels in skeletal muscle (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22051448
top
Cannabinoids and muscular pain. Effectiveness of the local administration in rat (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22354705
The role of the endocannabinoid system in skeletal muscle and metabolic adaptations to exercise: potential implications for the treatment of obesity (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22943701
Effect of omega-3 polyunsaturated fatty acids on the endocannabinoid system in osteoblast-like cells and muscle (abst–2012) http://docs.lib.purdue.edu/dissertations/AAI3444794/
Endogenous cannabinoid receptor CB1 activation promotes vascular smooth muscle cell proliferation and neointima formation (full–2013) http://www.jlr.org/content/early/2013/03/11/jlr.M035147.long
GPR55, a G-Protein Coupled Receptor for Lysophosphatidylinositol, Plays a Role in Motor Coordination (full–2013) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0060314
Palmitoylethanolamide and stearoylethanolamide levels in the interstitium of the trapezius muscle of women with chronic widespread pain and chronic neck-shoulder pain correlate with pain intensity and sensitivity (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23707281
Psychosis and Severe Rhabdomyolysis Associated with Synthetic Cannabinoid Use (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23518784
Motor effects of the non-psychotropic phytocannabinoid cannabidiol that are mediated by 5-HT1A receptors (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23924692
The effects of cannabidiol on the antigen-induced contraction of airways smooth muscle in the guinea-pig (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23428645
Magnolol inhibits colonic motility through down-regulation of voltage-sensitive L-type Ca(2+) channels of colonic smooth muscle cells in rats (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23972358
Magnolol inhibits migration of vascular smooth muscle cells via cytoskeletal remodeling pathway to attenuate neointima formation (abst–2013)
http://www.ncbi.nlm.nih.gov/pubmed/23906924
Signaling cross-talk between cannabinoid and muscarinic systems actives Rho-kinase and increases the contractile responses of the bovine ciliary muscle (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23396229
The endocannabinoid 2-AG controls skeletal muscle cell differentiation via CB1 receptor-dependent inhibition of Kv7 channels (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24927567
The endocannabinoid 2-AG controls skeletal muscle cell differentiation via CB1 receptor-dependent inhibition of Kv7 channels (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4066524/
Increased angiotensin II contraction of the uterine artery at early gestation in a transgenic model of hypertensive pregnancy is reduced by inhibition of endocannabinoid hydrolysis (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24935942
Increased angiotensin II contraction of the uterine artery at early gestation in a transgenic model of hypertensive pregnancy is reduced by inhibition of endocannabinoid hydrolysis (full–2014) http://hyper.ahajournals.org/content/64/3/619.long
top
Molecular Basis for the Improvement in Muscle Metaboreflex and Mechanoreflex Control in Exercise-Trained Humans with Chronic Heart Failure (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25305179
Molecular Basis for the Improvement in Muscle Metaboreflex and Mechanoreflex Control in Exercise-Trained Humans with Chronic Heart Failure (full–2014) http://ajpheart.physiology.org/content/307/11/H1655
Effects of cannabinoids on tension induced by acetylcholine and choline in slow skeletal muscle fibers of the frog (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24218022
Clinical endocannabinoid deficiency (CECD) revisited: can this concept explain the therapeutic benefits of cannabis in migraine, fibromyalgia, irritable bowel syndrome and other treatment-resistant conditions? (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24977967
Presence and Colocalization of Type-1 Cannabinoid Receptors with Acetylcholine Receptors in the Motor End-Plate of Twitch Skeletal Muscle Fibers in the Frog (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25161032
Severe rhabdomyolysis and intracranial hemorrhage associated with synthetic cannabinoid: a case report (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25179201
Capsaicin and N-Arachidonoyl-dopamine (NADA) Decrease Tension by Activating Both Cannabinoid and Vanilloid Receptors in Fast Skeletal Muscle Fibers of the Frog (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25228331
The endocannabinoid anandamide regulates the peristaltic reflex by reducing neuro neuronal and neuro-muscular neurotransmission in ascending myenteric reflex pathways in rats (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24911079
Involvement of central and peripheral cannabinoid receptors on antinociceptive effect of tetrahydrocannabinol in muscle pain (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25446925
Effects of Two Different Specific Neck Exercise Interventions on Palmitoylethanolamide and Stearoylethanolamide Concentrations in the Interstitium of the Trapezius Muscle in
Comparative biochemical characterization of the monoacylglycerol lipase inhibitor KML29 in brain, spinal cord, liver, spleen, fat and muscle tissue (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25497453
Effects of Two Different Specific Neck Exercise Interventions on Palmitoylethanolamide and Stearoylethanolamide Concentrations in the Interstitium of the Trapezius Muscle in
Comparative biochemical characterization of the monoacylglycerol lipase inhibitor KML29 in brain, spinal cord, liver, spleen, fat and muscle tissue (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25497453
CB2R orchestrates fibrogenesis through regulation of inflammatory response during the repair of skeletal muscle contusion (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4466920/
Pharmacological Blockade of Cannabinoid CB1 Receptors in Diet-Induced Obesity Regulates Mitochondrial Dihydrolipoamide Dehydrogenase in Muscle (full–2015) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0145244
top
Dietary DHA reduced downstream endocannabinoid and inflammatory gene expression, epididymal fat mass, and improved aspects of glucose use in muscle in C57BL/6J mice (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/26219414
Dietary DHA reduced downstream endocannabinoid and inflammatory gene expression, epididymal fat mass, and improved aspects of glucose use in muscle in C57BL/6J mice (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4722239/
Beneficial effects of cannabinoid receptor type 2 (CB2R) in injured skeletal muscle post-contusion (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25588471
Beneficial effects of cannabinoid receptor type 2 (CB2R) in injured skeletal muscle postcontusion (full–2015) http://www.hh.um.es/pdf/Vol_30/30_6/Yu-30-737-749-2015.pdf
Direct activation of the proposed anti-diabetic receptor, GPR119 in cardiomyoblasts decreases markers of muscle metabolic activity (abst–2015) http://www.sciencedirect.com/science/article/pii/S0303720715000106
Cannabinoid Receptor 1 and Acute Resistance Exercise – In vivo and In vitro Studies in Human Skeletal Muscle (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25796352
The monoacylglycerol lipase inhibitor JZL184 decreases inflammatory response in skeletal muscle contusion in rats (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25912803
Cannabinoids for the Treatment of Chronic Non-Cancer Pain: An Updated Systematic Review of Randomized Controlled Trials (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25796592
Cannabinoids for the Treatment of Chronic Non-Cancer Pain: An Updated Systematic Review of Randomized Controlled Trials (full–2015) http://tinyurl.com/zgg4vmz
Deletion of G-protein coupled receptor 55 promotes obesity by reducing physical activity (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26447738
β-caryophyllene-complexed in β-cyclodextrin Produces Antihyperalgesic Activity in Animal Model for Fibromyalgia (abst–2015) http://www.fasebj.org/content/29/1_Supplement/616.4.abstract?sid=edf921ac-0690-4aa6-ac81-0546314dd384
CB1 receptor blockade counters age-induced insulin resistance and metabolic dysfunction (full–2016) http://onlinelibrary.wiley.com/doi/10.1111/acel.12438/full
Docosahexaenoic acid-supplementation prior to fasting prevents muscle atrophy in mice (full–2016) http://onlinelibrary.wiley.com/doi/10.1002/jcsm.12103/full
Acetylcholine receptors from human muscle as pharmacological targets for ALS therapy (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4801305/
Effects of chronic exercise on the endocannabinoid system in Wistar rats with high-fat diet-induced obesity (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26880264
β-caryophyllene, a dietary cannabinoid, complexed with β-cyclodextrin produced antihyperalgesic effect involving the inhibition of Fos expression in superficial dorsal horn (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26883973
Circulating levels of endocannabinoids and oxylipins altered by dietary lipids in older women are likely associated with previously identified gene targets (abst–2016) http://www.sciencedirect.com/science/article/pii/S1388198116302013
Muscle elastography: a new imaging technique for multiple sclerosis spasticity measurement (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27904961


MUSCULAR DYSTROPHY/MD
Aberrant Location of Inhibitory Synaptic Marker Proteins in the Hippocampus of Dystrophin-Deficient Mice: Implications for Cognitive Impairment in Duchenne Muscular Dystrophy (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25260053
top